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1. Introduction 
1.1.  Chirality 
 
Chirality is an important and interesting phenomenon in nature. Most of the chiral molecules 
such as amino acid derivatives or sugars are present in high enantiomeric excess. The origin 
of homochirality in biomolecules and thus the origin of life is still unknown, despite many 
theories which are debated in the scientific community.1 
Enantiomers, which are defined as mirror image from each other and not superimpose, exhibit 
the same physical and chemical properties, except the capability to polarize the light to the 
right (+) for the dextrorotatory isomer and to the left (−) for the levorotatory isomer. Louis 
Pasteur was the first who separated enantiomers. He succeeded in the separation of both 
enantiomers of tartaric acid by careful look at the shape of the crystals. He observed that each 
solution of the separated enantiomers deviated the light either to the right or to the left, 
whereas a solution of both crystals did not polarized the light. Pasteur proposed as explanation 
two different structures of tartaric acid and thus opened the field of stereochemistry.2  
The physical and chemical properties of enantiomers become different in the presence of 
other chiral molecules by formation of diatereoisomers. This is nicely exampled when a drug 
interacts with its receptor site. Huge differences can be observed in the drug activity of 
enantiomers. In the best cases, one of the enantiomer shows less activity or even no activity 
than the other one, as for example propanalol 1 which exhibits β-blocker activities. The (+)-R-
1 isomer is 100 times less reactive than its isomer (−)-S-1 (Figure 1).3 Another pertinent 
example is illustrated by limonene 2. The (+)-R-2 isomer has an orange smell whereas the (−)-
S-2 isomer has a lemon smell.  
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Figure 1: Harmless differences in the biological properties of enantiomers. 
 
The differences in drug activity between enantiomers can be much more impactfull (Figure 2). 
While the (+)-S-ketamine 3 is an active anesthetic and analgesic, the (−)-R-ketamine 3 is 
responsible for undesirable side-effects like hallucinations. The famous case of Thalidomide 4 
is also a tragic example of the physiological properties of enantiomers. Thalidomide 4 was 
prescribed to pregnant woman as an antiemetic to combat morning sickness. The (+)-R-4 form 
was responsible for these effects, whereas the (−)-S-4 enantiomer causes fetal deformities.4 
Unfortunately, even if the (+)-R-4 isomer would be used in optically pure form, it epimerizes 
in vivo. This drug is still used in the treatment of tuberculosis, leprosy and some cancers. 
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Figure 2: Harmfull differences in the biological properties of enantiomers. 
 
Nevertheless, even in the early 1990s, about 90% of synthetic chiral drugs were still racemic, 
reflecting the difficulty in the practical synthesis of single-enantiomeric compound and the 
cost of this operation.5 In 1992, the Food and Drug Administration in USA introduced a 
guideline regarding “racemic switches”, in order to encourage the commercialization of 
clinical drugs consisting of single enantiomers.6 Therefore, the synthesis of optically pure 
enantiomers is a challenge.  
The ultimate source of chirality in all asymmetric synthesis is nature. The chiral compounds 
which occur in nature provide enormous range and diversity of possible starting materials, 
such as amino acids, hydroxy acids, alkaloids, terpenes and carbohydrates. The synthesis of 
chiraly pure compounds can be performed by: 
• substrate control methods, i.e. starting from a chiraly pure starting material.7  
• reagent control methods, which involve the use of equimolar amount of chiral 
reagents. 8 
• using a chiral auxiliary, which is utilized in equimolar amount and additional steps for 
attaching and removing the auxiliary are required.9  
• resolution method, which involve the synthesis of a racemate and the use of at least 
0.5 equivalent of chiraly pure reagent.10  
• Kinetic resolution.11  
• chiral catalysts, which required a catalytic amount of organic or organometallic 
catalysts.12  
(+)-S-3 
anesthetic 
(−)-R-3 
hallucinogene 
(+)-R-4 
sedative 
(−)-S-4 
teratogen 
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Also the synthesis of optically pure compounds can be carried out using the above methods, 
the use of chiral catalysts is advantageous because of the costs of the required chiral 
information and thus, asymmetric catalysis represents a very attractive method, not only in 
term of costs but also in term of atom economy. 
  
1.2. Asymmetric Catalysis 
1.2.1. Historical 
 
In 1971, Kagan et al. introduced the C2 symmetric diphosphine DIOP 5 prepared from 
enantiomerically pure tartric acid (Scheme 1).13 For the first time, high enantiomeric excess 
were obtained in Rh-catalyzed hydrogenation of dehydroamino acids at room temperature and 
atmospheric pressure leading to amino acids. For example phenylalanine was obtained in 95% 
yield with 72% ee. As cited by Knowles, “It is most appropriate that this invention using 
tartric acid should have come from a Frenchman in the land of Louis Pasteur, who, of course, 
was the one who got it all started”. 14  Afterwards, Knowles came out with his own C2 
symmetric diphosphine DIPAMP 6, where the chirality resides at the phosphorus atoms 
(Scheme 1). 15  Hydrogenation of Z-enamides using rhodium-DIPAMP complexes led to 
excellent enantioselectivities. In particular the synthesis of non natural amino acids like L-
DOPA, used for the treatment of Parkinson disease, was prepared in an industrial scale by 
Mosanto using a Rh-catalyzed asymmetric hydrogenation of Z-enamide as a key step.16  
 
OO
PPh2Ph2P
P P
OMe
MeO
H
Ar NHCOCH3
CO2H rhodium catalyst H
Ar NHCOCH3
CO2H
H2
H+
Ar NH2
CO2H
 
 
 
Scheme 1: Rh-catalyzed hydrogenation of enamides using (R,R)-DIOP 5 and (R,R)-DIPAMP 6 leading to 
phenylalanine derivative and L-DOPA. 
R,R-DIOP-5 
Kagan 
 
R,R-DIPAMP-6 
Knowles 
 
R,R-5:  Ar = Ph: 72% ee  
 
R,R-6: Ar = Ph: 96% ee  
 m-OMe, p-OAc-Ph: 94% ee  
 
Ar = m-OMe, p-OAc-Ph: 
         L-Dopa 
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Two breakthroughs were made in 1980, making the year a pivotal date in the development of 
asymmetric catalysis. Sharpless and Katsuki described a very general method for epoxidation 
of allylic alcohols using titanium catalysts and chiral diethyl tartrate. 17  The asymmetric 
hydrogenation was boosted towards synthetic applications with the preparation of the C2 
symmetric diphosphine BINAP 7,18 which found spectacular applications in hydrogenation of 
unsaturated substrates like alkenes or ketones (Scheme 2).19 Ru-BINAP complex was used in 
hydrogenation for the synthesis of naproxene 8, and for the isomerization of enamines in a 
key step of the industrial scale synthesis of (–)-menthol 9 (Scheme 2).20 
 
NEt2 NEt2
96-99% ee OH
PPh2
PPh2
MeO
CO2H
MeO
CO2H
97% ee
 
 
 
Scheme 2: Selected applications of Ru-BINAP complexes. 
 
Later C2 symmetric bidentate N,N semicorrins ligands 10 were investigated by Pfaltz et al. 
and gave excellent results in Cu-catalyzed cyclopropanation of olefins and Co-catalyzed 
conjugated reduction of α,β-unsaturated carboxylic acid derivatives (Figure 3).21 Reported 
independently by different research groups in 1990-1991, the analogous C2 symmetric 
bidentate N,N bisoxazoline (BOX) ligands 11 were developed (Figure 3).22 They have been 
established as one of the most versatile ligand classes for asymmetric catalysis.23  
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Figure 3: C2 symmetric bidentate N,N ligands semicorrin 10 and BOX 11. 
 
One advantage of C2 symmetric ligands is that the number of possible isomeric metal 
complexes as well as the number of different substrate-catalyst arrangements and reaction 
pathways is reduced. Mechanistical investigations are therefore easier to perform due to the 
restricted reaction intermediates involved in the reaction. Although the concept of C2 
symmetry has been very successful, there is no fundamental reason why C2 symmetric ligands 
should exhibit higher enantiocontrol and reactivity than C1 symmetric ligands. The BOX 
ligands 11 were desymmetrized independently by three research groups, i.e. Pfaltz, Helmchen 
and Williams, by replacing one of the oxazoline moiety by a phosphino group, leading to 
phosphine oxazoline ligands 12 (PHOX) (Figure 4). 24  
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Figure 4: C2 symmetric N,N BOX ligand versus C1 symmetric P,N PHOX ligand. 
 
The distinctly different characteristics of a soft P-ligand with pi-acceptor properties and a hard 
N-ligand acting primarily as a σ-donor will affect the coordinated substrates in a different way 
than P,P or N,N bidentate ligands.25 The C1 symmetric ligand PHOX 12 was successfully 
used in asymmetric catalysis including Heck reactions, Cu-catalyzed 1,4-additions, Ir-
catalyzed hydrogenation of alkenes and imines, as well as Pd-catalyzed asymmetric allylic 
alkylation.24 
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1.2.2. Asymmetric Allylic Alkylation 
 
Asymmetric allylic alkylation belongs to the most intensively studied homogenous catalytic 
process. These reactions are highly versatile and have become part of the standard repertoire 
of the modern organic synthesis (Scheme 3).26,27  
 
X + Nu
[cat.]
Nu + X
 
 
Scheme 3: General representation of allylic substitution. 
 
Typical leaving groups X− are acetates, carbonates, or more reactive chlorides or sulfonates, 
and the use of appropriate nucleophiles leads to C−C, C−H, C−O, C−S or C−N bond 
formation. A variety of transition metal complexes derived from palladium, nickel, platinum, 
rhodium, iron, ruthenium, iridium, cupper, molybdenum and tungsten are known to catalyze 
allylic substitutions. But the most widely used catalysts are palladium complexes and their 
structure and mode of action are well understood.27 Since the first example of an 
enantioselective metal-catalyzed allylic alkylation has been reported by Trost et al. in 1977,28 
strong efforts were done in order to understand the chemical pathway and thus to design 
efficient catalysts to perform allylic alkylations with a high enantiocontrol on various types of 
substrates.  
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Scheme 4: Simplified catalytic cycle of palladium catalyzed allylic alkylation. 
 
As depicted above (Scheme 4), the catalytic active species is a Pd (0) complex having 2 “type 
L” ligands in its coordination sphere. 29  This complex can coordinate the olefin 13 and 
undergoes an oxidative addition leading to the cationic (η3-allyl)palladium(II) complex 14. 
The electrophilic Pd(II) centre activates the allyl system for nucleophilic attack at the allyl 
termini. Attack at the centre atom is rarely observed. 30  The addition of the nucleophile 
generates Pd(0)-olefin complex 15 which can release product 16 to undergo a second 
oxidative addition with the substrate. Thus, if the intermediate allyl complex does not undergo 
any isomerization that changes its configuration, the overall process proceeds with retention 
of configuration, i.e. the oxidative addition as well as the nucleophilic addition take place with 
inversion of configuration. This is true for so called nucleophile “soft” nucleophiles (typically 
its conjugated acid having pKa < 25). In contrary, “hard” nucleophiles (typically its 
conjugated acid having pKa > 25) would not directly attack the allyl ligand but first 
coordinate to the metal and then be transferred to the allyl ligand intramolecularly. This will 
lead to a retention of configuration during the nucleophilic addition. 
 
13 
14 
15 
16 
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In order to obtain high conversion together with high enantioselectivity starting from a 
racemic substrate, the palladium-allyl complex must isomerize. Two different pathways are 
admitted. The first one is a Pd(0)-catalyzed allyl exchange. As shown below (Scheme 5), the 
electrophilic allyl system bound to Pd(II) can react with a Pd(0) complex. 
 
R1 R2
Pd
LBLA
R1 R2
Pd
LBLA
[Pd0LALB]
 
Scheme 5: Pd(0)-catalyzed allyl exchange. 
 
Addition of the Pd(0) complex to the free face of the allyl ligand displaces the Pd(II) complex 
on the backside. Therefore, this process results in an inversion of configuration at all the three 
allyl carbon atoms.27 Due to the low concentration of Pd(0) compare to these of the product 
and substrate, this isomerization process is rather slow. Isomerization pathways involving the 
palladium(II)-allyl complex depicted in Scheme 6 are much more faster. The pi-σ-pi 
isomerization can result in syn-anti interconversion by rotation around the σ-(C-C) bond in 
the η1-intermediate. In general, the thermodynamic equilibrium is shifted in favour of the syn-
isomer and only if a substituent is sufficiently small (R2 = H/D, alkyl) the anti-isomer is 
present in notable amount. However, certain ligands which exert strong steric hindrance in the 
coordination plane of the syn-isomer can shift this equilibrium to the other side.31 
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Scheme 6: pi-σ-pi isomerization pathways of pi-allyl palladium complexes. 
 
The second isomerization process is denoted as apparent allyl rotation. The two termini R1 
and R2 of the allyl system switch position with respect to the other two coordination sites, and 
at the same time, the central allyl C-atom moves from one side of coordination plane to the 
other. If the two ligands LA and LB are different or chiral as, e.g., in complexes with 
unsymmetrical bidentate ligands, this isomerization leads to a diastereomeric complex even if 
the allyl system has structurally identical termini. However, if LA and LB are identical as, e.g., 
in symmetrical C2-symmetrical chiral bidentate ligands, allyl rotation generates two identical 
structures and, therefore, has no consequences. 
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In contrary to the C2 symmetric ligands DIOP 5, DIPAMP 6, BOX 11 or Trost 17, phosphine 
oxazolines ligands (PHOX) 12 break this symmetry and have two different coordinating 
atoms: a “hard” nitrogen atom which is σ-donor, and a “soft” phosphorus atom which is σ-
donor but also pi-acceptor (Figure 5). 
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Figure 5: C2-symmetric DIOP, DIPAMP, BOX and Trost ligands versus C1-symmetric PHOX ligand. 
 
σ-donor ligands provide electron density to the metal centre, stabilizing metals with high 
degree oxidation state. Π-acceptor ligands have the ability to accept electron density from the 
metal d orbitals into either d orbitals or pi-antibonding orbitals, stabilizing metals with low 
degree oxidation state (back-bonding). The pi-allyl-palladium complexes bearing a bidentate 
P,N-ligand will exhibit two electronically non-equivalent allyl termini. This electronic 
differentiation of the allylic termini is clearly reflected in the Pd-C bond lengths in X-ray 
analysis of PHOX-palladium allyl complexes.32 The one trans to the pi-acceptor coordinating 
atom is less electron-rich due to the pi-back bonding to the phosphorus atom (trans 
influence29b),33 and thus this bond become weaker than the one trans to the σ-donor atom N. 
This is reflected by a longer P-C bond trans to the phosphorus atom compared to this trans to 
the nitrogen atom. 
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In the case of PHOX ligands, NMR studies and computational calculations showed that the 
more stable exo and the endo isomers are in rapid equilibrium. 34  However, the energy 
difference between these two complexes is not the origin of the enantioselectivity induced by 
these ligands because the nucleophilic attack is slow compared to the interconversion endo-
exo. The product distribution depends in fact on the energy between the four transition states 
leading to the complexes A, B, C and D (Scheme 7).  
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Scheme 7: Origin of the selectivity using PHOX ligand. 
 
The nucleophile will attack the pi-allyl system in trans to the phosphorus atom, excluding the 
pathways leading to the complexes A and B. Helmchen and Reggelin were able to identify the 
complex C at low temperature and characterized it by NMR spectroscopy. 35 The pathway 
leading to the complex D is disfavoured due to steric interaction between the coordinated 
olefin and the ligand backbone. 
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1.3. Sulfoximines 
1.3.1. Historical 
 
Sulfoximine chemistry36,37 started in the late 1940s by a series of papers about a toxic factor 
occurring in many proteins treated with “agene” (NCl3).38,39 The responsible substance was 
synthesized and isolated in 1949 by Bentley and Whitehead by reaction of methionine 
sulfoxide with HN3.39 They also observed the presence of 2 diastereoisomers and deduced that 
the new functional group should have a stereogenic centre. The new class of compound was 
called sulfoximines following the proposal of Sir Robinson40 and the toxic factor 18 named 
methionine sulfoximine (Figure 6). 
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H3C
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Figure 6: Methionine sulfoximine 18. 
 
Since 1965 the official IUPAC name is sulfoximide41 but this designation is rarely used. 
General structure of sulfoximine group is schematized as follows (Figure 7). 
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Figure 7: General representation of sulfoximine features. 
 
The sulfoximine group is usually drawn with two double bonds between the sulphur and the 2 
heteroatoms. According to ab initio calculations, a more appropriate representation of the 
electronic structure of the sulfoximine group is the polar structure drawn on the right (Figure 
7). 42  Due to its configurationally stable sulphur atom, sulfoximines found numerous 
18 
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applications in asymmetric synthesis as chiral auxiliary,36 as chiral ligands or in peptide 
mimetic.43  
 
1.3.2. Synthesis of Sulfoximines 
 
Sulfoximines can be synthesized either by imination of the corresponding sulfoxide Erreur ! 
Source du renvoi introuvable. or by oxidation of the corresponding sulfilimine 21 (Scheme 
8).36  
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Scheme 8: Possible ways for the synthesis of sulfoximine 22 starting with thioether 19. 
 
Oxidation of thioether 19 with H2O2 in CH3CO2H followed by imination of the corresponding 
racemic sulfoxide 20 with NaN3 and H2SO4 leads to racemic sulfoximine 22.44 The sequence 
order of the synthesis can be inverted and started by the imination of thioether 19 to the 
corresponding sulfilimine 21.45  Imination of the sulfoxid is also possible by using either 
bis(N-Tosyl) sulfurdiimide,46 N-sulfinyl-p-toluene sulfonamide46a or aryl sulfonamides in the 
presence of P2O5/NEt3,47  which produces sulfilimine 21. The oxidation of sulfilimine 21 
affords the corresponding sulfoximine 23, which should be deprotected to access the N-
unsubstituted sulfoximine 22. The oxidation of sulfilimine 21 to sulfoximine 23 can be 
achieved using a large range of oxidizing agents including KMnO4,45a MCPBA, 45b  
NaIO4/RuO245c  and alkaline H2O2, 45d and dimethyl dioxirane.48 
Since Brandt and Gais49 developed an efficient method for the resolution of racemic (±)-S-
methyl-S-phenylsulfoximine 24, both enantiomers are accessible in optically pure form on a 
19 
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molar scale through a separation with camphorsulfonic acid following the method of half-
quantities (Scheme 9)50. 
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Scheme 9: Resolution of (±)-S-methyl-S-phenylsulfoximine 24. 
 
Unfortunately, the resolution can not be applied for a wide range of sulfoximines. In order to 
access chiraly pure sulfoximines 22, asymmetric oxidation of prochiral sulfoxides 19 can be 
performed either by Kagan 51  or Bolm 52  procedures or by addition of an organometallic 
reagent to diastereomerically pure sulphur derivatives 25 (Scheme 10).53  
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Scheme 10: Synthesis of enantiomerically enriched sulfoximines. 
 
Imination of chiral sulfoxides 20 by the methods described above (except the procedure 
involving NaN3-H2SO4 which lead to partial racemisation) proceeds under retention of 
configuration and affors chiral sulfoximines 22.54 The imination of optically pure sulfoxides 
20 can also be performed using BocN3, 55  and the deprotection of the nitrogen atom of 
sulfoximines 23 can be carried out using either with CF3CO2H or a lewis acid (TiCl4 or AlCl3) 
together with PhOMe.56 Other reagents for the imination of optically pure sulfoxides 20 are 
rac-24 
(+)-24 
(−)-24 
(−)-24 
(+)-24 
19 
23 22 
(+) or (−)-20 25 
INTRODUCTION 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 17 
TsN3,57 PhI=NTs with and catalytic amount of Cu,58 Fe,55 Mn,59 or Ru.60 Alternatively, the 
imination is possible by using amide or sulfonamide catalyzed by Rh,61 Ag,62 Fe.63 The major 
disadvantage of these methods is the cleavage of the N-bond substituent of sulfoximines 23 to 
access N-unsubstituted sulfoximines 22. It is worth noting that Jonhson developed an efficient 
and direct method for the imination of chiral sulfoxides 20 to access enantiomerically pure 
“free” sulfoximines 22 using o-mesitylene sulfonyl hydroxylamine (MSH). 64  
 
1.3.3. Sulfoximines as Ligands 
 
Due to the chelating properties of the nitrogen of sulfoximines and its proximity to the chiral 
suphur atom, sulfoximines can be used as ligand in asymmetric catalysis. The first application 
of chiral sulfoximines as ligands in asymmetric transformations was reported in 1979 by 
Johnson and Stark. 65  Acetophenone was reduced in the presence of sulfoximine 26 and 
diborane to give the alcohol 27 in 69% yield and 82% ee (Scheme 11).  
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Scheme 11: First asymmetric transformation using chiral sulfoximine 26 as ligand.  
 
Fourteen years later, Bolm et al. used chiral β-hydroxy sulfoximines 28 in the catalytic 
reductions of ketones with BH3-SMe2 as hydride source to afford secondary alcohols with up 
to 95% ee (Figure 8).66 Afterwards, many ligands were designed for catalytic asymmetric 
transformations like Diels-Alder and hetero Diels-Alder reaction, hydrogenation, 1,4 
additions, Mukaiyama Aldol and vinylogous aldol reaction and allylic alkylations. (Figure 8). 
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Figure 8: Overview of ligands containing a sulfoximine moiety and their applications. 
 
The C1 symmetric N,N sulfoximine 36 was the first ligand used in Pd-catalyzed asymmetric 
allylic alkylation and the acetate 43 was converted to malonate 44 with ee up to 73% (Scheme 
12, Table 1, entry 1).  
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Scheme 12: Pd-catalyzed allylic alkylation of acetate 43 using sulfoximine ligands. 
 
Table 1: Sulfoximines used as ligand in Pd-catalyzed allylic alkylation of acetate 43. 
 
Entr
y ligand 
T 
(°C) base Pd precatalyst 
Catalyst 
loading 
(%) 
time 
Yield 
of 44 
(%) 
ee of 
44 
1 36 -5 BSA, KOAc [Pd(allyl)Cl]2 10 - 77 73 (S) 
2 35 0 BSA, KOAc [Pd(allyl)Cl]2 10 11 d 75 93 (S) 
3 41 66 BSA, KOAc Pd2(DBA)3 2.5 3.5 h 69 86 (R) 
4 29 20 BSA, KOAc Pd2(DBA)3. CHCl3 4 - 95 64 (-) 
5 30 20 BSA, KOAc [Pd(allyl)Cl]2 10 1 h 95 95 (R) 
6 31 20 BSA, NaOAc [Pd(allyl)Cl]2 5 48 h 72 93 (R) 
7 34 - BSA, NaOAc [Pd(allyl)Cl]2 - - 88 66 (R) 
-: information not available 
 
C2 symmetric N,N sulfoximines 35 and 41 proved to be also excellent ligand for this 
transformation (entry 2 and 3), as well as C1 symmetric P,N ligands 29, 30, 31 (entry 4, 5, 6 
respectively). Finally, the BINOL derived N-phosphino sulfoximines showed moderate ee of 
the malonate 44 in the Pd-catalyzed allylic alkylation of acetate 43 (entry 7).  
 
1.4. Phospha-Michael Addition 
1.4.1. Intoduction 
 
Except the well-known Michaelis-Arbuzov82 and Michaelis-Becker83 reactions (reaction of 
trialkyl phosphite with alkyl halides and of dialkyl phosphonate alkali salts with alkyl halides, 
respectively), the phospha-Michael addition is probably one of the most important and 
powerful tool for P−C bond formation.84 The phospha-Michael addition is a base catalyzed so 
called Pudovik reaction (or hydrophosphination). The Pudovik reaction is an addition of an 
organophosphorous compound having a labile P−H bond to an unsaturated substrate.85 This 
can be performed under acidic, basic or radical conditions. Furthermore, the phospha-Michael 
conditions 
see Table 1 
43 44 
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addition and, to a greater extend, the Pudovik reaction is an atom economy reaction since all 
the atoms are used for the formation of the product (Scheme 13). 
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Scheme 13: Hydrophosphination of substituted alkenes. 
 
Reviewed in 1979 by Pudovik, the reaction of phosphorus acid ester with various substituted 
alkenes in the presence of alkali metal alkoxides afforded air stable phosphonates (Scheme 
14).85 In fact, diarylphosphites exist in two tautomeric forms, the phosphate and the H-
phosphonate.  
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Scheme 14: Phospha-Michael addition of monosubstituted alkene. 
 
Not only phosphorus acid esters undergo Michael-addition, but phosphates, phosphonites, 
dialkyl phosphinites and their thio-analogues, alkyl phosphorothioites, phosphoramidates and 
monoalkyl phosphates react also with α,β-unsaturated esters. 
Phosphine (PH3), primary and secondary phosphines undergo Michael addition (Scheme 15) 
to produce primary, secondary and/or tertiary phosphines.86 These transformations are often 
catalyzed by an alkoxide. This is a valuable alternative to SN2 reaction to access phosphines, 
which are widely used as ligand for transition metal catalysis.87 Knochel et al. reported the 
reaction between secondary phosphines and activated alkenes in the presence of t-BuOK 
(Scheme 15).88 The addition proceeded in moderate to excellent yield to give phosphines, 
which could potentially be used as ligand.89 
 
X = lone pair, O, S 
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Scheme 15: Michael addition of phosphine (PH3), primary and secondary phosphines catalyzed by t-BuOK. 
 
Since phosphine ligands are widely used in asymmetric catalysis, asymmetric variants of the 
phospha-Michael addition have been studied. In 1990, Feringa et al. reported the 
stereoselective trans-addition of lithium diphenylphosphide to the chiral furanone 45 (Scheme 
16).90 Changing the methoxy group to menthyl, the one pot sequence involving the phospha-
Michael addition of lithium diphenylphosphide to furanone 45 and in situ quenching of the 
anion with diphenylphosphine chloride afforded diphosphine 46 as a single isomer. Three 
further steps were required to access the (S,S)-CHIRAPHOS in 35% overall yield after 
purification by crystallization via the Bosnich’s procedure involving nickel salts.91 Helmchen 
et al. reported in 1995 the highly diastereoselective addition of lithium diphenylphosphide to 
the myrtenate derivative 47 (Scheme 16). After hydrolysis of the ester and removal of the 
borane, this ligand showed excellent enantioselectivies and activities in palladium catalyzed 
allylic alkylation of cyclic substrates.  
 
R1 = Ph, SPh, SiPh3, 
        PPh2, 2-pyridine, 
       3-pyridine 
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Scheme 16: Selected examples of diastereoselective phospha-Michael additions. 
 
Apart from this work, the addition of various organophosphorous reagents towards N-vinyl 
sulfoximines92 was studied by Gais et al.93 (Scheme 17).  
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Scheme 17: Hydrophosphination of N-vinyl sulfoximines. 
 
Since the hydrophosphination reactions carried out in this work were base-catalyzed, the term 
phospha-Michael addition will be used to describe these reactions.  
 
1.4.2. Vinyl Sulfoximines as Michael Acceptor 
 
Due to the electron-withdrawing properties of the sulfoximine group, vinyl sulfoximines are 
prompt to undergo Michael additions with a variety of nucleophiles. Moreover, due to the 
chiral sulfur atom, the Michael additions can proceed in a diastereoselective way. One of the 
first successful asymmetric conjugated addition of carbon nucleophiles to a chiral vinyl 
sulfoximine was reported in 1986 by Pyne et al. (Scheme 18).94 The addition of organolithium 
(S,S)-CHIRAPHOS 45 46 
48 47 
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reagents or Gilman-cuprates (R2CuLi) occurred from the Si-face at the ß-position of the vinyl 
sulfoximine 49, whereas organocopper compounds (RCu) attacked the double bond from its 
Re-side. The diastereoselectivity of sulfoximine 50 was quite high (80 to 96% de) and 
explained by a complexation model involving the sulfoximine heteroatoms as well as the 
methoxy group of the auxiliary. 
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Scheme 18: Michael addition of carbon nucleophile with vinyl sulfoximines. 
 
Aza- and oxa-Michael additions95,96 were mainly investigated by Gais and Reggelin. Highly 
substituted enantiomerically pure pyrrolidines, tetrahydrofurans and oxabicyclic systems were 
synthesized97 using the highly stereoselective γ-hydroxy- and γ-amino-alkylation reactions97,98 
combined with a stereoselective intramolecular oxa- and aza-Michael addition, respectively 
(Scheme 19).  
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Scheme 19: Michael addition of vinyl sulfoximines with oxygen and nitrogen nucleophiles. 
 
49 50 
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Although a variety of nucleophiles were investigated, no phospha-Michael addition of vinyl 
sulfoximines was reported at the beginning of this project. 
 
1.5. Aim of the Project 
Despite the availability of several classes of P,N-ligands, there is still a quest for this new type 
of ligands.99 Among them, 1,5-P,N-ligands, which are prompt to form 6-membered chelate 
with a transition metal, proved to be very effective in various catalyzed asymmetric 
transformations (Figure 9).24  
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Figure 9: β-phosphino-sulfoximine and PHOX ligands. 
 
The strategy choosen to access the new class of P,N-phosphino-sulfoximines 51 is based on a 
phospha-Michael addition of the vinyl sulfoximines to introduce the phosphine functionality 
(Scheme 20).  
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Scheme 20: Retrosynthetic analysis for the synthesis of 1,5-P,N-phosphino-sulfoximines. 
 
51 12 
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The first part of this work described the synthesis of acyclic 1,5-P,N-phosphino-sulfoximines 
which were then tested in Pd-catalyzed allylic alkylation. The results obtained with the 
acyclic 1,5-P,N-phosphino-sulfoximines led in the second part to the modification of the 
ligand backbone and to the design of cyclic 1,5-P,N-phosphino-sulfoximines which were also 
evaluated in Pd-catalyzed asymmetric allylic alkylation. 
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2. Acyclic Phosphino-Sulfoximines  
2.1. Introduction 
 
Due to the pronounced acidity of the NH-proton of free sulfoximine 24 (pKa = 24.3), its 
substitution by electrophiles is straightforward. Silylation, alkylation, sulfonylation and 
carbamoylation can easily be achieved. 100  Also interesting N-vinylation and N-arylation 
reactions of the sulfoximine 24 were developed by Bolm et al.101 All these transformations 
allow the introduction of a broad range of substituents, which have a direct effect on the 
basicity and the nucleophilicity of the nitrogen, and on the acidity of the protons attached to 
the S-methyl group. For example, the pKa value of the N-methylsulfoximine 52 is 32, whereas, 
the pKa of N-tosylsulfoximine 54 is 23.102 
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Scheme 21: Functionalization of sulfoximine 24 at the nitrogen atom. 
 
In the present studies, the NH-proton of sulfoximine 24 was substituted by four different 
groups (Scheme 21, Table 2). An efficient methylation of sulfoximine 24 under Eschweiler-
Clark conditions afforded sulfoximine 52 in excellent yield (93%).103 The synthesis could be 
performed on 50 g scale without complication as sulfoximine 52 could be easily purified by 
distillation. The synthesis of N-benzylsulfoximine 53 was carried out following the protocol 
of Johnson104 by using KH, PhCH2Br and Bu4NBr as phase transfer catalyst.105  
 
Table 2: Yields and conditions for the functionalization of sulfoximine 24. 
 
sulfoximines R1 reagents yields (%) 
52 Me HCHO, HCO2H, H2SO4 93 
53 Bn BnBr, KH, Bu4NBr, DME 90 
54 Ts TsCl, pyridine 92 
55 TBDPS t-BuPh2SiCl, imidazole, DMF 96 
reagents 
see Table 2 
R1 = Me: 52 
         Bn: 53 
          Ts: 54 
 TBDPS: 55 
24 
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In this case, an excellent yield of sulfoximine 53 was obtained on a 10 g scale following 
purification by distillation.106 Tosylation of sulfoximine 24 using tosyl chloride in pyridine 
afforded the N-tosylsulfoximine 54 in excellent yield (92%), 107  and silylation using                  
t-BuPh2SiCl and imidazole in DMF afforded N-t-butyldiphenylsilylsulfoximine 55 in 96% 
yield. 108  The N-substituted sulfoximines 52−55 were used as starting materials for the 
following transformations. 
 
2.2. Synthesis of Acyclic Vinyl Sulfoximines 
 
Several protocols have been developed for the synthesis of vinyl sulfoximines. In 1985, Gais 
et al. reported an “in situ Peterson olefination” for their synthesis.109  Good yields were 
obtained with a high E-selectivity. This method has been successfully applied in an 
asymmetric synthesis of isocarbacyclin.110 Vinyl sulfoximines are also accessible by using a 
one pot procedure involving a Wittig-Horner reagent and an aldehyde. 111  This method 
provides N-tosylsulfoximines in good to excellent yields with high E-selectivity. Vinyl 
sulfoximines can also be prepared using a hydroxyalkylation/elimination sequence 
(addition/elimination), which involves the addition of an aldehyde or ketone to a metallated 
sulfoximine, conversion of the hydroxyl group to a leaving group (sulfonyl, carbonate) and a 
base-promoted elimination.112 This procedure was used here to synthesize vinyl sulfoximines 
58−61 (Scheme 22). 
 
 
ACYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 28 
S
ON
CH3
R1 1)  n-BuLi2)  PhCHO
S
ONR1 O
Li
S
ONR1 O
S
ONR1
O
OMe
ClCO2Me
THF
DBU
 
 
 
 
 
Scheme 22: Synthesis of acyclic vinyl sulfoximines 58, 59, 60 and 61. 
 
Thus, the S-methylsulfoximines 52−55 were metallated with n-BuLi and the resulting anion 
was trapped with benzaldehyde to give the alkoxides 56 as a mixture of epimers. Alkoxides 
56 were not isolated but treated immediately with ClCO2Me which afforded the 
corresponding carbonates 57. The elimination was effected by adding DBU as a base to the 
reaction mixture and the corresponding E configured vinyl sulfoximines 58−61 were obtained 
as single isomer in 85 to 92% yield. The vinyl sulfoximines 58−61 were then tested as 
Michael acceptors towards secondary phosphines. 
 
2.3. Phospha-Michael Addition of Acyclic Vinyl Sulfoximines 
2.3.1. Reactivity of Organophosphorous Compounds 
 
Most phosphines are subject to oxidation and the simple mono-, di and trialkylphosphines 
have great affinity for atmospheric oxygen. For example, trimethylphosphine vapour is 
spontaneously inflammable in air. Arylphosphines, especially the tertiary phosphines, are 
somewhat more stable in this respect. The oxidation of phosphines depends on their 
basicity.113 Trialkylphosphines are more basic than dialkylphosphines and, therefore, more 
R1  =  Me: 58   : 88 % 
         Bn: 59   : 91 % 
                Ts: 60    : 92 % 
        TBDPS: 61   : 85 % 
R1     =  Me: 52    
         Bn: 53  
                 Ts: 54   
         TBDPS: 55   
 56 
R1 = Me, Bn, Ts, TBDPS 
 
57 
R1 = Me, Bn, Ts, TBDPS 
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reactive toward oxygen. Consequently the handling of phosphines should be performed under 
an oxygen-free atmosphere using degassed solvents. 
The handling of such air sensitive compounds requires precautions and specific apparatus (e.g. 
Schlenk flasks or glove box), especially for purification processes. Useful methods to 
overcome this problem have been designed which protect the lone pair of the phosphorus 
atom. One of these methods is to carry out the synthesis with a phosphorus (V) derivative, 
which is already oxidized. Phosphine oxides and phosphine sulfides are commonly used. 
Working with such organophosphorous compounds not only has the benefit of avoiding 
phosphorus oxidation, it also increased the pKa values of the neighbouring protons, 
facilitating deprotonation and further functionalizations. However one of the major drawbacks 
of these protecting groups is that reduction of phosphorus (V) to phosphorus (III) is required. 
In the case of phosphine oxides, their reduction is carried out using either aluminium hydrides 
(LiAlH4 or i-Bu2AlH) or silanes at elevated temperature (typically 100 °C)114,115,116 In the case 
of phosphine sulfides, their reduction is typically performed with LiAlH4,117 Raney nickel118 
or silane119. These methods require relatively harsh reaction conditions and side-reactions can 
occur at other functional groups in the molecule. 
 
Another approach to overcome oxidation is to protect the phosphine as a phosphine borane 
adduct.120,121 This strategy was used for the first time by Imamoto in the synthesis of chiral 
phosphines having a stereogenic phosphorus centre. In the same way, phosphines, 
phosphoramidites and phosphites form an adduct with BH3, which is more or less labile 
depending upon the electronic properties of the phosphorus. These borane adducts can be 
handled like common organic compounds allowing, for example, purification by standard 
silica gel column chromatography. Moreover, the deboronation is most of the time carried out 
using an amine under mild conditions. This topic will be developed in detail in section  2.5. 
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2.3.2. Phospha-Michael Addition of Vinyl Sulfoximine 58 
 
In order to find the optimal conditions for the phospha-Michael addition, different 
experimental procedures were tested by using the N-methylsulfoximine 58 as substrate 
(Scheme 23). 
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Scheme 23: Attempted phospha-Michael addition of vinyl sulfoximine 58 using KPPh2. 
 
KPPh2 from a commercial 0.5 M solution in THF was first investigated as nucleophile. The 
reaction was carried out at −78 °C using 1.1 equiv. of KPPh2. After 30 min, 2 equiv. of 
MeOH were added to quench the postulated anion 67 and give the addition products 68 and 
69 (Scheme 24).122b  
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Scheme 24: Postulated mechanism for the formation of alkene 64 and bis-phosphine 65. 
 
After 2 h, BH3-THF was added at 0 °C to the reaction mixture and the mixture was stirred for 
1 h at RT. The workup was performed using 1N HCl to hydrolyse the excess of borane. Only 
18% of the desired phosphino-sulfoximine 62 could be isolated, together with alkene 64, bis-
phosphine borane 65 and sulfinamide 66 (Table 3). However, the phosphine borane SSRC-62 
was formed in excellent diastereoselectivity (de > 98%). 
The more hindered alcohol t-BuOH was used to protonate anion 67. Here, the yield of 
phosphine boranes 62 and 63 slightly increased (28%) in detriment to the de (86%).  
 
Evidence for the formation of phosphino-sulfoximine borane 62 is the broad signal appearing 
in the 31P NMR spectrum at 25 ppm, which is typical for a diarylalkylphosphine boranes. Of 
note, the broadness of the signal is due to the 1JP-B coupling.121,122 
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Table 3: Product distribution for the phospha-Michael addition of vinyl sulfoximine 58 using KPPh2. 
 
isolated yields of products 
alcohol 
conversion of 
vinyl sulfoximine 
58 (%) 62 + 63 (62:63) 64 65 (ee) 66 
MeOH 100 18 (>98:2) 31 24 (0) n.d. 
t-BuOH 100 28 (93:7) n.d. n.d. n.d. 
 
It was suspected that the alkene 64 and the bis-phosphine borane 65 were formed through the 
mechanism depicted above (Scheme 24). The anion 67, generated by the addition of KPPh2 to 
vinyl sulfoximine 58, is protonated by methanol, which leads to the formation of KOMe and 
phosphines 62 and 63. The methoxide can then deprotonate phosphines 62 and 63 at the alpha 
position of the phosphino group and the anion 70 undergoes an E1CB elimination to form 
sulfinamide 71 and alkene 72. Moreover, the achiral alkene 72 can act as a Michael acceptor 
and reacts further with KPPh2 to afford the bis-phosphine borane 74 without any asymmetric 
induction (ee = 0%), which is in accordance with the postulated mechanism. The high de 
value (>98%) of the phosphine borane 62 can be explained either by a highly stereoselective 
addition of KPPh2 on the vinyl sulfoximine 58 or by the higher reactivity of the other isomer 
69 towards elimination. 
 
An alternative to the use of stoichiometric amount of the nucleophilic salts is to generate the 
KPPh2 in situ from diphenylphosphine with a catalytic amount of base. This can be done 
easily with an equimolar amount of primary or secondary phosphine and a catalytic amount of 
an alkoxide. At room temperature, the deprotonation of diphenylphosphine by t-BuOK is fast 
and the addition proceeded smoothly. All of the starting material was consumed within 1 h 
according to TLC analysis. BH3-THF was added to the reaction mixture to protect the 
phosphine and after hydrolysis with HCl, phosphine boranes 62 and 63 were obtained in a 
78% combined yield. Unfortunately, the diastereoselectivity decreased under these conditions 
(dr: 78:22). The major isomer 62 could be isolated from a mixture of both isomers 62 and 63 
by crystallization from CH2Cl2/hexane. 
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Table 4: Phospha-Michael addition of vinyl sulfoximine 58 using various nucleophiles. 
 
entry Conditions Time (h) 
Conversion of 
vinyl 
sulfoximine 
58 
Yield of 
phosphine 
boranes       
62 + 63 
dr (62:63) 
1 1) HPPh2, 10% t-BuOK, RT 2) BH3−THF, 0 °C, 2 h 1 100 78 78:22 
2 HPPh2(BH3), 10% t-BuOK, 0 °C, 50 h 50 85 41 50:50 
3 LiPPh2(BH3), −50 °C, 26 h 26 50 28 69:31 
 
In an attempt to achieve higher diastereomeric excesses of phosphine borane 62, the bulky 
diphenylphosphine borane was tested in combination with a catalytic amount of t-BuOK. The 
mixture of phosphine boranes 62 and 63 was isolated in 41% in a ratio of 1:1 (entry 2). A 
small amount of the saturated sulfoximine 75 was formed as side product (Scheme 25). 
 
Hydroboration of alkenes using phosphine borane adducts has been studied by Pelter et al..123 
1-Octene and cyclohexene could be hydroborated with triphenylphosphine borane adduct in 
97% yield in both cases. Indeed, the phosphine borane adduct and the free phosphine are in 
equilibrium. Free borane is therefore present in the reaction mixture and can hydroborate the 
double bond. Similarly, following the equilibrium depicted below, vinyl sulfoximine 58 is 
hydroborated by the free borane which is in equilibrium with the phosphine borane adduct 
and, after acidic treatment, saturated sulfoximine 75 is isolated (Scheme 25).124  
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Scheme 25: Hydroboration of vinyl sulfoximine 58 in the presence of HPPh2(BH3). 
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In order to induce a better control of the selectivity during the diphenylphosphine addition to 
vinyl sulfoximine 58, the reaction was carried out at lower temperature. Diphenylphosphine 
borane was deprotonated with n-BuLi prior to reaction with vinyl sulfoximine 58. Half 
conversion occurred after one day, and the mixture was worked up. Only 28% of the 
diastereomeric mixture of 62 and 63 could be isolated with a diastereomeric ratio of 69:31 
respectively. Traces of hydroborated sulfoximine 75 were also detected by 1H NMR. 
 
2.3.3. Phospha-Michael Addition of N-Substituted Vinyl Sulfoximines 
 
The procedure which gave the best yield of phosphine-boranes 62 and 63 was applied to the 
N-substituted vinyl sulfoximines 59−61 (Scheme 26). The results are listed in Table 5.  
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Scheme 26: Synthesis of borane protected acyclic phosphino-sulfoximines 62, 63 and 76−81. 
 
Table 5: Synthesis of borane protected acyclic phosphino-sulfoximines 62, 63 and 76−81. 
 
Vinyl 
sulfoximine R
1
 
Phosphino-
sulfoximines 
(SSRC : SSSC) 
Yield  Diastereomeric ratio (SSRC : SSSC) 
58 Me 62 : 63 78 78:22 
59 Bn 76 : 77 78 64:36 
60 Ts 78 : 79 70 27:73 
61 TBDPS 80 : 81 80 58:42 
 
The phosphino-sulfoximines 62, 63 and 76−81 were obtained in 70 to 80% yield. For the N-
methyl- and N-benzylvinyl sulfoximine 58 and 59 respectively, the major isomers have both 
the SSRC configuration. But for the N-tosyl vinyl sulfoximine 60, the selectivity of the 
     SsRc           SsSc 
 
R1 = Me:                 62             63 
         Bn:                 76             77 
         Ts:                  78             79 
         TBDPS:          80             81 
R1 = Me: 58  
         Bn: 59 
          Ts: 60 
 TBDPS: 61 
ACYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 35 
addition is reversed and the major phosphino-sulfoximine borane 79 has the opposite SSRC 
configuration.  
Although the diastereoselectivities of the phospha-Michael addition of the vinyl sulfoximines 
are not high, the causes of discrimination can be postulated as followed. Both vinyl 
sulfoximines 58 and 59 (R1 = Me and Bn respectively) have a basic nitrogen atom, which can 
form a 6-membered transition state during the addition via coordination of the cation to the 
nitrogen of the sulfoximine (Scheme 27). Two 6-membered transition states having a chair 
conformation can be postulated, where the phenyl group of the sulfoximine adopts either an 
equatorial position (Re-face addition) or an axial position (Si-face addition). The Re-face 
addition would be favoured because the equatorial position of the phenyl group of the 
sulfoximine moiety minimizes the 1-3 diaxial repulsions.  
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Scheme 27: Postulated 6-membered transition state during the phospha-Michael addition of the vinyl 
sulfoximines 58 and 59. 
 
In contrary, for sulfoximine 60 having an electrowithdrawing tosyl goup, the nitrogen is much 
less basic. In the case of sulfoximine 61, the bulky silyl group TBDPS prevents any 
coordination to the nitrogen atom. Consequently for the sulfoximines 60 and 61, the addition 
will not proceed via the 6-membered transition state depicted in Scheme 27. For sulfoximine 
SSSC
minor
 
SSRC 
major 
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60, only a coordination via the oxygen atom would be possible and consequently the 
configuration at the C-stereogenic centre will be opposite. 
 
During the conduct of this research project, Reggelin et al. reported an intermolecular 
phospha-Michael addition of unsubstituted vinyl sulfoximine 82 (Scheme 28).125 
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Scheme 28: Phospha-Michael addition of the unsubstituted vinyl sulfoximines 82. 
 
The phospha-Michael addition was carried out with the unsubstituted vinyl sulfoximine 82 
using HPPh2−(BH3) and t-BuOK. Phosphine borane 83 was isolated in 80% yield. In this case, 
a hydroboration of the activated double bond was apparently not observed.  
 
2.4. Determination of the Absolute Configuration of Acyclic Phosphine Boranes 
The absolute configuration of phosphine borane (RSSC)-ent-62 was determined by X-ray 
crystal structure analysis (Figure 10). Crystals of phosphine borane (RSSC)-ent-62 suitable for 
X-ray crystal structure analysis were obtained in CH2Cl2/hexane solution. 126  Phosphine 
borane (RSSC)-ent-62 was synthesized from the corresponding R-configured vinyl sulfoximine 
ent-58. The absolute configuration of the stereogenic carbon atom of phosphine borane 
(RSSC)-ent-62 could be assigned because of the known R configuration of the sulphur atom. 
Phosphine borane (RSSC)-ent-62 crystallized in two symmetric independent molecules in the 
asymmetric unit. The B-P bond lengths (1.923(3) and 1.922(3) Å) are in the average of P-B 
bond lengths.120 Moreover, in the solid state, the borane group is bonded to the phosphorus 
atom and does not interact with the basic nitrogen atom of the sulfoximine moiety. 
82 83 
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Figure 10: Structure of phosphine borane (RSSC)-ent-62 in the crystal. Selected bonding parameters: S−O 
1.455(2), S−N 1.521(4), C−S 1.786(7), P−B 1.923(3), C−P 1.853(5). 
 
The 1H and 13C NMR spectra of (SSRC) phosphine borane 62 could be fully assigned with the 
help of the 2D 1H-1H, 1H-13C and 31P-1H as well as 1H{31P} and 13C{31P} NMR spectroscopy 
(Figure 11 and Figure 12).  
 
 
 
Figure 11: 1H NMR spectrum of (SSRC) phosphino-sulfoximine borane 62 in CDCl3. 
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Figure 12: 13C NMR spectrum of (SSRC) phosphino-sulfoximine borane 62 in CDCl3. 
 
An inspection of the signals of the aromatic protons of the SSRC-configured phosphino-
sulfoximine boranes 62, 76 and 78 revealed a similarity for the signals assigned to the protons 
i, j and k. Indeed, the signal of the ortho and meta protons i and j appear at the same chemical 
shift at 6.80 ppm and are overlapped, whereas the signals of the para protons k appear at 
6.90 ppm (Figure 13). In contrast, the SSSC-configured phosphino-sulfoximine boranes 77, 63 
and 79 do not exhibit the same chemical shift for the ortho and meta protons i and j and their 
signals are well separated (Figure 13).   
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Figure 13: Region of the aromatic protons in the NMR spectra of N-substituted phosphino-sulfoximine boranes. 
SSRC (top) and SSSC (bottom) configuration. 
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The absolute configuration of acyclic phosphino-sulfoximine boranes were suggested from 
these observations. Only in the case of the N-silyl phosphino-sulfoximine boranes 80 and 81, 
the chemical shifts of the protons i, j and k could not be distinguish due to the high number of 
aromatic protons (total 30). After several trials, a crystal of (SSRC) phosphino-sulfoximine 
borane 80 suitable for X-ray crystal structure analysis was obtained in n-heptane/isopropanol 
(95:5).  
                   
Figure 14: Structure of phosphino-sulfoximine borane (SSRC)-80 in the crystal. Selected bonding parameters: 
S−O 1.453(4), S−N 1.489(4), C−S 1.796(5), P−B 1.913(5), C−P 1.858(4). 
 
For N-silyl phosphino-sulfoximine boranes 80, the borane group is also bounded to the 
phosphorus atom and does not interact with the nitrogen atom of the sulfoximine moiety. The 
P-B bond length is 1.913(6), which is shorter than phosphino-sulfoximine borane ent-62  (P-B 
bond length of phosphine borane ent-62: 1.923(3)). 
 
2.5. Deboronation of Acyclic Phosphine Boranes 
 
As enounced in section  2.3.1, borane is often used as protecting group for phosphines. Several 
methods have been found to convert the phosphine boranes into tricoordinated phosphines.120 
The most common methods involve a nucleophilic amine such as diethylamine 127 , N-
methylmorpholine128, TMEDA or DABCO129. Brønsted acids (HBF4130 or CF3SO3H)131 can 
be used for electron-rich phosphines like trialkylphosphines. All these methods proceed with 
retention of configuration, which is really advantageous for compounds containing a chiral 
phosphorus atom.  
The reaction of a phosphine borane with an amine leads to an equilibrium in which the 
position of the borane group depends on the relative basicity of the amine and the phosphine 
80 
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(Scheme 29).113 The more basic phosphorus atom is, the more difficult the cleaving of P-B 
bond is. 
 
R3P BH3 + NR'3 PR3 + R'3N BH3
 
Scheme 29: Equilibrium between phosphine borane and amine borane. 
 
The decomplexation of phosphino-sulfoximine boranes 62, 63 and 76−81 was carried out 
using 1.1 equiv. DABCO in toluene (Scheme 30). The reaction proceeded smoothly at 40 °C 
and could be easily monitored by 31P NMR spectroscopy. Phosphino-sulfoximine boranes 62, 
63 and 76−81 exhibit a broad singlet around 26 ppm whereas the corresponding free 
phosphines exhibited a sharp singlet around 1 ppm. After 2 h, complete conversion was 
observed for phosphino-sulfoximine boranes 62, 63 and 76−80. The equilibrium depicted in 
Scheme 29 is pulled towards the right side, showing that DABCO is more basic than the free 
phosphines. Furthermore, the 1H NMR spectrum exhibited a signal for DABCO-BH3 at 2.93 
ppm. A sharp singlet was also sometimes observed at 3.14 ppm and was attributed to 
DABCO-(BH3)2.  
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Scheme 30: Deboronation of phosphino-sulfoximine boranes 62, 63 and 76−80. 
 
In all cases, the reaction proceeded quantitatively without traces of side products, except for 
phosphino-sulfoximine borane 79 where the deboronation reaction was not completed due to 
the low solubility of the compound. The purification of the phosphino-sulfoximines 68, 69 
and 84−88 was carried out by passing the crude mixture trough a plug of silica gel. The polar 
DABCO-BH3 remained on the top of the column and after evaporation of the solvents, 
phosphines 68, 69 and 84−88 were obtained for most of them as a white solid in >95% yields.  
89 
    SsRc     SsSc 
 
R1 = Me:     62       63 
        Bn:      76       77 
         Ts:      78 
 TBDPS:     80      81 
     SsRc     SsSc 
 
R1 = Me:   68       69 
        Bn:    84       85 
         Ts:    86 
 TBDPS:   87       88 
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Precautions regarding the exclusion of oxygen were required for the synthetic steps involving 
the presence of the phosphines and diphenylphosphine since they react with oxygen to give 
the corresponding phosphine oxide. Therefore, the solvents used for the manipulations of the 
phosphines were degassed prior to use, and the reactions were performed under argon.  
All the attempts to purify phosphino-sulfoximines 68, 84 and 87 by crystallization failed. The 
white solid, which was collected after crystallization exhibited a 31P NMR signal around 
33 ppm, characteristic of diarylalkylphosphine oxides.122b 
 
2.6. Reactivity of Phosphine Boranes and Phosphino-Sulfoximines 
 
Although the phosphino-sulfoximine boranes were stable towards oxygen, they showed a 
tendency to decompose with formation of the corresponding sulfinamide and phosphino-
alkene borane (see section  2.3.2). This degradation was much faster in solution than in the 
solid state, and the rate of this degradation depended on the substituent attached to the 
nitrogen of the sulfoximine. The stability of the phosphine boranes decreases in the following 
order: 
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Figure 15: Stability scale of the phosphino-sulfoximine boranes. 
 
As seen in the previous section, an equilibrium exists between the phosphine borane and the 
phosphine in the presence of an amine (Scheme 29). Therefore it seems reasonable to suppose 
that the borane group can migrate from the phosphorus atom to the basic nitrogen of the 
sulfoximine moiety in an intra- and/or intermolecular way. This would result in an 
equilibrium between structure I and II (R1 = Me, Bn, Ts, t-BuPh2Si) (Scheme 31). Phosphino-
sulfoximine borane I can deprotonate the N-boronato-sulfoximine II which undergoes an 
elimination. The corresponding N-methyl sulfinamide 90 and N-benzyl sulfinamide 91 as well 
as the alkene 64 were isolated for the N-methyl phosphino-sulfoximines 62 and 63 and N-
benzyl phosphino-sulfoximines 76 and 77 respectively. 
 
 80 and 81 78 and 79  76 and 77 62 and 63 
 
ACYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 43 
 
S
ON
Ph
R1
Ph
PPh2
H3B
S
O
N
H
Ph
R1 PPh2
Ph
BH3
+
S
ON
Ph
R1
Ph
PPh2
BH3
H S
O
NPh
R1
+
PPh2
Ph
+
BH3
S
ON
Ph
R1
Ph
PPh2
H3BH
decomposition
S
ON
Ph
R1
Ph
PPh2
BH3
H
 
 
Scheme 31: Postulated mechanism for the decomposition of phosphino-sulfoximine boranes. 
 
The simplest way to overcome this problem is to deboronate the phosphino-sulfoximine 
boranes into phosphines. In fact, the phosphines are oxygen sensitive in solution, but are 
much more stable towards oxidation in the solide state. Their handling is therefore very easy 
(no use of a glove box to weigh an appropriate quantity of phosphine). The phosphines were 
stored under argon at 4 °C, and neither oxidation nor decomposition was observed after 6 
months. 
The characterisation of phosphino-sulfoximine boranes 62, 63 and 76−80 by high resolution 
mass spectroscopy was not possible. The high temperature required for the evaporation of the 
sample and the high energy transfer (electronic impact: 70 eV) during the measurement led to 
decomposition of the phosphino-sulfoximine boranes. 
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2.7. Acyclic Phosphino-Sulfoximines in Asymmetric Allylic Alkylation 
2.7.1. Phosphino-Sulfoximine 62 in Asymmetric Allylic Alkylation 
 
The phosphino-sulfoximines 68, 69 and 84−88 were tested as ligands in the allylic alkylation 
of the standart substrate rac-(E)-1,3-diphenyl-2-propenyl acetate rac-43 (Scheme 32). 
Following the procedure of Trost, the dimethyl malonate anion was generated as nucleophile 
using the combination of dimethyl malonate, bis-trimethylsilylacetamide (BSA) and a 
catalytic amount of acetate (typically 1%).132 
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Scheme 32: Pd-catalyzed allylic alkylation of acetate 43 using the phosphino-sulfoximines as ligands. 
 
Since this reaction is strongly influenced by the reaction conditions, like the solvent or the 
counterion, various parameters were first investigated using phosphino-sulfoximine 68 as 
ligand. 
 
2.7.2. Solvent Variation 
 
A variety of solvents can be used in allylic alkylation ranging from benzene and CH2Cl2 to 
more polar media such as THF or DMF that strongly influence the reaction rate and the ee 
value. Therefore, in a first set of experiments, the coordinating polar solvent THF and the less 
polar non coordinating CH2Cl2 were tested. These experiments were carried out using the 
crude mixture obtained in the deboronation reaction of phosphine borane 62 with DABCO 
(Scheme 33). The results are sum up in Table 6. 
 
43 44 
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Scheme 33: Pd-catalyzed allylic alkylation of acetate 43 with ligand 68 and 89.  
 
Table 6: Effect of the solvent and the amount of nucleophile towards the allylic alkylation reaction. 
 
entry solvent 
m 
(equiv. of dimethyl 
malonate) 
n 
(equiv. of 
BSA) 
time 
(h) 
recovered 
starting 
material 43 
yield 
of 44 
ee
1
 of 
44 
(R) 
1 THF 1.1 1.1 42 84 8 59 
2 CH2Cl2 1.1 1.1 42 36 60 56 
3 THF 2.5 2.5 40 66 22 25 
4 CH2Cl2 2.5 2.5 30 0 96 60 
1
 The ee value of malonate 44 was determined by chiral HPLC: chiralcel-OD-H column, detector 254 nm, n-
heptane/isopropanol: 95/5, flow: 0.75 ml/min, 40 bar, Rt ((R)-44): 15.28 min; Rt ((S)-44): 19.53 min. The 
absolute configuration of malonate 44 was determined by comparison of the optical rotation with the literature 
value.133 
 
The first catalytic reaction was carried out in THF. After 42 h reaction, the malonate 44 was 
isolated in poor yield (8%) but promising ee (59%, Table 6, entry 1). When the reaction was 
carried out in CH2Cl2, the yield of the malonate 44 increased to 60% (entry 2). Only a minor 
decrease of 3% of the enantioselectivity was observed. 
To perform a catalytic reaction with complete conversion of the acetate 43, the amount of 
base (dimethyl malonate and BSA) was raised from 1.1 equiv. to 2.5. This was beneficial in 
term of kinetic in THF as well as in CH2Cl2. The yield of malonate 44 in THF increased to 
22%, while the ee dropped drastically to 25% (entry 3). When performed in CH2Cl2, a 
complete conversion of acetate 43 was observed and the malonate 44 was obtained in 96% 
yield with an ee value of 60% (entry 4).  
The non-reacted acetate 43 was always recovered in a racemic form, indicating that no kinetic 
resolution occurred during the reaction.134  
rac-43 (+)-R-44 
68 89 
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These first experiments showed that the catalytic reactions proceeded faster in CH2Cl2 than in 
the more polar and coordinating solvent THF, and complete conversions were reached in 
CH2Cl2 using an excess of nucleophile. The enantioselectivities obtained at this early stage 
was promising. 
 
2.7.3. Ligand to Metal Ratio, DABCO-BH3 and Counterion Effects  
 
The previous experiments were performed using phosphino-sulfoximine 68, which was 
synthesized by reaction of phosphine borane 62 and DABCO. After evaporation of the solvent, 
the crude mixture containing the phosphine 68 and the DABCO-BH3 89 were used as ligand. 
As DABCO-BH3 89 contains a free nitrogen atom which can coordinate to the palladium 
atom, its influence was investigated.  
 
Table 7: Effect of the cation, the ligand to metal ratio and the presence of DABCO-BH3 on the allylic alkylation 
reaction of acetate 43 with ligand 68. 
 
entry ligand 
x 
(equiv. of 
ligand in 
mol%) 
y 
(equiv. of Pd 
in mol%) 
cation yield of 44 
ee of 
44 
(R) 
1 68 + 89 2 2 K 84 44 
2 68 + 89 3 2 K 96 60 
3  68 + 891 3 2 K 80 46 
4 68 3 2 K 89 33 
5 68 + 89 4 2 K 99 33 
6 68 6.6 3 K 96 46 
7 68 2 3 K 12 61 
8 68 3 3 K 40 65 
9 68 3 3 NBu4 54 43 
10 68 3 3 Li 96 65 
1
 The reaction was performed with double amount of solvent. 
 
The role of DABCO-BH3 89 was not fully understood.135 It gave a beneficial effect on the 
yield of the product 44, but contentious results in term of ee values (Table 7, entry 1-5). The 
variation of the ligand to metal ratio (L:M) also affected the yield as well as the ee value. 
When this ratio increased, the yield of the malonate 44 raised, but the ee value decreased 
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(entry 6). At a ratio L:M = 1:1, product 44 was isolated in only 40% yield, but with the 
highest ee (65%, entry 8). At a ratio L:M = 2:3, malonate 44 was isolated in poor yield (12%) 
with an ee value of 65% (entry 7). A similar study has been reported by Burgess et al.136 The 
higher ligand to metal ratio was, the poorer enantioselectivities were obtained. This was 
explained by the fact that the bidentate phosphine-oxazoline ligand 92 is hemilabile (Scheme 
34). Complex 93, formed at L:M ≤ 1:1 and in which the ligand 92 acts as a chelate, could 
efficiently transfer the chirality to the substrate and thus malonate 44 was obtained in high ee. 
But complex 94, formed at L:M > 1:1, in which two ligands 92 coordinate as mono-phosphine, 
led to low ee of malonate 44. As complex 94 catalyzed faster than complex 93, the overall 
enantioselectivities obtained were lower at L:M ratio higher than 1:1.  
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Scheme 34: Burgess hemilabile phosphine-oxazoline 92 acting as mono and bidentate ligand in Pd-catalyzed 
allylic alkylation of acetate 43. 
 
Trost et al. examined the role of the counter ion on the enantioselectivity of the palladium 
catalyzed allylic alkylation of cyclic allylic carbonates using ligand 17 (Figure 16). 137 
94 93 
44 
92 
43 
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Figure 16: Trost ligand. 
 
Their studies demonstrated that the bigger the counter ion is, greater the ee value is. For this 
reason, several counter ions were tested in the catalytic reaction using the ligand 68. The trend 
which came out from these experiments was reversed to those observed by Trost. The 
hindered counter ion NBu4 was generated following the Trost’s procedure,137 and 
interestingly the ee value of malonate 44 decreased (43%) compared to the less hindered 
cation K (Table 7, entry 9). Therefore the smallest cation Li was tested in the reaction, and 
malonate 44 was isolated in 96% yield with an ee value of 65% (entry 10). The smallest 
cation Li proved to be the best choice for this catalytic system and similar observations were 
reported by Helmchen et al. on the role of the cation.122a 
 
2.7.4. Phosphino-Sulfoximines 68, 69 and 84−88 in Asymmetric Allylic Alkylation 
 
The acyclic phosphino-sulfoximine ligands 68, 69, 84−88 depicted below (Scheme 35) were 
tested under the reaction conditions which gave the highest ee value of malonate 44. The 
results are summarized in Table 8.  
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Scheme 35: Pd-catalyzed allylic alkylation of acetate 43 using acyclic phosphino-sulfoximines 68, 69, 84−88 as 
ligands. 
 
Table 8: Pd-catalyzed allylic alkylation of acetate 43 using acyclic phosphino-sulfoximines 68, 69, 84−88 as 
ligands. 
 
entry ligand absolute 
configuration T° solvent cation 
yield of 
malonate 44 
ee of 44 
(R)2 
1 68 SSRC RT CH2Cl2 Li 96 65 
2 69 SSSC RT CH2Cl2 Li 40 −10 
3 84 SSRC RT CH2Cl2 Li 98 82 
4 85 SSSC RT CH2Cl2 Li 72 −40 
5 87 SSSC RT CH2Cl2 Li 5 15 
6 86 SSRC RT CH2Cl2 K 17 −5 
7 84 SSRC −1 CH2Cl2 Li 40 89 
8  841 SSRC −1 CH2Cl2 Li 57 90 
9 84 SSRC RT CH3CN Li 28 69 
10 84 SSRC RT Toluene Li 5 88 
     1
 Using 6 mol% of ligand and palladium. 
     2
 A – sign refers to the S-configured product which was obtained as major isomer. 
 
Interestingly, using the SSSC phosphino-sulfoximine 69 as ligand, the malonate 44 was 
isolated in 40% yield and 10% ee (Table 8, entry 2). It is worth noting that product 44 have 
the opposite absolute S-configuration compared to the reaction catalyzed with SSRC 
phosphino-sulfoximine 68. This shows that the stereogenic C-atom but also the stereogenic S-
atom plays an important role in the selectivity and activity of the catalyst. The nitrogen 
SSRC-68 SSRC-84 
SSSC-85 SSSC-69 
rac-43 44 
SSSC-87 
SSRC-86 
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substituent has also a significant effect on the selectivity of the catalyst. While the reaction in 
the presence of N-methyl substituted phosphino-sulfoximine 68 gave malonate 44 with 65% 
ee, the N-benzyl substituted phosphino-sulfoximine 84 gave product 44 in almost quantitative 
yield and 82% ee (entry 1 and 3). Decreasing the reaction temperature to –1 °C was 
favourable for the enantioselectivities of malonate 44 which increased to 89%, but the 
conversion was lower (50%, entry 7). Even an increase of the catalyst loading (3% to 6%) had 
only a minor effect on the yield of malonate 44 which increased to 57% (entry 8). The ee 
value of product 44 was in the same range at 90%. 
The N-benzyl isomer SSSC-85 was also tested in the catalytic experiment and exhibited a 
better activity than the N-methyl SSSC-isomer 69. Product 44 was isolated in 72% yield with 
an ee value of 40% in favour of the S-isomer (entry 4). The S-configuration of the stereogenic 
C-atom led in the case of N-methyl and N-benzyl substituted ligands 69 and 85 to the S-
configured product 44, whereas the R-configuration led to the R-configured product 44. 
The catalytic experiments carried out with the N-tosyl and N-silyl substituted ligand 86 and 87 
revealed very low activities of these catalysts, in term of yield and enantioselectivities (entry 5 
and 6). It is most probably due to the reactivity of the nitrogen atom which is, as previously 
pointed out, reacting neither with electrophiles nor Lewis acids.100, 138  Therefore it is 
meaningful to think that these phosphino-sulfoximines are not coordinating in a bidentate 
fashion to the Pd-atom, but most probably as monodentate phosphine. Consequently for 
L:M = 1:1, there is not enough ligand to coordinate the metal centre to produce an active 
catalyst and therefore the reaction rate is low. 
 
Acetonitrile and toluene were tested as solvent in the catalytic experiment using the best 
candidate 84. In the first case, the reaction rate diminished and product 44 was isolated in 
28% yield with an ee of 69% (entry 9). In contrary, the use of toluene as solvent increased the 
ee value of malonate 44 from 82 to 88%, but unacceptable yield (5%) was obtained (entry 10). 
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Scheme 36: Investigation of cyclic substrate 95 in Pd-catalyzed allylic alkylation using ligand 68. 
 
Cyclic substrate 95 was investigated in the Pd-catalyzed allylic alkylation in the presence of 
ligand 68 (Scheme 36). Unfortunately, no conversion was observed after 24 h reaction.  
 
2.7.5. C-N and C-S Bond Formation 
 
Aza nucleophiles were investigated using the crude mixture obtained in the deboronation 
reaction of the phosphine borane 62 with DABCO. (Boc)2NH, phtalimide, 1,2,4-triazol and 
benzyl amine were chosen as nucleophile (Scheme 37).  
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Scheme 37: Pd-catalyzed allylic substitution of acetate 43 using aza and sulfa nucleophiles. 
 
Unfortunately, none of the catalytic reactions showed any conversion. This may be due to the 
coordinating properties of amines. The catalyst could be deactivated by coordination of the 
nucleophile to the metal centre. 
A sulfinate was also investigated as nucleophile. The reaction was quenched after 24 hours 
and vinyl sulfone 97 was isolated in 60% yield with an ee value of 42%. Unfortunately, the 
absolute configuration of the product was not determined. 
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rac-95 96 
Nu = SO2Ph: 97 
89 68 
43 
68 
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2.7.6. Origin of the Selectivity for the Acyclic Phosphino-Sulfoximine Ligands 
 
As asymmetric allylic alkylation has been extensively studied in the mechanistical aspects,27 
models of the pi-allyl palladium complex bearing the SSRC phosphino-sulfoximine ligand 68 or 
84 can be drawn (Scheme 38). The 6-membered palladacycle could adopt a boat conformation, 
which places the phenyl group of the sulfoximine as well as the phenyl group at the C-
stereogenic centre in pseudo equatorial position. Thus the 1-3 diaxial interactions will be 
minimised. A chair conformation will not be favoured because these both phenyl substituents 
would be in axial position. Following this conformation, the two phenyl groups attached to 
the phosphorus atom are non-equivalent, e.g. one adopts a pseudo-axial position and the other 
a pseudo-equatorial position. In the case of PHOX ligands, the two phenyl groups are non-
equivalent and therefore induce a discrimination between the endo and the exo isomers.35 
Also in this case, two pi-allyl complexes could be formed: the complex 98 where the R 
substituents of the allyl fragment are above the P-Pd-N plane, and complex 99 where they 
point below it.  
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Scheme 38: Origin of the selectivity using acyclic phosphino-sufoximines 68 and 84. 
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The origin of the selectivity depends on the energy difference between the two transition 
states leading to the Pd(0)olefin complexes 100 and 101. For complex 101, steric repulsions 
between the olefin and the ligand would destabilize the transition state and consequently the 
attack of the pi-allyl complex 98 would be favoured, leading to the Pd(0)olefin complex 100.  
 
 
2.8. Conclusion 
 
The acyclic phosphino-sulfoximines 68, 69, 84−88 were synthesized in a 3 steps procedure in 
good overall yields starting from N-substituted sulfoximines 52−55. The feasibility of the 
phospha-Michael addition of substituted vinyl sulfoximines was demonstrated and applied to 
introduce the phosphine functionality. The diastereoselectivities of these additions were low 
to moderate, allowing the screening of both isomers of the phosphino-sulfoximine in Pd-
catalyzed allylic alkylation. Both the sulfoximine moiety and the proper (R)-configuration at 
the stereogenic C-atom are required to induce a high level of selectivity in the catalytic 
process. A matched (SSRC) and a mismatched (SSRS) effect were observed for these 
phosphino-sulfoximines. Moreover, the non-coordinative solvent CH2Cl2, as well as the 
lithium counterion were required to achieve excellent yield and high enantioselectivity toward 
the substrate (E)-1,3-diphenyl-2-propenylacetate 43 with dimethyl malonate. The use of 
amine as nucleophile completely inhibited the catalytic reaction and acyclic phosphino-
sulfoximine 68 did not show any activity towards cyclic substrate 2-cyclohexenylacetate 95. 
The investigation of the ligand to metal ratio revealed that a L:M = 1:1 was required to 
achieve high enantioselectivities. The fact that the acyclic phosphino-sulfoximine coordinates 
in a monodentate fashion at higher L:M ratio could not be excluded. This could mean that the 
acyclic phosphino-sulfoximines are hemilabile. The substituent at the nitrogen atom of the 
sulfoximine is also crucial in the chelation of the metal centre and to induce a high degree of 
enantiocontrol. 
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3. Cyclic Phosphino-Sulfoximines 
 
The enantioselectivities obtained with the acyclic phosphino-sulfoximines in Pd-catalyzed 
allylic alkylation of (E)-1,3-diphenyl-2-propenylacetate 43 were high, especially in the case of 
phosphine 84. The optimisation of the ligand structure was required to achieve even greater ee 
values. As seen in the preview chapter, the hemilability of acyclic phosphino-sulfoximine 
ligands was suggested by the drop in enantioselectivity at high L:M ratio. Indeed, the S−CH2 
as well as the CH2−CH sp3 bonds can easily rotate, making both coordinating sites N and P to 
move away from each other (Figure 17). Thus, a bidentate coordination mode will not be 
favoured. 
 
S
O N
Ph
R
Ph
PPh2 S
O N
Ph
PhPh2P
R
S
O N
Ph
R
Ph
PPh2
S
O N
Ph
R
PPh2
n
 
 
Figure 17: Design of a more conformational stable phosphino-sulfoximine backbone. 
 
Therefore, both sulfoximine and phosphino groups were embedded into a more 
conformational stable backbone to confine its flexibility. Both coordinative nitrogen and 
phosphorus atoms would be forced to stay close to each other, and thus chelate the metal 
centre.  
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3.1. Synthesis of Cyclic Vinyl Sulfoximines 
 
As the phospha-Michael addition methodology proved to be successful for the acyclic vinyl 
sulfoximines, the same strategy was planned to introduce the phosphino functionality to 
synthesize cyclic phosphino-sulfoximines. To access the key intermediate cyclic vinyl 
sulfoximine 102, three retrosynthetic pathways were designed (Scheme 39). The first route (A) 
involved a halogenation-dehydrohalogenation sequence of cycloalkyl derivative 103. The 
route B involved the formation of carbanions in alpha position of vinyl sulfoximines, which 
was already reported.139,140 The intermediate 104 could be synthesized via the well established 
Addition-Elimination one-pot procedure. The third pathway C involved a ring closing 
metathesis of triene 105, which could be accessed from vinyl sulfoximine 106. The vinyl 
sulfoximine 106 would also be synthesized by the one-pot Addition-Elimination procedure.  
 
 
CYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 56 
S
ON
Ph
PPh2R
n
S
ON
Ph
R
n
S
ON
Ph
R
X
S
ON
Ph
R
S
ON
CH3Ph
R
+
S
ON
Ph
R
X
S
ON
Ph
R
S
ON
CH3Ph
R
+
O
X S
ON
Ph
R
S
ON
CH3Ph
R
+
O
Br Br
4+n
n
n
3+n
n
m
m
m
 
 
Scheme 39: Retrosynthetic analysis of cyclic phosphino-sulfoximine. 
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3.1.1. Route A: Dehydrohalogenation 
 
This first route involves the formation of the carbocycle moiety prior to the formation of the 
alkene functionality by dehydrohalogenation.141 Following the procedure described by Peter 
Bruns,142 sulfoximine 107 was prepared starting from sulfoximine 52 and dibromopentane 
(Scheme 40).  
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Scheme 40: Postulated mechanism for the formation of cyclohexylsulfoximine 107. 
 
As reported, only 50% of the desired sulfoximine 107 was isolated. Indeed, sulfoximine 52 is 
metallated with n-BuLi and alkylated to give ω-bromo-sulfoximine 109. As soon as this 
alkylation occurs, ω-bromo-sulfoximine 109 is deprotonated by lithiated sulfoximine 108, and 
cyclizes faster than the alkylation of lithiated sulfoximine 108. Consequently only 50% yield 
can be obtained among with 50% of starting material 52. Optimisation of the reaction using 
2.2 equiv. of base (n-BuLi or LDA) was not successful.  
 
The next step involved the halogenation of the tertiary carbon atom of sulfoximine 107. In 
1978, Johnson reported an efficient chlorination procedure of sulfoximines involving t-butyl-
hypochlorite. 143  If this procedure works well for the chlorination of the N-S-
dimethylsulfoximine 52, they were not able to achieve the chlorination of the cyclohexyl 
derivative 107. Four years later, Johnson published the halogenation of N-tosylsulfoximines 
using hexahaloethanes. 144  Under these conditions, mono-, bis- and tri-substituted α-
halosulfoximines were synthesized. Following this procedure, no reaction occurred on 
sulfoximine 107 (Scheme 41). This is probably due to the pKa difference between the N-
108 
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110 109 
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methyl- and the N-tosylsulfoximines.100 Therefore NaH, which was used as base for the N-
tosylsulfoximines, is not strong enough to deprotonate N-methylsulfoximine 107. The use of 
n-BuLi was required to achieve the deprotonation of sulfoximine 107 and addition of 2 equiv. 
of 1,2-dibromo-1,1,2,2-tetrachloroethane led to a 55:45 inseparable mixture of α-chloro and 
α-bromosulfoximines 111 and 112 respectively in 91% yield (Scheme 41).  
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Scheme 41: α-halogenation of cyclohexylsulfoximine 107. 
 
The GC-MS spectra of the mixture of 111 and 112 confirmed the presence of a chloride and a 
bromide atom. This inseparable mixture was then subjected to dehydrohalogenation upon 
treatment with t-BuOK in THF. Sulfinamide 90 and cyclohexylsulfoximine 107 were isolated 
as major products. Only traces of the desired product could be detected (afterwards) in the 
crude 1H NMR. A mechanism for the formation of these side products is proposed below 
(Scheme 42). 
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Scheme 42: Postulated mechanism for the formation of compounds 90 and 107. 
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As the 1H and 13C NMR spectra of both chloro and bromo-sulfoximines 111 and 112 exhibit 
similar chemical shifts, their conformation should be the same. Although their conformation 
in solution is not known, the sulfoximine group could adopt an axial position to explain the 
formation of sulfinamide 90 through an E2 mechanism. If the sulfoximine moiety would be in 
equatorial position, the halogen would adopt an axial position, and the dehydrohalogenation 
would be favoured. The formation of the dehalogenated sulfoximine 107 can be rationalized 
by a bromo- and/or chlorophilic reaction.145 
As route B was giving more promising results, the dehydrohalogenation reactions were not 
further studied using different bases (nitrogen containing bases such as DBU or quinoline)141 
and solvents. 
 
3.1.2. Route B: Alpha Lithiation and Cyclization 
 
The second route was planned on the basis of several results. First the Addition/Elimination 
route is a well established procedure which gives very good to excellent yield using 
functionalized aldehydes. 146  The second step involving the deprotonation of a vinyl 
sulfoximine in α-position is known139 and was also investigated in the laboratory.140 The 
cyclization of such systems with the parent functional group sulfoxide was reported by 
Tanaka et al. under treatment of bromo and iodo sulfoxides 113 with LDA at –78 °C in THF 
(Scheme 43).147 
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Scheme 43: Cyclization of vinyl sulfoxides 113. 
 
The 5, 6 and 7 membered ring sulfoxides 114 were isolated in very good yields (81, 82 and 
79% respectively) without loss of chirality at the sulphur atom, which could occur in the case 
of sulfoxides.148 It was postulated that the base deprotonated the sulfoxide 113 to give the α-
lithio vinyl sulfoxide which underwent cyclization to give the cyclic vinyl sulfoxide 114. 
Even the (Z) configured sulfoxide was subjected to the standardized reaction conditions and 
114 113 
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also led to the same product 114, presumably via rapid Z-E isomerization of the double bond. 
The Z-E isomerization was also observed in the case of vinyl sulfoximines, but at higher 
temperature.140  
 
ω-Bromo-vinyl sulfoximines 115 and 116 were synthesized starting from sulfoximines 52 and 
53 respectively and 5-bromo-pentanal in good yields (83 and 73%, Scheme 44). 5-Bromo-
pentanal was prepared by Swern oxidation from the commercially available 5-bromo-
pentanol.149 
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Scheme 44: Synthesis of ω-bromo-vinyl sulfoximines 115 and 116. 
 
ω-Bromosulfoximines 115 and 116 were purified by flash column chromatography but were 
still contaminated by a non identified side product which could not be removed by preparative 
HPLC. The ω-bromosulfoximines 115 and 116 were not stored for a long time but further 
subjected to cyclization due to slow decomposition of these compounds. Based on Tanaka’s 
work, the cyclization reaction was initiated by deprotonation at the α-position of the 
sulfoximine moiety using LDA as base (Scheme 45). The cyclic vinyl sulfoximines 117 and 
118 were obtained in very good yields (80 and 92% respectively).  
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Scheme 45: Synthesis of cyclic vinyl sulfoximines 117 and 118. 
R = Me: 52 
       Bn: 53 
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The use of 1.5 equiv. LDA diminished the yield of cyclic sulfoximine 118 and allyl 
sulfoximine 119 were formed as side products in 8% yields as a mixture of epimers (Scheme 
46). 
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Scheme 46: Formation of the allyl sulfoximine 119 as side product using an excess of base. 
 
Both cyclic vinyl sulfoximines 117 and 118 were then tested as Michael acceptor in the 
phospha-Michael addition. 
 
3.2. Phospha-Michael Addition of Cyclic Vinyl Sulfoximines 
 
Both cyclic vinyl sulfoximines 117 and 118 were tested in the phospha-Michael addition 
using the standardized procedure developed for the acyclic substrates (Scheme 47). As 2 
stereogenic centers are generated, four possible diastereomers can be formed. In both cases, 
only the trans isomers SSRCRC and SSSCSC were isolated in good yields with a dr of 1:1:0:0 
(determined by 1H NMR, Table 9). The formation of the cis isomers might be prevented by 
steric repulsions between the sulfoximine and the phosphino borane group. The isomers 
SSRCRC and SSSCSC could be easily separated by flash chromatography. 
 
116 
118 
65% yield 
119 
8% yield 
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Scheme 47: Synthesis of cyclic phosphine boranes 120−123 via Michael addition. 
 
Table 9: Synthesis of cyclic phosphine boranes 120−123. 
 
Starting 
material R 
Products 
SSRCRC:SSSCSC: 
SSRCSC:SSSCRC 
dr  
SSRCRC:SSSCSC: 
SSRCSC:SSSCRC 
yield (%) 
SSRCRC 
yield (%) 
SSSCSC 
117 Me 120:121:124:125 1:1:0:0 35 46 
118 Bn 122:123:126:127 1:1:0:0 41 39 
 
As discussed above (section  A.2.6), the acyclic phosphine boranes tend to fragment into 
sulfinamide and alkene. This is also true for the cyclic phosphine boranes, especially for N-
methyl substituted phosphine boranes 120 and 121 which rearrange very fast in solution as 
well as “neat”. Therefore phosphine boranes 120 and 121 were subjected to deboronation 
directly after purification by flash column chromatography to avoid this rearrangement. 
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3.3. Optimisation of the Diastereoselectivity of Phospha-Michael Addition of 
Cyclic Vinyl Sulfoximines 
 
The diastereomeric ratio obtained in the phospha-Michael addition of N-methyl cyclic vinyl 
sulfoximine 117 and N-benzyl cyclic vinyl sulfoximine 118 was 1:1:0:0 in both cases, and 
only the trans-isomers (SSRCRC) and (SSSCSC) were formed. To obtain a higher overall yield of 
the desired phosphino-sulfoximine, a more diastereoselective phospha-Michael addition of the 
cyclic vinyl sulfoximine 117 and 118 was investigated.  
 
3.3.1. Diastereoselective Phospha-Michael Addition with Substrate Control 
 
The phospha-Michael addition of vinyl sulfoximine with diphenylphosphine is a base 
catalyzed reaction, but the sulfoximine has itself a basic feature. Therefore, speculations were 
done about a hypothetical 6-membered transition state where an intermolecular hydrogen 
bond between the acidic proton of diphenylphosphine and the basic nitrogen of cyclic vinyl 
sulfoximine 118 would direct the addition (Figure 18).  
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Figure 18: Speculated 6-membered transition state during the phospha-Michael addition of cyclic vinyl 
sulfoximines 117 and 118 and HPPh2 without addition of base. 
  
The first reaction was performed in toluene to increase the hydrogen bonding between cyclic 
vinyl sulfoximine 118 and diphenylphosphine but unfortunately, no reaction was observed at 
RT for 12 h nor at 70 °C. Even neat, the reaction did not proceed at RT, 90 °C nor 130 °C 
during 1 day (Scheme 48). Some decomposition of the starting material was observed. 
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Scheme 48: Attempts on the self catalyzed Michael-addition of the cyclic sulfoximine 118 with HPPh2. 
 
The pKa value of a protonated N-methylsulfoximine is around 11, whereas the pKa value of 
diphenylphosphine is 22.9.150 This large difference of pKa values may be the reason why the 
reaction did not occur. 
 
The role of the cation during the phospha-Michael addition was also investigated at room 
temperature using t-BuOLi instead of t-BuOK. Unfortunately, the reaction catalyzed by the 
lithium salts did not occur. This may be due to the stonger ion pair of t-BuOLi compared to    
t-BuOK.151 
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Scheme 49: Attempts to catalyze the phospha-Michael addition of cyclic vinyl sulfoximine 118 with HPPh2 
using t-BuOLi or Ti(OiPr)4. 
 
The hydrophosphination was also investigated under acidic conditions to enhance the 
electrophilicity of the Michael acceptor. Yao reported a titanium catalyzed 
118 
118 
118 
118 
118 
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hydrophosphonylation of activated alkenes. 152  The reaction was catalyzed by 14 mol% 
Ti(OiPr)4 but no conversion was observed after 24 hours (Scheme 49). 
The phospha-Michael addition of acyclic vinyl sulfoximine 58 with KPPh2 at −78 °C and 
subsequent treatment with MeOH as proton source was not satisfactory due to the basicity of 
the generated KOMe (section  2.3.2). The stronger acid camphorsulfonic acid was used to 
quench the reaction because its conjugated base should not interfere during the reaction. 
Moreover, camphorsulfonic acid is a solid and therefore easier to handle as a liquid for small 
scale reactions. A closer look to the pKa values of the protagonists in this reaction revealed 
that HPPh2 (pKa = 22.9) is more acidic than the phosphinosulfoximine (pKa > 32) and thus, 
the anion 128 could be protonated by a further equivalent of HPPh2 (Scheme 50).  
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Scheme 50: Phospha-Michael addition of cyclic vinyl sulfoximine 118 using an excess of HPPh2 as proton 
source.  
 
The first set of experiments was carried out at low temperature either using LiPPh2 (generated 
by reaction of n-BuLi with HPPh2) or KPPh2 (from a commercial 0.5 M solution in THF). 
Different ratios of diphenylphosphine and metallated diphenylphosphide were tested and the 
results are summarized below (Table 10).  
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Table 10: Phospha-Michael addition of cyclic vinyl sulfoximine 118 using an excess of HPPh2 as proton source.  
equiv. HPPh2 equiv. MPPh2  cation Time (min) 
Diastereomeric ratio 
(SSRCRC:SSSCSC: 
SSRCSC:SSSCRC) 
0.1 1.9 Li 60 1:3:0:0 
1 2  Li 10 1:2.3:0:0 
2 1 K 30 1:2.5:0:0 
 
At lower temperature, the addition of diphenylphosphide proceeded in a more selective way. 
Changing the amount of diphenylphosphine and diphenylphosphide as well as the cation had a 
minor effect of the diastereomeric ratio. In all the cases, the major isomer was the (SSSCSC) 
configured phosphine borane 123. These experiments showed that at low temperature, the 
sulfoximine moiety directs the addition of HPPh2 to the Si face of cyclic vinyl sulfoximine 
118. 
The phospha-Michael addition of the cyclic and acyclic vinyl sulfoximines using 
diphenylphosphine and a catalytic amount of n-BuLi at low temperature was not investigated 
but with consideration, these reaction conditions could have been tested.  
 
3.3.2. Diastereoselective Phospha-Michael Addition Using Chiral Catalysts 
 
Chiral phosphines, which are valuable ligands for metal-catalyzed enantioselective 
transformations, are generally prepared either from an enantiopure starting material, by 
resolution, or by using a stoichiometric amount of chiral auxiliary.87 Although 
hydrophosphinations proved to be valuable for the synthesis of phosphines, methodologies for 
enantioselective P-H additions are limited.153 The use of metal catalyzed processes is not 
trivial due to the coordination ability of the phosphorus atom. Even though, a few metal 
catalyzed asymmetric hydrophosphinations were reported using lanthanide or aluminium154, 
platinum155 and nickel153 catalysts.  
Togni et al. reported an asymmetric hydrophosphination of methacrylonitrile using a chiral 
nickel catalyst (Scheme 51). Methacrylonitrile coordinates to the nickel centre via the nitrile 
nitrogen which ehance the electrophilicity of the activated double bond. 
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Scheme 51: Ni-catalyzed hydrophosphination of methacrylonitrile using pigiphos 129 as chiral ligand. 
 
Thus, the addition of secondary phosphine is much more facilitated, and as the 
methacrylonitrile ligand is sterically contained within a chiral environment, the overall 
process induces chirality.  
Chemists overcame the problem of the coordination capability of the phosphorus atom to 
metal centres using organocatalysts, and some processes are very efficient.156 Even though, 
the use of secondary amine based catalysts implies the formation of an iminium ion157 or an 
enamine158 and therefore the presence of an aldehyde or a ketone is required, limiting the 
scope of such catalysts. Chiral organocatalysts derived from alkaloids as well as phase 
transfert catalysts proved also to be effective catalysts in asymmetric alkylations and Michael 
additions of glycerine derivatives.159  
 
Asymmetric hydrophosphination of styrene derivative was reported by Melchiorre et al. using 
cinchona alkaloid derivatives (Scheme 52).160 Using (DHQ)2PHAL 131 as catalyst, phosphine 
borane 130 was obtained in poor ee (18%) but in promising 76% yield.  
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CYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 68 
NHN
N
SHN
CF3F3C
MeO
NO2
Ph
+ HPPh2
1) chiral alkaloid (10%)
2) HCO2H, NaBH4 NO2
Ph
Ph2P
BH3
N N
RR
R =
N
N
MeO
O
(DHQ)2PHAL
 
 
Scheme 52: Asymmetric organocatalytic hydrophosphination of nitrostyrene using cinchona alkaloids 
derivatives. 
 
After a short catalyst screening, the bifunctional thiourea derivative 132 proved to be the most 
efficient for this transformation. Phosphine borane 130 was isolated in 86% yield with an ee 
value of 67%. The amino group of catalyst 132 activates the phosphino group whereas the 
thiourea functionality activates the nitro group, which leads to a better stereocontrol. 
 
The commercially available quaternary ammonium salt 134 was tested as phase transfer 
catalyst for the diastereoselective phospha-Michael addition of cyclic vinyl sulfoximines 117 
and 118 with diphenylphosphine (Scheme 53). The results are listed in Table 11. The first 
reaction was performed in CH2Cl2 using 10% of chiral quaternary ammonium salt 134 and 
BTPP 133 as a base (Figure 19, Table 11, entry 2). 
 
P NN
N
N
tBu
 
 
Figure 19: Schwesinger base BTPP 133. 
 
The advantages of using the Schwesinger base 133 are multiple: it is a non ionic base and 
therefore soluble in many organic solvents, and the pKa is rather high (pKa = 17 in 
131 
132 
131: 76% yield 
        18% ee 
 
132: 86% yield 
        67% ee 
130 
BTPP 133 
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DMSO).161 No conversion was observed after 24 h (entry 2), which may be due to the ability 
of the base to deprotonate diphenylphosphine, i.e. a too low pKa value. 
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Scheme 53: Diastereoselective phospha-Michael addition of cyclic vinyl sulfoximine 117 and 118 using the 
chiral ammonium salt 134. 
 
Table 11: Diastereoselective phospha-Michael addition of cyclic vinyl sulfoximine 117 and 118 using the chiral 
ammonium salt 134. 
entry substrate 
concentration 
of substrate 
(mol/L) 
phosphorous  
reagent (equiv.) Base 
equivalent 
of 134 solvent 
Conversion 
(%) 
1 118 0.125 HPPh2 (1.1) t-BuOK - THF 100 
2 118 0.3 HPPh2 (1.4) 133  0.1 CH2Cl2 0 
3 117 0.06 HPPh2 (1.1) t-BuOK 0.1 THF 10 
4 117 0.13 HP(O)Ph2 (1.1) 133 0.1 CH2Cl2 0 
5 117 0.19 HP(O)Ph2 (1.1) t-BuOK - THF 0 
6 118 0.03 HPPh2 (1.1) t-BuOK 0.11 THF 0 
7 118 0.005 KPPh2 (1.1) - 1.1 THF 0 
1
 The NR4+ 134 was dried over P2O5 under high vacuo for 3 days.  
 
A second experiment was carried out using t-BuOK as base in THF (entry 3). Due to the 
rather low solubility of quaternary ammonium salt 134 in THF, the amount of solvent was 
increased. Nevertheless after 24 h, the reaction was treated with BH3−THF and worked up. 
Around 10% conversion was observed by 1H NMR spectroscopy.  
The more acidic diphenylphosphine oxide (pKa = 20.6 in DMSO)113 was chosen as 
nucleophile (entry 4). The pKa difference between the acid (diphenylphosphine oxide) and the 
base 133 is around 3.6 units. Disappointingly, the reaction did not proceed even after 24 h. As 
R = Me: 117 
       Bn: 118 
X = none, O  
see Table 11 
134 
base, 134  
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the reactivity of the diphenylphosphine oxide towards vinyl sulfoximines was not investigated, 
the standard conditions for the phospha-Michael addition, i.e. the use of t-BuOK as base were 
tested (entry 5). Interestingly, the addition did not occur.  
The reactivity of organophosphorus compounds in the Pudovik reaction was investigated by 
Koenig et al..162 Radical as well as anionic pathways were studied and from the experimental 
results the following order of reactivity was proposed: 
 
(EtO)2P(O)H  <  Ph2P(O)H  <  Ph2P(S)H  <  Ph2PH 
pKa:                                   20.8               20.7                12.8              22.9               
 
The order of the reagents in the reactivity scale corresponds to the one in the acidity scale 
except for diphenylphosphine which is out of line dramatically. This explains why the 
phospha-Michael addition did not occur with diphenylphosphine oxide.  
When the phospha-Michael additions were not performed under strict oxygen-free conditions, 
no conversion of the vinyl sulfoximine was observed. If 10% of HPPh2 is oxidized to the 
corresponding phosphine oxide, the catalytic amount of t-BuOK will deprotonate 
preferentially the more acidic phosphine oxide and thus, the reaction will be inhibited. 
 
The quaternary ammonium salt 134 was dried over P2O5 during 3 days under high vacuo to 
remove the residual water which could hydrolyse the base, and the reaction was repeated but 
without success (entry 6). In a last experiment, the quaternary ammonium salt was used in 
equimolar amount with KPPh2. As KBr is low soluble in THF, HPPh2 and quaternary 
ammonium salt 134 would be forced to build an ion pair. But also in this reaction, no 
conversion of the cyclic vinyl sulfoximine was observed. A quinoline derivative could be 
isolated after column chromatography, as well as an aromatic phosphorated unidentified 
compound.  
 
Interestingly, the phospha-Michael addition proceeds smoothly without quaternary 
ammonium salt 134 but is inhibited by its use. Several side reactions can be considered. 
Quinolines react in position 2 under treatment with an organolithium or Grignard reagents to 
form the corresponding functionalized dihydroquinolines. 163  This type of nucleophilic 
addition with potassium diphenylphosphide can not be excluded but seems improbable. Upon 
prolonged treatment over KOH, quaternary ammonium salts 134 reacts to afford the enol 
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ether 135 (Scheme 54). Interestingly, in the presence of a nucleophile, a substitution occurred 
and led to the tertiary amine 137 and to the alkylated iminoester 138. 164  
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Scheme 54: Decomposition of quaternary ammonium salt Erreur ! Source du renvoi introuvable.. 
 
3.4. Determination of the Absolute Configuration of the Cyclic Phosphine 
Boranes 
 
The configuration of phosphine boranes 120−123 was determined by 1H, 1H{31P}, 2D 1H-1H, 
1H-13C, 1H-31P NMR and NOE experiments and was later confirmed by a X-ray crystal 
structure analysis of phosphine borane 122. For cyclic phosphine boranes 120−123, no 
coupling as well as no correlation peaks in 2D 1H-1H spectrum was observed between the 
protons α to sulfoximine moiety (proton Ha, Figure 20) and α to phosphino group (proton Hb). 
Protons Ha and Hb were unambigousely assigned by 2D 1H-13C spectroscopy. Indeed, Ca and 
Cb are both tertiary carbons. Ca appears around 60 ppm, which is typical for a sp3 carbon atom 
in alpha position of a sulfoximine group. Cb appears around 25-30 ppm, which is also typical 
for a sp3 carbon atom in alpha position of a borane protected diphenylphosphino group. 
Furthemore, both carbon atoms Ca and Cb are coupled with the phosphorus atom and appear 
as doublet.  
134 135 
136 137 138 134 
CYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 72 
P
BH3
S*
Ha
Hb
S
ON
Ph
R PPh2
BH3
a
b
c
d
e
f
S
ON
Ph
R
S* =
Ph2
90 °
140 °
 
Figure 20: General formula of cyclic phosphine boranes and nomination of the ring protons. 
 
According to the Karplus equation, this would imply a dihedral angle between these two 
protons of nearly 90 °. Therefore, in the most favoured conformation, both sulfoximine 
moiety and phosphino group should adopt almost an axial position: both substituents are in 
trans position to each other. However, for a dihedral angle of 180 ° between the sulfoximine 
and the phosphino group, the dihedral angle between protons Ha and Hb would be around 60 °. 
Therefore the dihedral angle between the sulfoximine and the phosphino group should be 
significantly smaller, around 140 °. Moreover a NOE was observed between both protons Ha 
and Hb in the phosphine boranes 120 and 121. The NOE observed by irradiation the protons 
Ha and Hb of the phosphine boranes 120 and 121 are depicted below (Figure 21 and Figure 
22).  
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Figure 21: NOE observed by irradiation of proton Ha (left) and Hb (right) in the phosphine borane 120. 
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Figure 22: NOE observed by irradiation of proton Ha (left) and Hb (right) for the phosphine borane 121. 
 
For phosphine boranes 120−123, both protons Ha and Hb exhibit a multiplicity of doublet of 
doublet. Each proton Ha and Hb is coupled with the phosphorus atom and with the neighbour 
protons Hfax and Hcax respectively. The 3JHa-Hfeq and 3JHb-Hceq coupling are not observed and are 
therefore smaller than 2 Hz. The J values are represented in Figure 23. 
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Figure 23: Coupling partners of protons Ha and Hb and corresponding J values (Hz) for the cylic phosphine 
boranes 120 and 121. 
 
It is worth noting that in the four phosphine boranes 120−123, the sulfoximine moiety should 
adopt a conformation in which the smallest substituent, the oxygen atom, points below the 
cyclohexyl ring to minimise the steric interactions, whereas the N-methyl and the phenyl 
substituents are directed in the opposite direction. A major difference is observed in the 1H 
NMR spectra of SSRCRC configured phosphine boranes 120 and 122 and SSSCSC configured 
phosphine boranes 121 and 123. In the case of the SSRCRC configured phosphine boranes 120 
and 122, the proton Hb appears at 4.57 ppm and 4.70 respectively, which is close to the 
average value found for the acyclic phosphine boranes (4.5 ppm). In contrary, for the SSSCSC 
configured phosphine boranes 121 and 123, the proton Hb arises at 3.53 and 3.70 ppm 
respectively, which is a high field displacement of 1.07 and 1.00 ppm respectively. In fact for 
120 
 
121 
CYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 74 
the phosphine boranes 121 and 123, the proton Hb is in the anisotropic cone exerted by the 
phenyl ring of the sulfoximine moiety which induces an upfield displacement (Figure 24). 
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Figure 24: Anisotropic effect of the phenyl group of the sulfoximine moiety in cyclic phosphine boranes 
120−123. 
 
In the case of SSRCRC configured phosphine boranes 120 and 122, the Hfeq proton is affected 
by the anisotropic cone of the phenyl group of the sulfoximine moiety. For the phosphine 
borane 120, this induces a high field displacement of 0.73 ppm for the Hfeq proton and 0.09 
ppm for the Hfax proton compared to phosphine borane 121. This induces a high field 
displacement of 0.79 ppm of proton Hfeq of the phosphine borane 122 compared to phosphine 
borane 123.  
Due to these chemical shifts similarities, the absolute configuration of the phosphine boranes 
120 and 122 was assigned as SSRCRC and the absolute configuration of the phosphine boranes 
121 and 123 was assigned as SSSCSC. The absolute configuration of the phosphine borane 122 
was unambiguous confirmed by an X-ray crystal structure analysis (Figure 25).165 Single 
crystals of phosphine borane 122 suitable for X-ray crystal structure were grown at –26 °C in 
ether. 
   SSRCRC  
R = Me: 120 
       Bn: 122  
   SSSCSC 
R = Me: 121 
        Bn: 123 
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Figure 25: Structure of cyclic phosphine borane (SSRCRC)-122 in the crystal. Selected bonding parameters: S−O 
1.431(3), S−N 1.485(4), C−S 1.822(4), P−B 1.927(6), C−P 1.848(4), P−C−C−S 140.7(2). 
 
The crystal contains two symmetrically independent molecules in the asymmetric unit. The  
P-B bond length is 1.927(6), which is almost the same as in the acyclic phosphine borane ent-
62 (1.923(3)) but longer than in the phosphine borane 80 (1.913(5)). The sulfoximine moiety 
as well as the phosphino group adopts an axial conformation. The dihedral angle between the 
phosphorus and the sulphur atom is 140.7 °, and the one calculated between Ha and Hb is 
nearly 82 °. This is in accordance with the spectroscopic data obtained in solution. In the 
crystal structure, the oxygen of the sulfoximine moiety points towards the cyclohexyl ring and 
thus reduces steric hindrances. The conformation adopted by the phosphine borane 122 in the 
crystal and in solution should be similar at least for the P-C-C-S part and the sulfoximine 
moiety. 
 
 
3.5. Deboronation of Cyclic Phosphine Boranes  
 
Phosphino-sulfoximine boranes 120−123 were deprotected using the same procedure as for 
the acyclic phosphino-sulfoximine boranes. The reaction was performed in toluene at 40 °C 
under complete exclusion of air and monitored by 31P NMR.  
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Scheme 55: Deboronation of cyclic phosphino-sulfoximine boranes 120−123. 
 
The reaction time decreased from 2 to 1 hour, which reflects the less basic character of the 
cyclic phosphines compared to the acyclic phosphines. This is also reflected by the longer P-B 
bond length of the cyclic phosphine borane (cf section  3.4). 
Cyclic phosphines 139−142 were obtained in excellent yields (>93%) without side reaction.  
 
3.6. Cyclic Phosphino-Sulfoximines in Asymmetric Allylic Alkylation 
3.6.1. rac-(E)-1,3-Diphenyl-2-propenyl Acetate as Substrate 
 
The cyclic phosphines were tested in Pd-catalyzed asymmetric allylic alkylation of the 
substrate rac-(E)-1,3-diphenyl-2-propenyl acetate 43.  
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Scheme 56: Pd-catalyzed asymmetric allylic alkylation of acetate 43 using cyclic phosphines 139−142. 
SSRCRC   R = Me: 120 
                      Bn: 122  
 
SSSCSC    R = Me: 121 
                      Bn: 123  
 
SSRCRC   R = Me: 139 
                      Bn: 140 
 
SSSCSC    R = Me: 141 
                      Bn: 142   
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As listed below (Table 12), the catalytic experiment carried out with a L:M ratio of 1:1 
furnished the malonate 44 in 97% yield with 86% ee (entry 1).  
 
Table 12: Results obtained in allylic alkylation of acetate 43 using cyclic phosphines 139−142 as ligand. 
 
entry ligand 
x 
(equiv. of 
ligand in 
mol%) 
y 
(equiv. of Pd 
in mol%) 
L:M cation 
yield 
of 
44 
ee of 
44 
(R)1 
1 139 3 3 1:1 Li 97 86 
2 139 6 3 2:1 Li 95 86 
3 139 3 3 1:1 K 96 86 
4 141 3 3 1:1 Li 95 −73 
5 140 3 3 1:1 Li 98 97 
6 142 3 3 1:1 Li 96 −79 
    
1
 A – sign refers to the S-configured product which was obtained as major isomer. 
 
The same results were obtained at L:M = 2:1 (entry 2). This implies that the same catalytic 
active complex is formed at low and high L:M ratio and thus that the cyclic phosphine 
(SSRCRC)-139 most probably acts as a chelate ligand. In the case of the acyclic phosphino-
sulfoximines, the L:M ratio influenced the yield as well as the ee value and therefore, it was 
postulated that the acyclic phosphino-sulfoximines act as a hemilabile ligand. These first two 
experiments proved that the design of the cyclic phosphino-sulfoximines was gainful in term 
enantioselectivity. The best results obtained with acyclic N-methylphosphino-sulfoximine 68 
gave the malonate 44 in 96% yield with 65% ee. Thus, the catalyst containing the cyclic 
ligand (SSRCRC)-139 exhibited a higher enantioselectivity than this derived from the acyclic 
ligand 68. The use of the K as counterion did not influence the yield neither the ee value 
(entry 3). 
The isomer (SSSCSC)-141 was also investigated in Pd-catalyzed allylic alkylation of the acetate 
43 under the same conditions used for (SSRCRC) configured phosphine 139. The ee values 
obtained with the (SSSCSC) configured phosphine 141 was slightly lower than this obtained 
with its isomer (SSRCRC)-120 (entries 4 and 1, 73 versus 86% respectively). But the major 
change is in the absolute configuration of the malonate 44. The use of phosphine (SSRCRC)-
139 as ligand led to the R configured malonate 44, whereas the use of its isomer (SSSCSC)-141 
led to the opposite S configured malonate 44.  
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For the acyclic phosphino-sulfoximines, the replacement of the N-methyl group of the 
sulfoximine by a benzyl group had a beneficial effect in term of yield and enantioselectivity 
of the product 44. This is also true for the cyclic phosphino-sulfoximines. Using the (SSRCRC) 
configured N-benzyl phosphine 140 as ligand, the malonate 44 was isolated in 95% yield with 
an ee value of 97% (entry 5). Moreover, the kinetic of the reaction was much faster than those 
observed with any catalysts derived from the cyclic or acyclic phosphino-sulfoximines. 
Indeed, the catalytic experiment was completed at RT within 50 min using 3 mol% of catalyst. 
The corresponding reaction of the acetate 43 in the presence of the diastereomeric (SSSCSC) 
configured phosphine 142 furnished the opposite S-configured malonate 44 in 96% yield with 
ee of 79% (entry 6).  
 
The (SSRCRC) configured phosphino-sulfoximines 139 and 140 led to the R-configured 
malonate 44 whereas the (SSSCSC) configured phosphino-sulfoximines 141 and 142 led to the 
opposite S-configured malonate 44. In fact, the 2 C-stereogenic centres created during the 
phospha-Michael addition have the opposite configuration. These results show that the chiral 
backbone is the main criterium which influences the selectivity of the reaction whereas the 
sulfoximine moiety exerts only minor role. If the sulfoximine moiety would be discarded, the 
(SSRCRC)- and (SSSCSC)-configured phosphines would be enantiomers. Therefore the (SSRCRC) 
configured phosphines 139 and 140 have a so called matched configuration whereas the 
(SSSCSC) configured phosphines 141 and 142 have a mismatched configuration. 
 
3.6.2. Substrate, Nucleophile and Solvent Variations 
 
Cyclic phosphino-sulfoximines 139−142 proved to be excellent ligands in Pd-catalyzed allylic 
alkylation of (E)-1,3-diphenyl-2-propenyl acetate 43, and especially phosphine (SSRCRC)-140. 
Further catalytic reactions were carried out to explore the scope and the limitations of (SSRCRC) 
configured cyclic ligands 139 and 140 (Scheme 57). 
Several methods are available to generate the dimethyl malonate anion. The one used until 
now was the BSA method.132 The dimethyl malonate anion can also be prepared by reaction 
of dimethyl malonate with NaH. Using phosphine 139 as ligand, the allylic alkylation of the 
acetate 43 provided the product 44 in 87% ee but with a dramatic decrease of the yield (Table 
13, entry 1, 20%). This trend was also observed for the acyclic phosphines when the reaction 
was performed in THF (section  2.7.2). 
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Scheme 57: Allylic substitution of acetate 43 using aza, sulfa and carbo-nucleophiles in the presence of (SSRCRC) 
configured cyclic phosphines 139 and 140. 
 
Table 13: Allylic substitution of acetate 43 using aza, sulfa and carbo-nucleophiles in the presence of (SSRCRC) 
configured cyclic phosphines 139 and 140. 
 
entry ligand nucleophile solvent yield (product) 
ee of 
product 
1 139 dimethyl malonate, NaH THF 20 (44) 87 (R) 
2 139 Benzylamine CH2Cl2 111 (143) n.d. 
3 140 PhSO2Na CH2Cl2/H2O (3:1) cat. NBu4Br 45 (97) 6 (-)
2
 
4 140 PhSO2Na THF 13 (97) 20 (-)2 
  
1
 Conversion calculated on the crude 1H NMR spectroscopy. 
  2 The absolute configuration was not determined. 
 
Benzyl amine as well as benzyl sulfinate were also tested as nucleophile in allylic substitution 
using cyclic phosphines 139 and 140 as ligand. The reaction of the acetate 43 in the presence 
of the phosphine 139 and involving benzyl amine as nucleophile showed a very low 
conversion (entry 2). The yield of allylic amine 143 could be evaluated by 1H NMR of around 
11%. The allylic amination of the acetate 43 could not be performed in reasonable yield using 
either the cyclic or the acyclic phosphino-sulfoximines as ligand. The more rigid backbone of 
cyclic phosphine 139 did not increase the reactivity of the catalyst towards allylic amination 
of acetate 43. 
Sodium sulfinate was also investigated as nucleophile in allylic substitution of acetate 43 in 
the presence of the phosphine 140 as ligand. The first catalytic experiment was carried out in 
a biphasic solvent system composed of CH2Cl2/H2O (3:1) with a catalytic amount of NBu4Br. 
A moderate yield (45%) of the corresponding allylic sulfone 97 was isolated in almost 
43 
Nu = CH(CO2Me): 44 
                   BnNH: 143 
                   SO2Ph: 97 
SSRCRC-139 SSRCRC-140 
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racemic form (6% ee, entry 3). The use of THF as solvent led to a decrease of the yield (13%) 
with a slightly better ee value (20% ee, entry 4). Unfortunately, as CH2Cl2 was not 
investigated as solvent for this nucleophile, the comparison with the acyclic phosphines is not 
possible.  
 
Although high yields and ee values were obtained in allylic alkylation with the phosphino-
sulfoximine ligands, a drawback is the purification of the phosphino-sulfoximines which is 
carried out by chromatographic column under strict oxygen exclusion. This is the trickiest 
procedure for the synthesis of the phosphines and therefore, if this purification step can be 
avoided, i.e. if the activity of the catalyst is not impaired by the DABCO-BH3 adducts 89, 
their use would be consequently easier. Phosphine 140 was synthesised as usual from 
phosphine borane 122 and without any purification, the crude mixture containing phosphine 
140 was used to generate the active catalyst and reacted with acetate 43. The R-configured 
malonate 44 could be isolated within 1 hour in 96% yield with an ee value of 95%, which is a 
loss of only 2% of enantioselectivity compared to the purified phosphine 140. The same 
procedure was repeated with its diastereomer (SSSCSC)-142 and in this case, the S-configured 
malonate 44 was isolated in 96% yield with an ee value of 79%, which are exactly the same 
results obtained with the purified phosphine 142. The DABCO-BH3 adduct do not impair the 
catalyst activity or at least in a minimal proportion. 
 
1,3-Diphenyl-2-propenyl acetate 43 is often used as substrate to test the catalytic activity of a 
new catalysts in asymmetric allylic alkylation. The two phenyl groups at the allyl termini are 
much more bulky than alkyl groups and therefore the ee values obtained with this substrate 
are often high compared to those obtained with 1,3-dimethyl-2-propenyl acetate 144. The 
phosphine 140, which exerts the highest enantioselectivity in the allyl alkylation of 1,3-
diphenyl-2-propenyl acetate 43 with dimethyl malonate, was tested as ligand in the 
corresponding reaction with rac-1,3-dimethyl-2-propenyl acetate 144 (Scheme 58). 
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Scheme 58: Pd-catalyzed allylic alkylation of rac-(E)-1,3-dimethyl-2-propenyl acetate 144 using the cyclic 
phosphine 140 as ligand. 
 
After 3.5 h, the catalytic experiment was quenched and the R-configured malonate 145 was 
isolated in 95% yield with an ee value of 59%. The absolute configuration of malonate 145 
was the same than this obtained with the corresponding diphenyl substituted malonate 43.  
The asymmetric allylic substitution of cyclic substrates having a cyclopentenyl or 
cyclohexenyl backbone is of great interest because these structures are commonly found in 
natural products.166 The asymmetric allylic alkylation of rac-cyclohex-2-enyl acetate 95 was 
studied in the presence of phosphine 140.  
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Scheme 59: Pd-catalyzed allylic alkylation of rac-cyclohex-2-enyl acetate 95 with phosphine 140. 
 
After 24 h reaction, the R-configured malonate 96 was isolated in 70% yield with an ee value 
of 36%. Also in this case, the absolute configuration of the cyclic malonate 96 was the same 
than this obtained with the dimethyl and diphenyl malonates 145 and 44. To date, only few 
ligands induce a high degree of selectivity with such cyclic systems.167  
 
R-145 144 
140 
R-96 95 
140 
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3.7. Structure of the Palladium Complex  
Excellent results were obtained in Pd-catalyzed asymmetric allylic alkylation of 1,3-diphenyl-
2-propenyl acetate 43 using cyclic phosphino-sulfoximine 140 as ligand. A deeper 
understanding of the active catalyst could allow further modifications of the ligand structure. 
The coordination mode of cyclic phosphino-sulfoximine 140 was assumed to be bidentate but 
no concrete evidences were found. 
 
3.7.1. Pd2.DBA3.CHCl3 and Ligand 140 
 
The coordination mode of cyclic phosphino-sulfoximine 140 was examinated. Two different 
solutions of the catalyst were prepared in CD2Cl2 from the cyclic phosphino-sulfoximine 
ligand 140 and Pd2(DBA)3.CHCl3. Several complexes can be considered (Figure 26).  
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Figure 26: Conceivable complexes formed by reaction of phosphino-sulfoximine 140 and Pd2(DBA)3.CHCl3. 
 
The first solution of the catalyst contained a ratio L:M = 1:1 (solution A), whereas the second 
solution of the catalyst a ratio L:M = 2:1 (solution B). Both solutions A and B were analysed 
by NMR and mass spectroscopy.  
Due to the broadness of the signals appearing in the 1H NMR spectra of both solutions, the 
signal assignments were difficult. In contrary, the 31P NMR spectra were easier to analyze. 
The spectra of the solution A exhibited a sharp signal at 36.4 ppm and another small broad 
signal appeared around 40 ppm. The broadness of this signal may be due to dynamic 
phenomena. Indeed, the DBA can adopt different conformation in complexes [Pd(140)DBA] 
and [Pd(140)2DBA] leading to diastereomeric complexes which can be in fast equilibrium 
with each other.168 The 31P NMR spectrum of the solution B exhibited four signals. Among 
them, two signals corresponding to those in solution A were observed. The third signal at 
−13.1 ppm was assigned to the free ligand 140. The lowest field signal appeared at 41.4 ppm.  
[Pd(140)DBA] [Pd(140)2DBA] [Pd(140)2] 
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The assignment of the signals observed in 1H NMR and 31P NMR spectra was not trivial and 
therefore mass spectroscopy was used. 
 
The solution A was evaporated and the crude mixture was dissolved in CHCl3 and diluted 
with MeOH. A mass spectrum of this mixture A was recorded (Figure 27).  
 
Figure 27: ESI-mass spectrum of the crude mixture A. 
 
The cluster appearing at m/z = 838 was attributed to the complex 146 with formula 
[Pd(DBA)(140)H]+, and the MS/MS fragmentation showed its parent relationship by loss of 
DBA with the cluster at m/z = 604, which was attributed to complex 147 (Scheme 60). The 
isotopic distribution showed the presence of a palladium atom and the simulated isotopic 
pattern is in accordance with these formulas (see experimental part, Figure 32 and Figure 31, 
section  B.12). 
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Scheme 60: Proposed structures and fragment for the clusters at m/z = 604 and 838. 
 
The cluster appearing at m/z = 1441 was attributed to the ion of the dinuclear complex 148 
with formula [Pd2(DBA)(140)2]+ which showed a parent relationship by loss of DBA with 
complex 149 at m/z = 1207 with formula [Pd2(140)2H]+. The m/z value of 1209 (Figure 27) 
146 147 
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corresponds to one of the isotope of complex 149. The fragmentation of complex 149 led to a 
peak at m/z = 894, matching with the structure of ion 150. 
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Scheme 61: Proposed structures and fragments for the clusters at m/z = 1441 and 1209. 
 
The isotopic distribution of these clusters is in accordance with those obtained with the 
simulated spectra (see experimental part, Figure 33, section  B.12). Such palladium(0) 
dinuclear complexes were rarely described in the literature.169 The proposed structures and 
fragmentations presented in Scheme 60 and Scheme 61 are drawn for a better comprehension 
and may differ from the exact structure of these complexes.  
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The mass spectrum of mixture B was recorded under the same conditions as for mixture A. 
 
Figure 28: ESI-mass spectrum of the crude mixture B. 
 
The cluster at m/z = 904 was attributed to complex 151 and the loss of phosphine 152, 
observed by MS/MS, showed its parent relationship with complex 153 appearing at m/z = 638 
(Scheme 62).  
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Scheme 62: Proposed structures and fragment for the clusters appearing at m/z = 904 and 638. 
 
The MS/MS fragmentation of the cluster appearing at m/z = 1271 led to two ions with 
m/z = 1206 and 648 (Scheme 63). The structure of these ions remained unknown. 
 
m/z = 1271
m/z = 1206
m/z = 648
− 623
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Scheme 63: Fragmentation of the cluster appearing at m/z = 1271. 
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The MS/MS fragmentation of the cluster appearing at m/z = 1257 led to an ion with 
m/z = 1026 . Its further fragmentation led to an ion of m/z = 759 (Scheme 64). The structure 
of these ions remained also unknown. 
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Scheme 64: Fragmentation of the cluster appearing at m/z = 1257.  
 
Only traces of the complex [Pd(140)2] (m/z = 1100) could be detected in the mixture B which 
is a hint for the bidentate behaviour of ligand 140. The formation of complex 151 can be 
explained as follow. As two equivalents of ligand 140 are present in solution, the excess 
(calculated for a bidentate ligand) undergoes a rearrangement to phosphino-alkene 152 and 
sulfinamide (see section  2.6 for a similar mechanism with phosphine boranes). Thus, 
phosphino-alkene 152 acts as a ligand to form complex 151. 
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3.7.2. [Pd(diphenylallyl)Cl]2 and Ligand 140 
 
Although a crystal structure of a complex does not represent its behaviour in solution, this is 
still a valuable source of information. Therefore growing a crystal of [Pd(diphenylallyl)(140)] 
complex 155 was considered. The synthesis of the pi-allyl complex required the preparation of 
the starting palladium complex [Pd(diphenylallyl)Cl]2 154, which was synthesized following 
Bosnich procedure (Scheme 65).170 
 
PdCl2 Ph Ph
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+
Ph Ph
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2
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CO bubbling
 
Scheme 65: Synthesis of the [Pd(diphenylallyl)Cl]2 complexe 154. 
 
[Pd(diphenylallyl)Cl]2 complex 154 was reacted with phosphino-sulfoximine 140 and an 
anionic metathesis was performed using AgSbF6. After removal of the salts and the solvents, 
an orange sticky solid containing complex 155 was obtained (Scheme 66).  
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Scheme 66: Synthesis of [Pd(diphenylallyl)(140)]+SbF6- 155. 
 
Unfortunately, all attempts to crystallize complex 155 failed. Black palladium was observed 
after 2 weeks. Nevertheless, the orange sticky solid containing complex 155 was analyzed by 
NMR spectroscopy. Among the major signals assigned to complex 155, signals of lower 
intensity were also observed. Selected chemical shifts of phosphino-sulfoximine 140 and allyl 
complex 155 are reported below (Table 14).  
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Table 14: Selected NMR spectroscopic data (from 1H, 13C{1H} and 31P{1H} spectra) of phosphino-sulfoximine 
140 and pi-allyl complexes 155 and 156171 recorded at room temperature in CDCl3, THF-d8 and CDCl3 
respectively. 
 
 
 
S
ON
Ph
PPh2Bn
Ph Ph
Pd SbF6
pi1 pi3
pi2
 
P
O
N
iPr
Pd
Ph Ph
SbF6
pi1
pi2
pi3
 
entry atom 
number 
δH 
(ppm) δC (ppm) δH (ppm) δC (ppm) δH (ppm) δC (ppm) 
1 a 3.15 59.4 (d) 5.10 63.8 (d) - - 
2 b 4.14 29.4 (d) 3.12 28.0 (d) - - 
3 g 3.95 2.55  - - 
4 g' 4.30 
45.9 
3.40 
47.8 (s) 
- - 
5 pi1 - - 6.80 (n.d.) 106 (d) 5.84 (dd) 100.2 (d) 
6 pi2 - - 6.60 (m) 110 6.82 (dd) 111.6 
7 pi3 - - 4.11 (d) 67 4.28 (d) 70.9 
  δP (ppm) 
8  −13.1 (s) 33.1 (s) 22.7 (s) 
  coupling constants (Hz) 
9 3JHa-Hb < 2  11 - 
10 2JP-Cpi1 - 17  23 
11 3JP-Hpi1 - n.d. 9.4 
12 3JHpi1-Hpi2 - n.d. 13.8 
13 3JHpi2-Hpi3 - 10.4 11.0 
 
1H, 13C and 31P NMR spectra of phosphine 140 were fully and unambiguously assigned 
through 2D 1H-1H, 1H-13C, 31P-13C and DEPT and NOE experiments. Protons Ha and Hb were 
assigned by 2D 1H-13C. Ca and Cb are both tertiary carbons. Ca appears at 59.4 ppm, which is 
in the range of a sp3 carbon atom in alpha position of a sulfoximine group. Cb appears at 
29.4 ppm, which is typical for a sp3 carbon atom in alpha position of a diphenylphosphino 
group. Moreover, both carbon atoms Ca and Cb are coupled with the phosphorus atom and 
appear as doublet. 
The first obvious difference between phosphino-sulfoximine 140 and complex 155 lies in the 
chemical shift in the 31P NMR spectrum. The chemical shift of phosphino-sulfoximine 140 
155 140 
S
ON
Ph
PPh2
a b
c
d
e
f
g
Ph
156 
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appears at −13.1 ppm, whereas the chemical shift of complex 155 appears at 33.1 ppm (Table 
14, entry 8). This low field displacement is typical for a coordinated phosphorus atom to a 
transition metal.172  This is the evidence that at least the phosphorus atom of phosphino-
sulfoximine 140 coordinates to the palladium atom. The second observation is focused on the 
chemical shift displacement of protons Ha and Hb. Proton Ha appears at 3.15 ppm for 
phosphino-sulfoximine 140 whereas for complex 155 it appears at 5.10 ppm. This is a 
downfield displacement of nearly 2 ppm (entry 1). Proton Ha was assigned by 2D 1H-13C. The 
chemical shift of carbon Ca (63.8 ppm) is close to the one of phosphino-sulfoximine 140 and 
appears as a tertiary carbon in DEPT. Proton Hb appears at 4.14 ppm for phosphino-
sulfoximine 140 and 3.12 ppm for complex 155, which is a high field displacement of 
1.02 ppm (entry 2). Proton Hb was also assigned by 2D 1H-13C. The chemical shift of carbon 
Cb (28.0 ppm) is also close to the one of phosphino-sulfoximine 140 and appears as a tertiary 
carbon in DEPT. The diastereotopic protons Hg suffered a high field displacement which 
might be due to anisotropic effects of the phenyl rings of the allyl moiety (entries 3 and 4). 
The conformation of phosphino-sulfoximine 140 is close to the one in phosphine borane 122, 
at least for the S-C-C-P dihedral angle. In both cases, no coupling (< 2 Hz) is observed 
between protons Ha and Hb, either by selective irradiation of proton Ha or Hb, or by COESY 
spectrum (entry 9). Protons Ha and Hb are in trans position with a dihedral angle of nearly 90°. 
Consequently the sulfoximine as well as the phosphino moieties adopt an almost axial 
position (section  3.4). This is not true anymore in allyl complex 155. The coupling constant 
between protons Ha and Hb is 11 Hz, which translates into a dihedral angle between 130° and 
150° (entry 9). Thus, another conformation of phosphino-sulfoximine ligand in complex 155 
is adopted. This conformation change, which is not observed in phosphino-sulfoximine 140, is 
favoured in complex 155 due to a coordination of both the nitrogen and the phosphorus atom 
to the palladium atom. This a crucial point because it means that the phosphino-sulfoximine 
140 acts as a bidentate and not as a monodentate ligand. 
Moreover the chemical shift of Ca in phosphino-sulfoximine 140 is 59.4 ppm, whereas it 
appears at 63.8 ppm in complex 155 (entry 1). The σ-coordination of the nitrogen atom of the 
sulfoximine moiety induces an electro-deficiency of the neighbouring atoms. The chemical 
shift of Cb in phosphino-sulfoximine 140 is 29.4 ppm, whereas it appears at 28.0 in complex 
155 (entry 2).  
Carbon Cpi1 appeared at 106 ppm as a doublet with a coupling constant 2JP-Cpi1 through the 
palladium atom of 17 Hz. This shows that the allyl ligand is still coordinated to the palladium 
atom, and these values are close to those reported for complex 156.171 Unfortunately, the 
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coupling constant 3JP-Hpi1 could not be determined because of the overlapping of aromatic 
protons peaks. Thus, proton Hpi1 was detected via 2D 1H-13C correlation (entry 5). Proton Hpi2, 
assigned by 2D 1H-1H, appeared at 6.60 ppm together with an aromatic proton peak, which 
prevented the determination of coupling constants (entry 6). Carbon Cpi2 appeared at 110 ppm, 
whereas it appeared at 111.6 ppm in complex 156. Proton Hpi3, also assigned by 2D 1H-1H, 
appeared at 4.11 ppm as a doublet with a coupling constant of 10.4 Hz (entries 7 and 13). 
These values are close to those reported for complex 156, where proton Hpi3 appeared at 
4.28 ppm also as a doublet with a coupling constant of 11 Hz. For complex 156, proton Hpi2 
appeared at 6.82 ppm as doublet of doublet. Carbon Cpi3 appeared at 67 ppm. The high field 
resonance of carbon Cpi3 can be attributed to the amount of sp3 character due to the pi-back 
donation of the metal. In contrast, carbon Cpi1, which is trans to the pi-acceptor phosphorus 
atom, appeared at 106 ppm. 
To simplify the analysis of the pi-allyl moiety, the following designations will be used (Figure 
29). The exo and endo isomers refer to complexes in which the vectors Cpi2−Hpi2 and Cb−Hb 
point in the same or the opposite direction, respectively.  
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Figure 29: Exo and endo isomers. 
 
Thus, the eight possible stereoisomers of (η3-allyl) complex 155 are presented below (Figure 
30). Substituents on the terminal allylic carbon atoms can assume a syn or anti orientation 
with respect to proton Hpi2. 
 
 
exo isomer endo isomer 
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Figure 30: Eight possible stereoisomers of (η3-allyl) complex 155. 
 
Such pi-allyl complexes are usually in thermodynamic equilibrium. Anti,anti complexes are 
therefore not favoured due to steric hindrances, and only if the substituents R are sufficiently 
small, anti,syn or syn,anti isomers are present in notable amount. However, such complexes 
could be characterized with ligands exerting stong steric hindrance.31, 173  Usually, the 
thermodynamically favoured complexes are the syn,syn isomers.  
To differentiate between these eight isomers, the coupling constants between the allylic 
protons and NOE experiments can furnish helpfull information. For exemple, a NOE 
observed between Hpi1 and Hpi2 will exclude the isomers with syn,syn and anti,syn 
configuration. Moreover, an exo or an endo configuration could be indicated by a NOE 
between the allyl protons and the ligand backbone.  
As the 31P NMR spectrum exhibit only one strong singlet together with two other small 
singlets in a ratio 96:2:2, one major complex is present in solution or, several complexes are 
in fast equilibrium and the chemical shift in 31P NMR spectrum represents an average of their 
chemical shifts.  
The 3JHpi2-Hpi3 value was 10.4 Hz, which would imply that both hydrogens Hpi2 and Hpi3 are 
trans. The 3JHpi2-Hpi3 value of a cis arrangement is typically smaller than 10 ppm.31,173 Thus, the 
anti,syn configuration of the pi-allyl ligand can be excluded. A NOE was observed between 
proton Hpi3 and one of the signals at 6.60 ppm. Althought proton Hpi2 appeard at 6.60 ppm, this 
NOE is most probably due to the proximity of proton Hpi3 and either a proton of the 
diphenylphosphine moiety or the phenyl group of the pi-allyl ligand. A second NOE was 
observed between proton Hpi3 and a proton appearing in the aromatic region at 6.80 ppm, 
endo, syn, syn exo, syn, syn endo, anti, syn exo, anti, syn 
endo, anti, anti exo, anti, anti endo, syn, anti exo, syn, anti 
CYCLIC PHOSPHINO-SULFOXIMINES 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 92 
which could not be unequivocally assigned. A further NOE exists between signals at 6.4 ppm 
and 7.93 ppm. Further assignements could not be performed. 
According to the spectroscopic data, the following four isomers can be proposed: 
endo,syn,syn, exo,syn,syn, endo,syn,anti and exo,syn,anti. pi-Allyl complexes are usually in 
equilibrium and the major complex observed might not be the isomer which leads to the major 
product, i.e. the most reactive complex. The following scheme shows the allyl alkylation of 
these four complexes by dimethyl malonate anion (Scheme 67). 
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Scheme 67: Conceivable structures of the pi-allyl complexes 155 and their allylic alkylation. 
 
The models of the four isomers of complex 155 are drawn assuming that the 6-membered 
matallacycle adopts a boat or twisted boat conformation. Thus, the endo complexes would be 
disfavoured due to steric repulsions between the allyl ligand and the diphenylphosphino group.  
The catalyst prepared from the N-methyl and N-benzyl substituted phosphino-sulfoximines 
139 and 140 respectively lead both to the R-configured malonate 44 in 86 and 97% ee, 
respectively. The small N-methyl substituent of ligand 139 does probably not exert enough 
steric hindrances with the pi-allyl moiety to favour a syn,anti configuration. As both catalysts 
lead to the same R-configured malonate 44, the syn,anti configuration in complex 155 should 
also not be favoured, i.e. the N-benzyl substituent of ligand 140 does not exert enough steric 
hindrances with the pi-allyl moiety. Moreover, models of complex 155 do not show strong 
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steric hindrances of the ligand backbone with the pi-allyl moiety, which could stabilize a syn-
anti isomer. This argumentation, which should be taken with care, would favour the 
exo,syn,syn and the endo,syn,syn isomers of complex 155.  
A nucleophilic substitution trans to the phosphorus atom of the endo,syn,syn isomer of 
complex 155 would lead to the minor S-configured malonate 44, whereas a nucleophile 
substitution of the exo,syn,syn isomer would lead to the major R-configured malonate 44 
(Scheme 67). Nuclephilic substitution trans to the nitrogen atom is not expected due to the 
weaker Pd-C bond trans to the phosphorus atom. Thus, the most probable configuration of the 
most reactive isomer of complex 155 would be the exo,syn,syn isomer.  
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4. Conclusion  
 
This work was focused on the synthesis of chiral bidentate 1,5-P,N-phosphino-sulfoximines 
and their application as ligand in Pd-catalyzed allylic alkylation. The key step of their 
synthesis was a phospha-Michael addition of vinyl sulfoximines. Although carbon, oxa, aza 
and sulpha-Michael additions were largely reported, no phospha-Michael addition of vinyl 
sulfoximines was described at the beginning of this project. Starting from N-substituted 
sulfoximines 52−55, vinyl sulfoximines 58−61 were obtained in excellent yields. Phosphino-
sulfoximine boranes 62, 63 and 76−81 were obtained via phospha-Michael addition of vinyl 
sulfoximines 58−61 in good yields (70-80%) with de up to 56%. The de values could be 
increased at lower temperature but with lower yields. The separation of the phosphine borane 
isomers was achieved by crystallization and/or chromatographic column. The absolute 
configuration of the RSSC phosphino-sulfoximine ent-62 was determined by X-ray crystal 
structure analysis. Similarity in the 1H NMR spectra of the phosphino-sulfoximine boranes led 
us to assume their absolute configuration. The short three steps synthesis of phosphino-
sulfoximines 68, 69 and 84−88 was carried out with 14 to 48% overall yield (Scheme 68).  
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Scheme 68: Synthesis of acyclic phosphino-sulfoximines 68, 69 and 84−88. 
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Acyclic phosphino-sulfoximines 68, 69 and 84−88 were tested in Pd-catalyzed asymmetric 
allylic alkylation. Very good results were obtained with the SSRC phosphino-sulfoximine 84 
(Scheme 69).  
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Scheme 69: Best acyclic phosphino-sulfoximine ligand 84 for Pd-catalyzed allylic alkylation of 43. 
 
The configuration of the chiral C-atom is important and this showed a match (SSRC) and 
mismatched configuration (SSSC). A hemilability of these ligands was proposed, leding to the 
design of the cyclic phosphino-sulfoximines, expected to confine the flexibility of the ligand 
backbone. The phospha-Michael addition strategy was chosen to access the cyclic phosphino-
sulfoximines 139−142, and only the two trans isomers were isolated in a ratio 1:1 in good 
yield (80%). The absolute configuration of the cyclic phosphine boranes 120−123 was 
established by an X-ray crystal structure of the SSRCRC configured cyclic phosphine borane 
122 and NMR experiments. The overall 4 steps synthesis was carried out in 22 to 27% overall 
yield (Scheme 70). 
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Scheme 70: Synthesis of cyclic phosphino-sulfoximines 139−142. 
 
The optimisation of the ligand structure proved to be successful. SSRCRC configured N-benzyl 
phosphino sulfoximine 140 showed excellent results in Pd-catalyzed allylic alkylation of 
substrate 43 and the corresponding malonate 44 was obtained in 98% yield with 97% ee 
(Scheme 71). This is, to date, the best P,N-phosphino-sulfoximine ligand reported for Pd-
catalyzed allylic alkylation of malonate 44 in terms of selectivity.26 As expected, the 
alkylation of less bulky dimethy substrate 144 and cyclic substrate 95 proceeded with less 
enantiocontrol.  
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Scheme 71: Most selective cyclic phosphino-sulfoximine 140 for Pd-catalyzed allylic alkylation. 
 
Interestingly, when the SSSCSC configured N-benzyl phosphino sulfoximine 142 was used as 
ligand, the other enantiomer of malonate 44 was obtained. This shows that the sulfoximine 
moiety does not have a major influence on the selectivity. For the cyclic phosphino-
sulfoximines, there is also a match conformation SSRCRC and a mismatched conformation 
SSSCSC. The attempt to synthesis the SSRCRC configured N-benzyl phosphino sulfoximine 140 
in a better overall yield was not successful. At low temperature, the sulfoximine moiety 
induced a selectivity in favour to the other diastereomer SSSCSC 141.  
The coordination mode of the cyclic phosphino-sulfoximine was examined. NMR 
investigations of ligand 140 showed that both sulfoximine and phosphino groups adopt an 
axial position, whereas in allyl complex 155 these groups adopt a equatorial position. This 
distortion of the ligand backbone proved a bidentate P,N coordination mode of the ligand.  
Analysis of a solution of the phosphino-sulfoximine 140 with Pd2(DBA)3.CHCl3 by mass 
spectroscopy revealed the presence of an unexpected palladium(0) dimers. 
 
140 
R = Me: R-145  
95% yield, 59% ee 
        
        Ph: R-44 
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R = Me: 144 
        Ph: 43 
95 R-96 
70% yield, 36% ee 
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5. Outlook 
 
The synthesis of the SSRCRC phosphino-sulfoximine 140 in a better overall yield would be 
interesting to develop. Efforts should be done in a better diastereoselective phospha-Michael 
addition. The use of chiral amine to activate diphenylphosphine or bifunctional organocatalyst 
to activate simultaneously the diphenylphosphine and the Michael system could be envisaged 
(Scheme 72).  
S
ON
Ph
Bn
HPPh2
chiral amine
S
ON
Ph
Bn PPh2
NR
NR
H
S
ON
Ph
Bn
HPPh2+
BA
*
S
ON
Ph
Bn PPh2
PPh2
S
ON
Ph
Bn H
PPh2
BA
*
 
 
 
Scheme 72: Conceivable diastereoselective phospha-Michael addition of cyclic vinyl sulfoximine 118 with 
HPPh2 using either a chiral amine or a bifunctional chiral catalyst. 
 
The bit angle, especially for bis-phosphine,174 but also for P,N-ligands is a critical parameter 
for the activity and selectivity of catalysts.175 The cyclization of the ω-bromosulfoximines 
was based on the work of Tanaka et al. on the corresponding sulfoxides. 5 and 7 membered 
cyclic vinyl sulfoximines should be also accessible by this method and phospha-Michael 
addition of the corresponding cyclic vinyl sulfoximines would lead to the 5 and 7 cyclic 
phosphino-sulfoximines (Scheme 73). Moreover, the replacement of the methyl group by a 
benzyl group at the nitrogen atom of the sulfoximine was beneficial in term of 
enantioselectivity and kinetic in the Pd-catalyzed allylic alkylation of rac-(E)-1,3-diphenyl-2-
propenylacetate 43. Thus, substitution at the nitrogen atom with bulkier substituents can be 
considered.  
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Scheme 73: Conceivable tuning of the cyclic phosphino-sulfoximines. 
 
The synthesis of the acyclic and cyclic phosphino-sulfoximines starts with the 
functionalization at the nitrogen atom of the sulfoximine and thus, in order to test the 
influence of the nitrogen substituent in the Pd-catalyzed allylic alkylation, the synthesis of the 
ligand should start from the beginning. The convergent synthesis of the N-substituted 
phosphino-sulfoximine depicted in Scheme 74 shows a late functionalization at the nitrogen 
atom through the use of a labile silyl group, which can facilitate the screening of new 
phosphino-sulfoximines bearing various substituents at the nitrogen of the sulfoximine. 
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Scheme 74: Conceivable convergent synthesis for the screening of N-substituted phosphino-sulfoximines. 
 
Chiral and achiral P,N ligands are not only used in Pd-catalyzed allylic alkylation but also in 
Ir-catalyzed hydrogenation of alkenes and ketones, Cu-catalyzed Diels-Alder and hetero 
Diels-Alder reaction, Cu-catalyzed 1-4 additions, Rh-catalyzed hydroformylation.99 The 
cyclic and acyclic phosphino-sulfoximines could be tested in such catalytic reactions.  
 
The phospha-Michael addition of vinyl sulfoximines with diphenylphosphine catalyzed by    
t-BuOK was investigated in this work and led to diarylalkylphosphines. The reactivity of 
HP(OPh)2 towards the phospha-Michael addition of vinyl sulfoximines can be studied. If the 
addition is successful, diaryl alkylphosphonites could be synthesized and tested as ligand in 
Pd-catalyzed allylic alkylation, but also in Rh-catalyzed hydroformylation. Various aryl 
groups could be introduced, such as phenyl or naphtyl. A further chiral information could be 
introduce with a binaphtyl group. A biphenyl group could be also introduce and study the 
effect of the sulfoximine group on the atropoisomerism of the biphenyl group.176  
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Scheme 75: Conceivable phospha-Michael addition of cyclic vinyl sulfoximines with diarylphosphonites leading 
to diaryl alkylphosphonites. 
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B. Experimental Part 
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1. General Remarks 
 
All chemical operations including reactions, work-ups and purifications were carried out in a 
well ventilated hood, using safety glasses, lab coat and gloves.177 
The reactions involving air and moisture sensitive compounds were carried out under an 
argon or nitrogen atmosphere using the standard Schlenck techniques. Reagents and solvents 
were transferred using cannulas and syringes. Air and moisture sensitive compounds were 
stored in Schlenk flasks with a small pressure of argon at room temperature or at 4 °C. 
Compounds suffering from rearrangements were kept at −60 °C. 
 
2. Solvents and Chemicals 
2.1. Solvents 
Solvents used for flash chromatography, such as hexane, cyclohexane, EtOAc, Et2O and 
pentane were distilled before use. In the case of sensitive reactions, the solvents were purified 
according to standard techniques.178 
Et2O and THF: predried over KOH, passed through basic alumina, and distilled from sodium-
benzophenone ketyl under nitrogen. 
CH2Cl2: shacked several times with concentrated sulphuric acid to remove ethanol, washed 
with water and NaHCO3, dried over CaCl2, refluxed several hours over CaH2 and distilled 
under nitrogen. 
Toluene: one fifth is distilled off to remove water azeotropically, and the remaining four fifths 
are distilled from sodium under nitrogen. 
Methanol and ethanol: refluxed over Mg-turning (activated with I2), and distilled under argon. 
tert-Butanol: refluxed either over Na or LiAlH4 and then distilled under argon. 
1,2-Dimethoxyethane: Aldrich, quality: extra dry, stored over molecular sieve, water < 50 
ppm, used without other purification. 
N,N’-Dimethylformamide: Aldrich, quality: extra dry, stored over molecular sieve, water < 50 
ppm, used without any other purification. 
DMSO: Aldrich, quality: 99.9%, anhydrous. 
BnOH: Aldrich, quality: 99.8%, anhydrous. 
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For air sensitive compounds, oxygen-and water free solvents were used. Anhydrous solvents 
were degassed via three freeze-thaw cycles. The anhydrous solvents were transferred with a 
syringe equipped with a cannula into a Schlenck tube previously degassed and filled with 
argon, and closed with two Glindemann®-sealing rings and PARAFILM®M. The Schlenck 
tube which remained under argon was placed in liquid nitrogen until the entire solvent freeze. 
Then high vacuo was applied and the Schlenck tube was carefully taken out the liquid 
nitrogen. When the solvent was completely melted, the procedure was repeated twice. The 
solvents were stored in the Schlenck tube closed with two Glindemann®-sealing rings and 
further PARAFILM®M under argon without other manipulation. 
 
2.2. Chemicals 
2.2.1. Reagents 
 
All the reagents employed were purchased from commercial suppliers (Acros, Sigma-Aldrich, 
Fluka, Lancaster, Merck). 
t-BuOK and t-BuOLi: sublimed before use. 
Diisopropylamine: refluxed over CaH2 for 3 hours and then distilled under argon. 
n-BuLi: received as a 1.6 M solution, and titrated using either diphenylacetic acid or 
phenantroline and dried benzyl alcohol.179 
All other chemicals were used as received without further purification. 
 
2.2.2. Starting Materials Prepared According to the Literature 
 
The following starting materials were prepared according the literature: Pd2(DBA)3.CHCl3,180 
[Pd(1,3-diphenyl-pi-allyl)Cl]2, 181  (E)-1,3-diphenylprop-2-en-1-ol, 182  (E)-1,3-diphenylallyl 
acetate,182 cyclohex-2-enol, cyclohex-2-enyl acetate, cyclohex-2-enyl methyl carbonate, (E)-
pent-3-en-2-ol, (E)-pent-3-en-2-yl acetate, (S) and (R)-S-methyl-S-phenylsulfoximine183. 
 
2.3. Analytical Methods 
2.3.1. NMR Spectroscopy 
 
The coupling constants XJY-Z are given in Hertz. X refers to the number of σ-bonds between 
the nucleus Y and Z. The multiplicity of the signals was denoted as follow: s = singlet, 
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d = doublet, t = triplet, b = broad signal, and combination of them, like bs = broad singlet, 
dd = doublet of a doublet. Assignments of the peaks in the 1H NMR spectra were made by 
GMQCOSY, GNOE, or GTOCSY experiments, and those in the 13C NMR spectra were made 
by APT, DEPT and HETCOR experiments. 
 
1H NMR: recorded on a Varian Gemini 300 (300 MHz), Varian Mercury 300 (300 MHz), 
Varian Inova 400 (400 MHz) or Varian Unity 500 (500 MHz). The chemical shifts are given 
in ppm relative to tetramethylsilane (TMS, δ = 0.00 ppm) as internal reference, or to residual 
solvents signals (tetrahydrofuran = 1.73 and 3.58 ppm, chloroform = 7.26 ppm, 
methylenchlorid = 5.32 ppm). The NOE experiments were recorded on either on a Varian 
Inova 400 (400 MHz) or a Varian Unity 500 (500 MHz). 
 
13C NMR: recorded on a Varian Gemini 300 (75 MHz), varian Inova 400 (100 MHz) or 
Varian Unity 500 (125 MHz). The chemical shifts are given in ppm relative to 
tetramethylsilane (TMS, δ = 0.00 ppm) as internal reference, or relative to deuterated    
solvent signal (tetrahydrofuran = 25.4 and 67.6 ppm, chloroform = 77.0, 
methylenchlorid = 53.8 ppm). 
 
31P NMR: recorded on a Varian Gemini 300 (75 MHz) or a varian Inova 400 (100 MHz). The 
chemical shifts are given in ppm relative to H3PO4 as external reference. 
 
In the case of air and/or water sensitive compounds, dried and degassed deuterated solvent 
were used. The NMR tube was placed in a Schlenck tube, degassed and filled 4 times with 
argon. The compound was dissolved in the appropriate deuterated solvent, and transferred by 
using a syringe equipped with a cannula to the NMR tube by opening the Schlenck tube and 
keeping a flow of argon. The tube was removed from the Schlenck tube and closed rapidely 
with a plastic cap which was kept tight with a thin band of stretchable PARAFILM®M. 
 
In the case of highly air and/or water sensitive compounds, the NMR measurements were 
effectuated in sealed NMR tubes using the following procedure. A special NMR tube having a 
Schenck adaptor on the top was degassed and filled with argon 4 times. The compound was 
dissolved in the appropriate dried and degassed deuterated solvent, and transferred to the 
NMR tube by using a syringe equipped with a cannula. The solution was cooled to −78 °C 
and vacuum was applied. The NMR tube was sealed using an acetylene torch. The sample 
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was allowed to warm to room temperature behind a security glass, and was kept for further 15 
min aside before starting the measurement. 
 
2.3.2. IR Spectroscopy 
 
IR spectra were recorded on a Perkin-Elmer PE 1760 FT spectrometer as KBr pellets or in 
solution. Absorptions are given in cm−1 in a range of 4000 to 850 cm−1. The following 
abbreviations are used to describe the relative intensity of absorption: w = weak (65−85%), 
m = medium (26−65%), s = strong (0−25%). 
 
2.3.3. Mass Spectroscopy 
 
Mass spectra were recorded on a Varian Mat 212 S and Finnigan MAT 312 for ionisation 
through for EI (Electronic impact, 70 eV) and CI (chemical ionization, 100 eV), ESI 
(electrospray ionisation) and ESI−MS/MS were recorded on a Thermo Finnigan LCQ DECA 
XPlus. The masses are given in m/z.  
High resolution mass spectroscopy (HRMS) were recorded on a Finnigan MAT 95 (EI) or on 
a Micromass LCT (LC-TOF-HRMS, column Acquity UPLC BEH C18) and the values are 
given in amu (atomic mass unit). 
 
2.3.4. Gas Chromatography 
 
Gas chromatography analysis were performed on a Varian 3800 (Star Workstation 5.3) with 
FID and ECD detector, and a Carlo Erba MEGA (Labquest 6.4) with FID detector. The 
normal phase column used was CP-Sil-8, the chiral columns used were Lipodex-γ-6-Me 
(Macherey & Nagel) and Chiraldex βI (CP). 
Temperature programme 1: 50 °C, 15 min, then 10K/min to 80 °C, 5 min, then 10K/min to 
120 °C, 5 min, 10K/min, 100 kPa H2. 
Temperature programme 2: 50 °C, 15 min, then 2K/min to 80 °C, 5 min, then 10K/min to 
120 °C, 5 min, 100 kPa H2. 
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2.3.5. High Pressure Liquid Chromatography 
• Analytical HPLC 
Analytical HPLC were performed on a Millipore Waters (UV-481), Hewlett Packard HP 
1050 with DA detector. 3 types of columns have been used: Chiralcel-OD-H with precolumn, 
chiralpack AD and chiralpack IA. 
 
• Preparative HPLC 
Preparative HPLC were performed with a Varian SD1 (Star Workstation 5.3) with UV and RI 
detector, using either a column Kromasil (Si 100, ∅ 30  mm) or a Kromasil (Si 100, ∅ 
40 mm). 
 
2.3.6. Elemental Analysis 
 
Elemental analyses were performed on a Heraeus CHN-Rapid. All values are given in mass 
percentages. 
 
2.3.7. Melting Point 
 
Melting points were measured in an open glass capillary using a Büchi 510 
Schmelzpunktbestimmungsapparatur SMP-20. 
 
2.3.8. Optical Rotation 
 
Optical rotations [α]D were measured on a Perkin Elmer Polarimeter PE 241 and given in 
grad × mL/dm × g, and the concentration c in g/100 mL. The measurements were effectuated 
at 22 °C. 
 
2.3.9. Thin Layer Chromatography 
 
Thin layer chromatography (TLC) was carried out with aluminium sheets silica gel 60 F254 
(Merck) with fluorescent indicator. The detection was carried out either by UV-light detection 
(λ = 254 nm) or using dyes.184 
Dyes used:  
I2 in silica gel 
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p-Anisaldehyde (5.1 mL p-anisaldehyde, 2.1 mL acetic acid, 6.9 mL sulphuric acid and 
185 mL ethanol) 
Phosphomolybdic acid (5 g phosphomolybdic acid in 100 mL ethanol) 
Potassium permanganate (1 g KMnO4, 7 g K2CO3, 100 mL H2O) 
Ninhydrin (0.3 g ninhydrin, 3 mL acetic acid in 80 mL ethanol) 
 
2.3.10. Preparative Column Chromatography 
 
Flash column chromatography was carried out in glass columns using Merck silica gel 60, 
particle size 0.040-0.063 mm. The solvents used were simply distilled before use. 
Air and moisture sensitive compounds: 
Flash column chromatography was carried out in a glass column (20mm×1.7 mm) with an 
argon entry on the top and at the bottom a schlenck to collect fractions. The column was filled 
to a half and degassed. The solvents were dried and degassed before use. 
 
2.3.11. Crystallisation Techniques 
 
3 types of crystallisations have been carried out: 
 The compound (or crude mixture) was dissolved in the minimum amount of solvent, and a 
second less polar solvent was layered on the top this solution. 
 The compound (or crude mixture) was dissolved in the minimum amount of solvent and 
cooled down (4 °C or −26 °C). 
 The compound (or crude mixture) was dissolved in a polar solvent and the solution 
transferred in a test tube (typically 5×1 cm) which was kept into a bottle containing a less 
polar volatile solvent (1 to 2 cm). The bottle was closed and kept at a lower temperature 
(4 °C or −26 °C). 
 
2.3.12. X-ray Crystal Structure Analysis 
 
X-ray crystal structure analysis have been carried out on a Bruker Proteum X8 or a Enraf-
Nonius CAD4. 
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3. Abbreviations 
 
Ar  aryl 
BINAP 2-(diphenylphosphino)-1-(2-(diphenylphosphino)naphthalen-1-yl)naphthalene 
BTPP  t-butylimino-tri(pyrrolidino)phosphorane 
Boc  t-butyloxycarbonyl 
n-BuLi n-butyllithium 
t-BuOK potassium t-butoxide 
t-BuOLi lithium t-butoxide 
Bn  benzyl 
BSA  N,O-bis-(trimethylsilyl)acetamide 
∆  heating 
dba  trans,trans-dibenzylidene acetone 
de  diastereomeric excess 
DIOP  2,2-dimethyl-4,5-bis((diphenylphosphino)methyl)-1,3-dioxolane 
DIPAMP 1,2-bis((2-methoxyphenyl)(phenyl)phosphino)ethane 
DME  1,2-dimethoxy ethane  
DMF  dimethyl formamide 
dr  diastereomeric ratio 
ee  enantiomeric excess 
ent  enantiomer 
equiv.  equivalent 
Et2O  diethyl ether 
Fmoc  fluorenyl methoxy carbonyl 
eV  electron-Volt 
HPLC  High Pressure Liquid Chromatography 
L:M  ligand to metal ratio 
LDA  lithium diisopropyl amide 
MCPBA m-chloro-perbenzoic acid 
MSH  o-mesitylene sulfonyl hydroxylamine 
NMR  nuclear magnetic resonance 
NOE  Nuclear Overhauser Effect 
NuH  nucleophile 
Ph  phenyl 
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PHOX  phosphine oxazoline 
ppm  part per million 
rac  racemic 
RT  room temperature 
Rt  retention time 
T°  temperature 
TBDPS t-butyldiphenylsilyl 
THF  tetrahydrofurane 
TLC  Thin Layer Chromatography 
Tol  p-tolyl 
Ts  p-toluol sulfonyl 
 
4. General procedures 
4.1. General Procedure for the Preparation of Acyclic Vinyl Sulfoximines (GP-1) 
 
In an oven dried round bottom Schlenck flask, the appropriate N-substituted-S-methyl 
sulfoximine (1 mmol) was dissolved in anhydrous THF (2.5 mL) and cooled to –78 °C. A 
solution of n-BuLi (688 µL of a 1.6 M in n-hexane, 1.1 mmol) was added dropwise to the 
mixture, and the resulting yellow solution was stirred for 30 min. The appropriate aldehyde 
(1.1 mmol) was added within 5 min and the colourless solution was stirred at the same 
temperature for 1 h. To this mixture was added ClCO2Me (1.1 mmol) and it was allowed to 
warm to room temperature. After stirring the mixture for 1 h, it was cooled to –78 °C and 
DBU (1.1 mmol) was added dropwise. The mixture was allowed to warm to room 
temperature and was stirred overnight. The heterogeneous mixture was quenched with 
saturated aqueous NH4Cl and extracted with the appropriate organic solvent (4×15 mL). The 
combined organic phases were dried (MgSO4) and concentrated in vacuo. 
 
4.2. General Procedure for the Preparation of Cyclic Vinyl Sulfoximines (GP-2) 
 
In an oven dried round bottom Schlenck flask, freshly distilled diisopropylamine (143 µL, 
1.02 mmol) was dissolved in anhydrous THF (22 mL). The solution was cooled to –78 °C, 
and n-BuLi (638 µL of a 1.6 M in n-hexane, 1.02 mmol) was added dropwise. The mixture 
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was stirred for 15 min and was allowed to warm to room temperature for 5 min, and was 
cooled to –78 °C. A solution of the vinyl sulfoximine (1 mmol) in THF (22 mL), which was 
previously cooled to –78 °C, was added to the first Schlenck flask within 5 min via a double-
ended cannula. The yellow mixture was stirred for 40 min and was allowed to warm to 0 °C 
before quenching with saturated aqueous NH4Cl. The organic layer was separated, and the 
aqueous layer was extracted with EtOAc (3×30 mL). The combined organic phases were 
dried (MgSO4) and concentrated in vacuo. 
 
4.3. General Procedure for the Preparation of Phosphine Boranes (GP-3) 
 
The synthesis was carried out under strict oxygen- and water-free conditions. In an oven dried 
round bottom Schlenck flask, the appropriate N-substituted vinyl sulfoximine (1 mmol) was 
dissolved in anhydrous and degassed THF (8 mL). Then diphenylphosphine (205 mg, 
1.1 mmol) and freshly sublimed t-BuOK (11 mg, 0.1 mmol) were successively added at room 
temperature. The mixture was stirred at the same temperature until TLC indicated a complete 
conversion of the vinyl sulfoximine (1 to 2 h). The mixture was cooled to 0 °C and BH3-THF 
(2.2 mL of a 1 M solution in THF, 2.2 mmol) was added dropwise. The mixture was allowed 
to warm to room temperature, and after 1 h it was cooled to 0 °C. 1 M H2SO4 (CAUTION: 
gas evolution) was added carefully until a pH of 5 was reached, and the mixture was extracted 
with CH2Cl2 (3×10 mL). The combined organic phases were dried (MgSO4) and concentrated 
in vacuum. The ratio of diastereomeric phosphine boranes was determined by HPLC analysis 
or 1H NMR spectroscopy of the crude mixture. 
 
4.4. General Procedure for the Preparation of Phosphino-Sulfoximines (GP-4) 
 
The solvents used in this procedure for the reaction and the purification process were dried 
and degassed. The synthesis was carried out in an oven dried round bottom Schlenck flask 
under strict oxygen- and water-free conditions. To a solution of the phosphine borane adduct 
(1 mmol) in anhydrous and degassed toluene (10 mL) was added DABCO (117 mg, 
1.05 mmol) at room temperature. The solution was heated at 40 °C (1 h for the cyclic 
phosphine boranes, 2 h for the acyclic phosphine boranes), and the solvent was removed 
under reduced pressure to give a sticky solid. A short chromatographic column equipped with 
a Schlenck adaptor on the top and a 100 mL round bottom Schlenck flask at the bottom was 
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filled with silica gel. The chromatographic column was kept under high vacuum for 5 min and 
filled with argon. This was repeated 4 times. The silica gel was wetted with solvent 
(Et2O/CH2Cl2, 97:3) by applying a low argon pressure on the top of the column and low 
vacuum at the Schlenck flask so that the silica gel remained wett. Then the crude mixture was 
dissolved in the minimum amount of CH2Cl2, and the solution was loaded on the top of the 
chromatographic column using a syringe. The chromatographic column was eluted with 
approximately 25 mL of solvent (Et2O/CH2Cl2, 97:3) using a syringe and collected in the 
Schlenck flask. The Schlenck flask was disconnected from the column and the solvent was 
removed under high vacuo to yield the free phosphine. 
 
4.5. General Procedure for the Catalytic Allylic Alkylation Reactions (GP-5) 
 
This procedure was run in an oven dried round bottom Schlenck flask under oxygen- and 
water-free conditions. Pd2DBA3.CHCl3 (7.4 mg, 7 µmol) and phosphine (14 µmol) were 
dissolved in CH2Cl2 (2 mL). The mixture was heated at reflux for 1 h, allowed to reach room 
temperature and transferred to a Schlenck flask containing the appropriate allylic acetate 
(480 µmol). The volume of solvent was adjusted to 3 mL trough addition of CH2Cl2, and the 
mixture was treated subsequently with dimethyl malonate (138 µL, 1.19 mmol), N,O-
bis(trimethylsilyl)acetamide (320 µL, 1.19 mmol) and lithium acetate (1 mg). After TLC 
indicated the complete conversion of the allylic acetate, the mixture was quenched with water 
(3 mL) and extracted with EtOAc (3×3 mL). The combined organic phases were dried 
(MgSO4) and concentrated in vacuo. 
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5. Synthesis of N-Substituted S-Methyl-sulfoximines 
5.1. (+)-(S)-(N-Methyl-S-methyl-sulfonimidoyl)benzene (52) 
 
S
ON
CH3
H3C
 
52 
C8H11NOS 
MW = 169.24 g.mol-1 
 
Sulfoximine 24 (44.7 g, 290 mmol) and paraformaldehyde (19.2 g, 640 mmol) were dissolved 
in 98% HCO2H (850 mL) and the mixture was heated at reflux for 3 d. Then HCO2H was 
distilled of, the residue dissolved in water (400 mL) and Na2CO3 was added carefully until a 
pH of 9 was reached. The aqueous phases was extracted with EtOAc (6×150 mL) and the 
combined organic layers were dried (MgSO4) and concentrated in vacuo. High vacuum 
distillation (0.9 mBar, 88 °C) furnished sulfoximine 52 (45.7 g, 93%) as a colourless oil. 
 
1H NMR (300 MHz, CDCl3): δ = 2.59 (s, 3H, NCH3), 3.02 (s, 3H, SCH3), 7.47–7.60 (m, 3H, 
o-Ph and p-Ph), 7.84 (m, 2H, m-Ph). 
 
13C NMR (75 MHz, CDCl3): δ = 29.5 (CH3, NCH3), 45.0 (CH3, SCH3), 128.8 (CH), 129.5 
(CH) (S-o-Ph and S-m-Ph), 133.0 (CH, S-p-Ph), 138.7 (C, S-i-Ph). 
 
Analytical data are in agreements with those reported in the literature.185 
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5.2. (+)-(S)-(N-tert-Butyldiphenylsilyl-S-methyl-sulfonimidoyl)benzene (55) 
S
ON
CH3
Si
CH3
H3C
H3C
 
55 
C23H27NOSSi 
MW = 393.62 g.mol-1 
 
To a solution of sulfoximine 24 (5.46 g, 35.8 mmol) in anhydrous DMF (50 mL) was added 
imidazol (5 g, 73 mmol) and the mixture was cooled to 0 °C. A solution of t-butyldiphenyl-
chlorosilane (12 g, 44 mmol) in DMF (25 mL) was added to the mixture, which was stirred 
for 1 h at 0 °C and then 6 h at room temperature. The mixture was poured into ice cold water 
(120 mL) and extracted with cyclohexane (5×100 mL). The combined organic phases were 
dried (MgSO4) and concentrated in vacuo. Column chromatography (cyclohexane/EtOAc, 5:1) 
afforded sulfoximine 55 (14.55 g, 98%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3): δ = 1.10 (s, 9H, C(CH3)3), 2.86 (s, 3H, SCH3), 7.27–7.46 (m, 
8H, S-m-Ph Si-m-Ph and Si-p-Ph), 7.51 (m, 1H, S-p-Ph), 7.71 (m, 2H, Si-o-Ph), 7.77 (m, 2H, 
Si-o’-Ph), 7.94 (m, 2H, S-o-Ph). 
 
13C NMR (100 MHz, CDCl3): δ = 19.3 (C, Si-C), 27.1 (CH3, C(CH3)3), 48.9 (CH3, S-CH3), 
126.8 (CH, S-o-Ph), 127.19 (CH, Si-m-Ph), 127.23 (CH, Si-m-Ph’), 128.66 (CH, S-m-Ph), 
128.79 (CH, Si-p-Ph), 128.84 (CH, Si-p-Ph’), 132.0 (CH, S-p-Ph), 135.35 (CH, Si-o-Ph), 
135.41 (CH, Si-o-Ph’), 136.0 (C, Si-C), 136.1 (C, Si-C’), 144.2 (C, S-C). 
 
Analytical data are in agreements with those reported in the literature.186 
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5.3. (+)-(S)-(N-Tosyl-S-methyl-sulfonimidoyl)benzene (54) 
S
ON
CH3
S
O
O
 
54 
C14H15NO3S2 
MW = 309.40 g.mol-1 
 
To a solution of sulfoximine 24 (12.07 g, 77.76 mmol) in pyridine (52 mL) was added 
tosylchloride (15.00 g, 77.76 mmol) at room temperature whereby the solution turned brown. 
A precipitate appeared and the mixture was stirred overnight at the same temperature. The 
salts were filtered off and the mixture was poured into H2O (200 mL). The mixture was 
extracted with CH2Cl2 (3×120 mL) and the combined organic phases were washed twice with 
10% HCl (2×30 mL) and finally with water (50 mL). The organic phase was dried (MgSO4) 
and concentrated in vacuo. Cristallisation of the residue from EtOH afforded sulfoximine 54 
(22.00 g, 92%) as a white solid. 
 
 
1H NMR (300 MHz, CDCl3): δ = 2.40 (s, 3H, PhCH3), 3.43 (s, 3H, SCH3), 7.27 (d, 3JH-H = 
8.0 Hz, 2H, SO2-m-Ph), 7.61 (m, 2H, S-m-Ph), 7.71 (m, 1H, S-p-Ph), 7.86 (bd, 3JH-H = 8.5 Hz, 
2H, SO2-o-Ph), 8.01 (bd, 3JH-H = 8.0 Hz, 2H, S-o-Ph). 
 
13C NMR (75 MHz, CDCl3): δ = 21.5 (CH3, PhCH3), 46.6 (CH3, S-CH3), 126.5 (CH, SO2-o-
Ph), 127.3 (CH, S-o-Ph), 129.1 (CH, SO2-m-Ph), 129.5 (CH, S-m-Ph), 134.2 (CH, S-p-Ph), 
138.2 (C), 140.4 (C), 142.7 (C) (S-i-Ph, SO2-i-Ph and SO2-p-Ph). 
 
Analytical data are in agreements with those reported in the literature.187 
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5.4. (+)-(S)-(N-Benzyl-S-methyl-sulfonimidoyl)benzene (53) 
S
ON
CH3
 
53 
C14H15NOS 
MW = 245.34 g.mol-1 
 
In an oven dried round bottom Schlenck flask, sulfoximine 24 (7.76 g, 50 mmol) was 
dissolved in anhydrous DME (50 mL). This solution was added dropwise at 0 °C using a 
double-ended cannula to a suspension of potassium hydride (2.2 g, 55 mmol from a 35% 
suspension in mineral oil which was weighed after washing the suspension twice with hexane 
and dried in vacuo) in DME (50 mL). The mixture was stirred for 30 min at room temperature, 
and then solid n-Bu4NBr (0.80 g, 2.5 mmol) and benzylbromid (8.88 mL, 75 mmol) were 
successively added. After 1 h, TLC showed the complete conversion of the starting material 
24. Then the reaction mixture was cooled to 0 °C and ice cold 2 M sulphuric acid (CAUTION: 
gas evolution) was carefully added until a pH of 1 was reached. Et2O (120 mL) was added, 
and the organic phase was discarded. The aqueous phase was neutralized by careful addition 
of solid Na2CO3 and extracted with EtOAc (5×75 mL). The combined organic phases were 
dried (MgSO4) and concentrated in vacuo. Purification by Kugelrohr distillation (2.3 mbar, 
160 °C) afforded sulfoximine 53 (11.26 g, 90%) as a colourless oil. 
 
1H NMR (400 MHz, CDCl3): δ = 3.14 (s, 3H, SCH3), 3.98 (d, 2JH-H = 14.3 Hz, 1H, NCH2), 
4.20 (d, 2JH-H = 14.3 Hz, 1H, NCH2), 7.19 (tt, 3JH-H = 7.2 Hz, 4JH-H = 1.4 Hz, 1H, CH2-p-Ph), 
7.28 (m, 2H, CH2-m-Ph), 7.35 (m, 2H, CH2-o-Ph), 7.52–7.64 (m, 3H, S-o-Ph and S-p-Ph), 
7.94 (m, 2H, S-m-Ph). 
 
 
13C NMR (100.6 MHz, CDCl3): δ = 45.2 (CH3, S-CH3), 47.3 (CH2, N-CH2), 126.4 (CH, 
NCH2-p-Ph), 127.4 (CH, NCH2-o-Ph), 128.1 (CH, NCH2-m-Ph), 128.5 (CH, S-o-Ph), 129.3 
(CH, S-m-Ph), 132.7 (CH, S-p-Ph), 139.2 (C), 141.0 (C) (S-i-Ph and NCH2-i-Ph). 
Rf (cyclohexane/EtOAc, 2:1): 0.20. 
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Analytical data are in agreements with those reported in the literature.188 
 
6. Synthesis of Acyclic Vinyl Sulfoximines 
6.1. (+)-(E)-(2-((S)-N-Benzyl-S-phenylsulfonimidoyl)vinyl)benzene (59) 
S
ON
 
59 
 
Following GP-1, the vinyl sulfoximine 59 was prepared starting from sulfoximine 53 (2.30 g, 
9.38 mmol), n-BuLi (16.45 mL, 10.32 mmol), benzaldehyde (1.10 g, 10.32 mmol), ClCO2Me 
(980 mg, 10.32 mmol) and DBU (1.57 g, 10.32 mmol) in THF (30 mL). Purification by 
column chromatography (cyclohexane/EtOAc, 85:15) afforded the vinyl sulfoximine 59 
(3.84 g, 91%) as a pale yellow solid. Crystallisation by layering hexane on the top of a 
saturated solution of the crude mixture in CH2Cl2 afforded the vinyl sulfoximine 59 as fine 
white needles. 
 
1H NMR (300 MHz, CDCl3): δ = 4.22 (d, 2JH-H = 14.6 Hz, 1H, NCH2), 4.35 (d, 2JH-H = 14.6 
Hz, 1H, NCH2), 6.88 (d, 3JH-H = 15.3 Hz, 1H, SCH), 7.22 (m, 1H, Ph), 7.34 (m, 5H, Ph), 7.44 
(m, 4H, Ph), 7.56 (4H, m, Ph and S-CH=CH), 8.01 (m, 2H, Ph). 
 
13C NMR (75 MHz, CDCl3): δ = 47.2 (CH2), 126.5 (CH), 127.6 (CH), 127.8 (CH), 128.3 
(CH), 128.4 (CH), 128.7 (CH), 129.0 (CH), 129.3 (CH), 130.8 (CH), 132.7 (CH), 132.8 (C), 
140.1 (C), 141.5 (C), 142.6 (CH). 
 
MS (CI, methane) : m/z (%) = 334 [M++1] (100), 332 (5), 257 (4), 256 (7), 232 (5), 230 (4), 
229 (13),209 (5), 208 (12), 124 (3), 107 (3), 106 (8), 105 (6), 91 (10). 
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IR (KBr): ν = 3058 (m), 3027 (m) , 2922 (w), 2882 (s), 2836 (m), 1750 (w), 1612 (m), 1574 
(w), 1491(m), 1445 (m), 1349 (w), 1240 (s), 1122 (s), 1074 (s), 1025 (w), 974 (s), 921 (w), 
886 (m), 861 (m), 810 (m) cm−1. 
 
HRMS (EI, 70 eV): C21H19NOS Calculated Found 
  333.1187 333.1188 
 
Elemental analysis: C21H19NOS Calculated Found 
MW = 333.45 g.mol-1 C 75.64 75.70 
 
H 5.74 5.71 
 
N 4.20 4.17 
 
Melting point: 101 °C. 
 
Optical rotation: [α]D +24.0 (c 1.00, CH2Cl2). 
 
Rf (cyclohexane/EtOAc, 85:15): 0.23. 
 
6.2. (–)-(E)-(2-((S)-N-tert-Butyldiphenylsilyl-S-phenylsulfonimidoyl)vinyl) 
benzene (61) 
S
ON
Si
H3C
H3C CH3
 
61 
 
Following GP-1, the vinyl sulfoximine 61 was prepared starting from sulfoximine 55 (6.00 g, 
15.24 mmol), n-BuLi (10.5 mL, 16.77 mmol), benzaldehyde (1.78 g, 16.77 mmol), ClCO2Me 
(1.59 g, 16.77 mmol) and DBU (2.55 g, 16.77 mmol) in THF (45 mL). Purification by column 
chromatography (cyclohexane/EtOAc, 12:1) afforded the vinyl sulfoximine 61 (6.23 g, 85%) 
as a colourless oil which solidified upon standing at 4 °C. 
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1H NMR (300 MHz, CDCl3): δ = 1.13 (s, 9H, C(CH3)3), 6.63 (d, 3JH-H = 15.2 Hz, 1H, SCH), 
7.19 (m, 2H, Ph), 7.28 (m, 9H, Ph), 7.42 (m, 4H, Ph and S-CH=CH), 7.75 (4H, m, Ph), 7.93 
(m, 2H, Ph). 
 
13C NMR (75 MHz, CDCl3): δ = 19.5 (C), 27.2 (CH3), 127.32 (CH), 127.34 (CH), 127.36 
(CH), 128.2 (CH), 128.7 (CH), 128.8 (CH), 128.91 (CH), 128.93 (CH), 130.2 (CH), 131.8 
(CH), 132.0 (CH), 132.9 (C), 135.61 (CH), 135.64 (CH), 136.3 (C), 136.4 (C), 138.8 (CH), 
144.3 (C). 
 
MS (CI, methane): m/z (%) = 482 [M++1] (16), 466 (3), 432 (3), 426 (4), 425 (11), 424 (34), 
407 (3), 406 (10), 405 (29), 404 (100), 364 (4), 302 (3), 286 (3), 133 (3), 111 (3), 107 (6), 105 
(17), 101 (3), 99 (3), 91 (3), 79 (9), 75 (4), 73 (4), 71 (4), 61 (11). 
 
IR (KBr): ν = 3048 (m), 2952 (m), 2928 (m), 2887 (m), 2853 (m), 1616 (m), 1578 (w), 1472 
(w), 1445 (m), 1425 (m), 1390 (w), 1283 (s), 1185 (w), 1140 (s), 1103 (s), 1025 (m), 999 (w), 
965 (m), 870 (m), 820 (s) cm−1. 
 
HRMS (EI, 70 eV): C30H31NOSSi–C4H9 Calculated Found 
  424.1191 424.1195 
 
Elemental analysis: C30H31NOSSi Calculated Found 
MW = 481.19 g.mol-1 C 74.80 74.83 
 
H 6.49 6.78 
 
N 2.91 2.76 
 
Melting point: 69 °C. 
 
Optical rotation: [α]D –62.26 (c 1.30, CH2Cl2). 
 
Rf (cyclohexane/EtOAc, 15:1): 0.17. 
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6.3. (+)-(E)-(2-((S)-N-Methyl-S-phenylsulfonimidoyl)vinyl)benzene (58) 
S
ONH3C
 
58 
C15H15NOS 
MW = 257.09 g.mol-1 
 
Following GP-1, the vinyl sulfoximine 58 was prepared starting from sulfoximine 52 (4.05 g, 
23.93 mmol), n-BuLi (16.45 mL, 26.29 mmol), benzaldehyde (2.79 g, 26.29 mmol), 
ClCO2Me (2.49 g, 26.29 mmol) and DBU (4.00 g, 26.29 mmol) in THF (60 mL). Purification 
by column chromatography (cyclohexane/EtOAc, 3:2) afforded the vinyl sulfoximine 58 
(5.42 g, 88%) as a colourless oil, which crystallized at −26°C. 
 
1H NMR (300 MHz, CDCl3): δ = 2.81 (s, 3H, NCH3), 6.88 (d, 3JH-H = 15.3 Hz, 1H, SCH), 
7.37 (m, 3H, CH-m-Ph and CH-p-Ph), 7.47 (m, 2H, CH-o-Ph), 7.50–7.62 (m, 4H, S-o-Ph and 
S-p-Ph and S-CH=CH), 7.96 (m, 2H, S-m-Ph). 
 
13C NMR (75 MHz, CDCl3): δ = 29.5 (CH3, N-CH3), 127.4 (CH, S-CH), 128.4 (CH), 128.7 
(CH), 129.0 (CH), 129.4 (CH) (CH-o-Ph, CH-m-Ph, S-o-Ph and S-m-Ph), 130.8 (CH), 132.7 
(CH) (CH-p-Ph and S-p-Ph), 132.8 (C, CH-i-Ph), 139.4 (C, S-i-Ph), 142.6 (CH, S-CH=CH). 
 
Melting point: below 20 °C. 
 
Rf (cyclohexane/EtOAc, 3:2): 0.23. 
 
Analytical data are in agreements with those reported in the literature.189 
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6.4. (–)-(E)-(2-((S)-N-Tosyl-S-phenylsulfonimidoyl)vinyl)benzene (60) 
S
ONS
O
O
 
60 
C21H19NO3S2 
MW = 397.08 g.mol-1 
 
Following GP-1, the vinyl sulfoximine 60 was prepared starting from sulfoximine 54 (6.80 g, 
22.0 mmol), n-BuLi (15.3 mL, 24.2 mmol), benzaldehyde (2.57 g, 24.2 mmol), ClCO2Me 
(2.28 g, 24.2 mmol) and DBU (3.69 g, 24.2 mmol) in THF (60 mL). Purification by column 
chromatography (cyclohexane/EtOAc/DCM, 13:6:1) afforded the vinyl sulfoximine 60 
(5.42 g, 88%) as a white solid. 
 
1H NMR (300 MHz, CDCl3): δ = 2.36 (s, 3H, Ph-CH3), 6.90 (d, 3JH-H = 15.1 Hz, S-CH), 7.23 
(m, 2H, Ph), 7.34–7.47 (m, 4H, Ph), 7.52–7.67 (m, 5H, Ph and S-CH=CH), 7.86 (m, 2H), 8.01 
(m, 2H, Ph). 
 
13C NMR (75.4 MHz, CDCl3): δ = 21.5 (CH3), 125.5 (CH), 126.8 (CH), 127.7 (CH), 128.9 
(CH), 129.1 (CH), 129.3 (CH), 129.6 (CH), 131.7 (CH), 131.8 (C), 134.0 (CH), 138.7 (C), 
140.8 (C), 142.8 (C), 143.9 (CH). 
 
Rf (cyclohexane/EtOAc/CH2Cl2, 65:30:5): 0.25. 
 
Analytical data are in agreements with those reported in the literature.190 
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7. Synthesis of ω-Bromo Vinyl Sulfoximines 
 
The vinyl sulfoximines 115 and 116 were contaminated with unidentified side products even 
after several purifications including preparative HPLC. Moreover, the vinyl sulfoximines 115 
and 116 were not stored but used in the next step to avoid degradation. 
 
7.1.  (S,E)-(N-Methyl-6-bromohex-1-enyl-sulfonimidoyl)benzene (115) 
S
N O
Br
H3C
 
115 
C13H18BrNOS 
MW = 316.26 g.mol-1 
 
 
Following GP-1, the vinyl sulfoximine 115 was prepared starting from sulfoximine 52 
(540 mg, 3.19 mmol), n-BuLi (2.19 mL, 3.50 mmol), 5-bromopentanal (580 mg, 3.51 mmol), 
ClCO2Me (332 mg, 3.51 mmol) and DBU (486 mg, 3.51 mmol) in THF (8 mL). Purification 
by column chromatography (cyclohexane/EtOAc, 3:2) afforded the vinyl sulfoximine 115 
(2.65 g, 83%) as a pale yellow oil.  
 
1H NMR (300 MHz, CDCl3): δ = 1.63 (m, 2H, CHCH2CH2), 1.85 (m, 2H, BrCH2CH2), 2.27 
(m, 2H, CHCH2), 2.73 (s, 3H, NCH3), 3.38 (t, 3JH-H = 6.8 Hz, 2H, BrCH2), 6.34 (dt, 3JH-H = 
15.1 Hz, 3JH-H = 1.7 Hz, 1H, SCH), 6.85 (dt, 3JH-H = 15.1 Hz, 3JH-H = 6.8 Hz, 1H, SCHCH), 
7.56 (m, 3H, S-o-Ph and S-p-Ph), 7.87 (m, 2H, S-m-Ph). 
 
13C NMR (75 MHz, CDCl3): δ = 26.2 (CH2, CHCH2CH2), 29.4 (CH3, NCH3), 30.5 (CH2, 
CHCH2), 32.0 (CH2, BrCH2CH2), 33.0 (CH2, BrCH2), 128.7 (CH, S-m-Ph), 129.3 (CH, S-o-
Ph), 130.8 (CH, SCH), 132.6 (CH, S-p-Ph), 139.3 (C, S-i-Ph), 145.7 (CH, SCH=CH). 
 
Rf (cyclohexane/EtOAc, 1:1): 0.32. 
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7.2.  (S,E)-(N-Benzyl-6-bromohex-1-enyl-sulfonimidoyl)benzene (116) 
S
ON
Br
 
116 
C19H22BrNOS 
MW = 392.35 g.mol-1 
 
Following GP-1, the vinyl sulfoximine 116 was prepared starting from sulfoximine 53 (4.32 g, 
17.6 mmol), n-BuLi (12.1 mL, 19.3 mmol), 5-bromopentanal (3.19 g, 19.3 mmol), ClCO2Me 
(1.83 g, 19.3 mmol) and DBU (2.89 mL, 19.7 mmol) in THF (65 mL). Purification by column 
chromatography (cyclohexane/EtOAc, 3:1) afforded the vinyl sulfoximine 116 (5.0 g, 77%) 
as a slightly pale yellow oil. 
 
1H NMR (400 MHz, CDCl3): δ = 1.49 (m, 2H, CHCH2CH2), 1.82 (m, 2H, BrCH2CH2), 2.23 
(m, 2H, CHCH2), 3.35 (t, 3JH-H = 6.6 Hz, 2H, BrCH2), 4.12 (d, 3JH-H = 14.6 Hz, 1H, NCH2), 
4.26 (d, 3JH-H = 14.6 Hz, 1H, NCH2), 6.37 (dt, 3JH-H = 15.1 Hz, 3JH-H = 1.4 Hz, 1H, SCH), 6.88 
(dt, 3JH-H = 15.1 Hz, 3JH-H = 6.6 Hz, 1H, SCHCH), 7.20 (m, 1H, NCH2-p-Ph), 7.29 (m, 2H, 
NCH2-m-Ph), 7.38 (m, 2H, NCH2-o-Ph), 7.54 (m, 3H, S-o-Ph and S-p-Ph), 7.91 (m, 2H, S-m-
Ph). 
 
13C NMR (100 MHz, CDCl3): δ = 25.7 (CH2, CHCH2CH2), 30.4 (CH2, CHCH2), 31.8 (CH2, 
BrCH2CH2), 33.0 (CH2, BrCH2), 47.0 (CH2, NCH2), 126.3 (CH, NCH2-p-Ph), 127.3 (CH, 
NCH2-m-Ph), 128.0 (CH, NCH2-o-Ph), 128.4 (CH, S-m-Ph), 129.5 (CH, S-o-Ph or S-p-Ph), 
130.8 (CH, S-CH), 132.4 (CH, S-o-Ph or S-p-Ph), 139.6 (C, S-i-Ph), 141.2 (C, NCH2-i-Ph), 
145.6 (CH, S-CH=CH). 
 
MS (CI, methan) m/z (%): 394 [M++1] (88), 392 [M++1] (100), 390 (10), 350 (16), 349 (11), 
348 (46), 312 (13), 268 (11), 266 (13), 125 (13), 91 (20). 
 
Rf (cyclohexane/EtOAc, 4:1): 0.18. 
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8. Synthesis of Cyclic Vinyl Sulfoximines 
8.1.  (+)-(S)-(N-Methyl-(S-cyclohex-1-ene)sulfonimidoyl)benzene (117) 
S
ONH3C
 
117 
MW = 235.35 g.mol-1 
 
Following GP-2, the cyclic vinyl sulfoximine 117 was prepared starting from the ω-
bromosulfoximine 115 (4.21 g, 13.31 mmol) in THF (50 mL), diisopropylamine (1.91 mL, 
13.73 mmol) in THF (420 mL) and n-BuLi (8.58 mL, 13.73 mmol). Purification by column 
chromatography (cyclohexane/EtOAc, 3:2): afforded the vinyl sulfoximine 117 (2.50 g, 80%) 
as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 1.47–1.70 (m, 4H, CH2 ring), 2.06 (m, 1H, CH2 ring), 2.22–
2.38 (m, 3H, CH2 ring), 2.76 (s, 3H, NCH3), 7.02 (m, 1H, SCCH), 7.53 (m, 3H, Ph), 7.86 (m, 
2H, Ph). 
 
13C NMR (100 MHz, CDCl3): δ = 20.9 (CH2), 22.1 (CH2), 23.6 (CH2), 25.7 (CH2), 29.4 
(CH3), 128.80 (CH), 128.82 (CH), 132.1 (CH), 138.0 (C), 138.2 (CH), 138.5 (C). 
 
MS (CI, methane): m/z (%): 236 [M++1] (18), 235 [M+] (93), 234 (10), 187 (4), 186 (4), 158 
(6), 139 (11), 129 (11), 126 (11), 125 (25), 111 (9), 110 (100), 109 (16), 97 (13), 91 (8), 82 
(6), 81 (58), 80 (6), 79 (45), 78 (19), 77 (33), 69 (15), 68 (18). 
 
IR (KBr): ν = 3060 (w), 2935(s), 2867 (m), 2801 (m), 1444 (s), 1341 (w), 1244 (s), 1148 (s), 
1110 (m), 1081 (m), 1048 (w), 1022 (w), 937 (m), 864(m) cm−1. 
 
HRMS (EI, 70 eV): C13H17NOS Calculated Found 
  235.1031 235.1031 
 
Melting point: 49 °C. 
 
Optical rotation: [α]D +31.15 (c 0.26, Et2O). 
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Rf (cyclohexane/EtOAc, 1:1): 0.40. 
 
8.2. (–)-(S)-(N-Benzyl-(S-cyclohex-1-ene)sulfonimidoyl)benzene (118) 
S
ON
 
118 
MW = 311.44 g.mol-1 
 
Following GP-2, the cyclic vinyl sulfoximine 118 was prepared starting from the ω-
bromosulfoximine 116 (3.73 g, 9.51 mmol) in THF (90 mL), diisopropylamine (1.37 mL, 
9.70 mmol) in THF (240 mL) and n-BuLi (6.06 mL, 9.70 mmol). Purification by column 
chromatography (cyclohexane/EtOAc, 85:15) afforded the cyclic vinyl sulfoximine 118 
(2.74 g, 92%) as a white solid. 
 
1H NMR (300 MHz, CDCl3): δ = 1.45–170 (m, 4H, CH2 ring), 2.08 (m, 1H, CH2 ring), 2.20–
2.41 (m, 3H, CH2 ring), 4.18 (d, 3JH-H = 14.9 Hz, 1H, NCH2), 4.27 (d, 3JH-H = 14.9 Hz, 1H, 
NCH2), 7.09 (m, 1H, SCCH), 7.21 (m, 1H, NCH2Ph), 7.30 (m, 2H, NCH2Ph), 7.41–7.60 (m, 
5H, SPh and NCH2Ph), 7.91 (m, 2H, SPh). 
 
13C NMR (75 MHz, CDCl3): δ = 20.9 (CH2), 22.2 (CH2), 23.7 (CH2), 25.8 (CH2), 46.9 (CH2), 
126.3 (CH), 127.4 (CH), 128.1 (CH), 128.99 (CH), 129.00 (CH), 132.4 (CH), 138.63 (C), 
138.74 (CH), 138.86 (C), 141.8 (C). 
 
MS (CI, isobutane): m/z (%) = 312 [M++1] (100), 246 (3). 
 
IR (KBr): ν = 3379 (w), 3062 (m), 3021 (w), 2934 (s), 2859 (m), 1641 (w), 1491 (w), 1445 
(m), 1352 (w), 1257 (s), 1135 (s), 1078 (m), 1024 (w), 909 (m) cm−1. 
 
HRMS (EI, 70 eV): C19H21NOS Calculated Found 
  311.1344 311.1345 
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Melting point: 61–62 °C. 
 
Optical rotation: [α]D –0.80 (c 1.0, CHCl3). 
 
Rf (cyclohexane/EtOAc, 4:1): 0.47. 
 
9. Synthesis of Phosphine Boranes 
9.1. (–)-Diphenyl((1R)-1-phenyl-2-((S)-N-methyl-S-phenylsulfonimidoyl)ethyl) 
phosphine borane (62) and (+)-Diphenyl((1S)-1-phenyl-2-((S)-N-methyl-S-
phenylsulfonimidoyl)ethyl)phosphine borane (63) 
 
Following GP-3, the phosphine boranes 62 and 63 were prepared starting from the vinyl 
sulfoximine 58, (400 mg, 1.55 mmol), diphenylphosphine (335 mg, 1.70 mmol) and t-BuOK 
(17 mg, 170 µmol) in THF (12 mL). After the complete conversion of the sulfoximine 58, 
BH3•THF (3.41 mL, 3.41 mmol) was added and the mixture was worked up after stirring for 
1 h. The dr of 62:63 was 78:22 (Chiral OD-H column, detector 254 nm, n-
heptane/isopropanol: 98/2, flow: 0.75 mL/min, 36 bar, Rt (62): 22.4 min; Rt (63): 27.1 min. 
Purification by column chromatography (cyclohexane/EtOAc, 4:1) afforded the phosphine 
borane 63 (122 mg, 17%) as a white foam and the phosphine borane 62 (430 mg, 61%) as a 
white crystalline solid. The major isomer 62 could be recrystallised by layering hexane on the 
top of a saturated solution of a mixture of both isomers in CH2Cl2, which gave the phosphine 
borane 62 as colourless single crystals suitable for X-ray analysis. 
 
S
ONH3C P BH3
 
62 
 
Phosphine borane 62: 1H NMR (300 MHz, CDCl3): δ = 0.4–1.4 (bs, 3H, BH3), 2.51 (s, 3H, 
NCH3), 3.63 (ddd, 2JH-H = 15.1 Hz, 3JP-H = 10.2 Hz, 3JH-H = 1.6 Hz, 1H, SCH2), 4.06 (ddd, 2JH-
H = 15.1 Hz, 3JH-H = 11.8 Hz, 3JP-H = 1.9 Hz, 1H, SCH2), 4.46 (ddd, 2JP-H = 15.1 Hz, 3JH-H = 
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11.8 Hz, 3JH-H = 1.6 Hz, 1H, SCH2CH), 6.79 (m, 4H), 6.89 (m, 1H), 7.13–7.23 (m, 6H), 7.29 
(m, 2H), 7.37 (m, 2H), 7.59 (m, 3H), 8.01 (m, 2H). 
 
13C NMR (75 MHz, CDCl3): δ = 29.3 (CH3, NCH3), 38.0 (d, 1JP-C = 28.8 Hz, CH, SCH2CH), 
56.7 (d, 2JP-C = 7.9 Hz, CH2, SCH2), 125.9 (d, 1JP-C = 51.6 Hz, C, i-Ph), 127.0 (d, 1JP-C = 54.9 
Hz, C, i-Ph), 127.3 (d, JP-C = 2.4 Hz, CH), 127.6 (d, JP-C = 1.9 Hz, CH), 128.2 (d, JP-C = 10.1 
Hz, CH), 128.9 (CH), 129.1 (CH), 129.4 (d, JP-C = 9.7 Hz, CH), 130.0 (d, JP-C = 4.2 Hz, CH), 
131.2 (d, JP-C = 1.7 Hz, CH), 131.8 (C), 132.1 (d, JP-C = 1.8 Hz, CH), 132.4 (CH), 132.5 (d, JP-
C = 8.8 Hz, CH), 133.2 (d, JP-C = 8.6 Hz, CH), 136.8 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 25.48 (bs). 
 
MS (CI, methane): m/z (%) = 456 [M++1] (1), 453 (1), 303 (4), 301 (7), 300 (23), 299 (100), 
298 (24), 289 (11), 288 (7), 211 (2), 196 (6), 184 (14), 157 (5), 156 (54), 125 (28), 107 (4). 
 
IR (KBr): ν = 3908 (w), 3654 (w), 3465 (m), 3055 (m), 2974 (w), 2932 (m), 2871 (m), 2802 
(m), 2383 (s), 2348 (s), 2274(w), 1583 (w), 1491 (m), 1438 (m), 1403 (w), 1267 (m), 1236 (s), 
1142 (s), 1104 (s), 1064 (s), 997 (w), 916 (m), 855 (s), 823 (m) cm−1. 
 
Elemental analysis: C27H29BNOPS Calculated Found 
MW = 457.38 g.mol-1 C 70.90 71.04 
 
H 6.39 6.51 
 
N 3.06 2.86 
 
Melting point: 117 °C. 
 
Optical rotation: [α]D –116.54 (c 1.19, CH2Cl2). 
 
Rf (cyclohexane/EtOAc, 9:2): 0.10. 
 
 
 
 
 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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63 
 
Phosphine borane 63: 1H NMR (300 MHz, CDCl3): δ = 0.3–1.4 (bs, 3H, BH3), 2.61 (s, 3H, 
NCH3), 3.54 (ddd, 2JH-H = 14.9 Hz, 3JP-H = 10.3 Hz, 3JH-H = 1.5 Hz, 1H, SCH2), 3.98 (ddd, 2JH-
H = 14.9 Hz, 3JH-H = 11.8 Hz, 3JP-H = 1.9 Hz, 1H, SCH2), 4.39 (ddd, 2JP-H = 16.3 Hz, 3JH-H = 
11.8 Hz, 3JH-H = 1.3 Hz, 1H, SCH2CH), 6.88 (m, 2H), 6.92 (m, 2H), 7.04 (m, 1H), 7.14–7.34 
(m, 7H), 7.37–7.60 (m, 6H), 7.87 (m, 2H). 
 
13C NMR (75 MHz, CDCl3): δ = 29.4 (CH3, NCH3), 38.9 (d, 1JP-C = 28.7 Hz, CH, SCH2CH), 
56.7 (d, 2JP-C = 8.0 Hz, CH2, SCH2), 125.9 (d, 1JP-C = 51.6 Hz, C, i-Ph), 127.1 (d, 1JP-C = 56.0 
Hz, C, i-Ph), 127.5 (d, JP-C = 2.9 Hz, CH), 127.7 (d, JP-C = 2.4 Hz, CH), 128.2 (d, JP-C = 10.1 
Hz, CH), 128.9 (CH), 129.1 (CH), 129.7 (d, JP-C = 9.2 Hz, CH), 130.0 (d, JP-C = 4.3 Hz, CH), 
131.2 (d, JP-C = 2.4 Hz, CH), 131.9 (d, JP-C = 2.4 Hz, CH), 132.4 (C), 132.5 (CH), 132.6 (d, JP-
C = 8.8 Hz, CH), 133.2 (d, JP-C = 8.5 Hz, CH), 138.0 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 26.11 (bs). 
 
MS (ESI-MS, MeOH): m/z (%) = 458 [M++1] (100), 443 (28), 333 (12), 319 (24), 305 (32), 
299 (44), 289 (38), 156 (28). 
 
IR (KBr): ν = 3460 (w), 2922 (m), 2805 (w), 2375 (s), 1971 (w), 1900 (w), 1814 (w), 1673 
(w), 1585 (m), 1483 (m), 1438 (s), 1245 (s), 1128 (s), 1063 (s), 915 (m), 855 (w) cm−1. 
 
Elemental analysis: C27H29BNOPS Calculated Found 
MW = 457.38 g.mol-1 C 70.90 71.01 
 
H 6.39 6.36 
 
N 3.06 3.06 
 
Melting point: 53–55 °C. 
 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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Optical rotation: [α]D +142.94 (c 1.80, CH2Cl2). 
 
Rf (cyclohexane/EtOAc, 9:2): 0.11. 
 
9.2. (–)-Diphenyl((1R)-1-phenyl-2-((S)-N-benzyl-S-phenylsulfonimidoyl)ethyl) 
phosphine borane (76) and (+)-Diphenyl((1S)-1-phenyl-2-((S)-N-benzyl-S-
phenylsulfonimidoyl)ethyl)phosphine borane (77) 
 
Following GP-3, the phosphine boranes 76 and 77 were prepared starting from the vinyl 
sulfoximine 59 (700 mg, 2.10 mmol), diphenylphosphine (453 mg, 2.31 mmol) and t-BuOK 
(22 mg, 0.21 mmol) in THF (18 mL). After the complete conversion of the sulfoximine 59, 
BH3•THF (4.62 mL, 4.62 mmol) was added and the reaction mixture was worked up after 
stirring for 1 h. The dr of 76:77 was 64:36 (chiralpack-IA column, detector 230 nm, n-
heptane/isopropanol: 85/15, flow: 0.75 mL/min, 32 bar, Rt (77): 14.90 min; 
Rt (76): 21.28 min). Purification by column chromatography (cyclohexane/EtOAc, 85:15) 
afforded the phosphine borane 76 (592 mg, 53%) as a white crystalline solid and the 
phosphine borane 77 (277 mg, 25%) as a white foam. The major isomer 76 could be 
recrystallised by layering hexane on the top of a saturated solution of both isomers in CH2Cl2, 
which gave the phosphine borane 76 as fine white needles. 
 
S
ON P BH3
 
76 
 
Phosphine borane 76: 1H NMR (400 MHz, CDCl3): δ = 0.4−1.5 (bs, 3H, BH3), 3.70 (ddd, 2JH-
H = 14.8 Hz, 3JP-H = 10.1 Hz , 3JH-H = 1.4 Hz, 1H, SCH2), 3.98 (d, 2JH-H = 14.6 Hz, 1H, 
NCH2Ph), 4.04 (d, 2JH-H = 14.6 Hz, 1H, NCH2Ph), 4.08 (ddd, 2JH-H = 14.8 Hz, 3JH-H = 11.8 Hz, 
3JP-H = 1.8 Hz, 1H, SCH2), 4.54 (ddd, 2JP-H = 16.7 Hz, 3JH-H = 11.8 Hz, 3JH-H = 1.4 Hz, 1H, 
SCH2CH), 6.83 (m, 4H), 6.93 (m, 1H), 7.13−7.35 (m, 13H), 7.44 (m, 2H), 7.53−7.63 (m, 3H), 
8.01 (m, 2H). 
 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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13C NMR (100 MHz, CDCl3): δ = 37.9 (d, 1JP-C = 29.8 Hz, CH, SCH2CH), 46.9 (CH2, 
NCH2Ph), 56.3 (d, 2JP-C = 8.4 Hz, CH2, SCH2), 125.8 (d, 1JP-C = 51.9 Hz, C, i-Ph), 126.3 (CH), 
127.0 (d, 1JP-C = 54.2 Hz, C, i-Ph), 127.10 (CH), 127.13 (CH), 127.4 (d, JP-C = 2.3 Hz, CH), 
128.0 (CH), 128.3 (d, JP-C = 9.9 Hz, CH), 128.7 (CH), 128.8 (CH), 129.1 (d, JP-C = 9.9 Hz, 
CH), 129.7 (d, JP-C = 4.6 Hz, CH), 130.9 (d, JP-C = 2.3 Hz, CH), 131.82 (C), 131.85 (CH), 
132.2 (CH), 132.3 (d, JP-C = 9.1 Hz, CH), 133.0 (d, JP-C = 9.1 Hz, CH), 137.5 (C),141.0 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 25.75 (bs). 
 
MS (CI, isobutane): m/z (%) = 534 [M++1] (1), 533 (1), 532 (1), 531 (3), 530 (7), 300 (23), 
299 (100), 298 (25), 289 (4), 288 (3), 234 (3), 233 (9), 232 (56). 
 
IR (KBr): ν = 3866 (w), 3466 (w), 3047 (m), 2927 (m), 2879 (w), 2842 (m), 2363 (s), 2341 
(s), 1555 (w), 1492 (w), 1439 (m), 1387 (w), 1251 (s), 1201 (m), 1136 (s), 1072 (s), 920 (m), 
862 (w), 819 (w) cm−1. 
 
Elemental analysis: C33H33BNOPS Calculated Found 
MW = 534.47 g.mol-1 C 74.30 74.04 
 
H 6.24 6.45 
 
N 2.63 2.62 
 
Melting point: 140 °C. 
 
Optical rotation: [α]D –140.29 (c 1.03, CHCl3). 
 
Rf (cyclohexane/EtOAc, 85:15): 0.18. 
 
 
 
 
 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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77 
 
Phosphine borane 77: 1H NMR (400 MHz, CDCl3): δ = 0.35–1.40 (bs, 3H, BH3), 3.60 (ddd, 
2JH-H = 14.8 Hz, 3JH-H = 10.6 Hz, 3JP-H = 1.4 Hz, 1H, SCH2), 4.00 (d, 2JH-H = 14.9 Hz, 1H, 
NCH2Ph), 4.06 (ddd, 2JH-H = 14.8 Hz, 3JP-H = 11.6 Hz, 3JH-H = 1.7 Hz, 1H, SCH2), 4.16 (d, 
2JH-H = 14.9 Hz, 1H, NCH2Ph), 4.57 (ddd, 2JP-H = 16.5 Hz, 3JH-H = 10.6 Hz, 3JH-H = 1.7 Hz, 
1H, SCH2CH), 6.88 (m, 2H), 6.95 (m, 2H), 7.05 (m, 1H), 7.12–7.32 (m, 12H), 7.40 (m, 1H), 
7.48 (m, 4H), 7.56 (m, 1H), 7.92 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 38.7 (d, 1JP-C = 28.9 Hz, CH, SCH2CH), 46.4 (CH2, 
NCH2Ph), 57.1 (d, 2JP-C = 8.2 Hz, CH2, SCH2), 125.6 (d, 1JP-C = 51.7 Hz, C, i-Ph), 126.2 (CH), 
126.9 (d, 1JP-C = 54.6 Hz, C, i-Ph), 127.0 (CH), 127.2 (d, JP-C = 2.9 Hz, CH), 127.6 (d, JP-C = 
2.4 Hz, CH), 127.9 (CH), 128.0 (d, JP-C = 10.1 Hz, CH), 128.72 (CH), 128.76 (CH), 129.0 (d, 
JP-C = 9.6 Hz, CH), 129.8 (d, JP-C = 4.3 Hz, CH), 131.0 (d, JP-C = 2.3 Hz, CH), 131.8 (d, JP-C = 
2.3 Hz, CH), 132.2 (C), 132.39 (d, JP-C = 8.9 Hz, CH), 132.44 (CH), 133.0 (d, JP-C = 8.5 Hz, 
CH), 138.3 (C), 141.1 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 26.38 (bs). 
 
MS (CI, isobutane): m/z (%) = 534 [M++1] (20), 533 (10), 532 (19), 531 (5), 300 (20), 299 
(100), 298 (24), 289 (12), 288 (11), 279 (4), 257 (7), 234 (3), 233 (10), 232 (69), 218 (8), 214 
(8), 187 (11), 118 (5), 111 (5), 106 (15), 105 (10), 104 (6), 71 (7), 69 (5). 
 
IR (KBr): ν = 3052 (m), 2919 (m), 2847 (m), 2365 (s), 2344 (s), 1815 (w), 1582 (w), 1484 
(m), 1439 (s), 1247 (s), 1117 (s), 1061 (s), 920 (m), 820 (w) cm−1. 
 
Elemental analysis: C33H33BNOPS Calculated Found 
MW = 534.47 g.mol-1 C 74.30 74.27 
 
H 6.24 6.08 
 
N 2.63 2.50 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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Melting point: 94 °C. 
 
Optical rotation: [α]D +103.6 (c 0.50, CHCl3). 
 
Rf (cyclohexane/EtOAc, 85:15): 0.19. 
 
9.3. (–)-Diphenyl((1S)-1-phenyl-2-((S)-N-tosyl-S-phenylsulfonimidoyl)ethyl) 
phosphine borane (79) and (+)-Diphenyl((1R)-1-phenyl-2-((S)-N-tosyl-S-
phenylsulfonimidoyl)ethyl)phosphine borane (78) 
 
Following GP-3, the phosphine boranes 79 and 78 were prepared starting from the vinyl 
sulfoximine 60 (2.0 g, 5.03 mmol), diphenylphosphine (1.03 g, 5.5 mmol) and t-BuOK 
(56 mg, 500 µmol) in THF (60 mL). After the complete conversion of the sulfoximine 60, 
BH3•THF (11 mL, 11 mmol) was added and the reaction mixture was worked up after stirring 
for 1 h. The dr was 73:27 (79:78) (Kromasil Si 100 column, detector 254 nm, 
cyclohexane/EtOAc/CH2Cl2: 11/2/0.5, flow: 1 mL/min, 30 bar, Rt (78): 8.49 min; 
Rt (79): 11.07 min). The crude mixture was dissolved in CH2Cl2 and silica gel was added 
before the evaporation so that the crude mixture was adsorbed on silica gel. This was loaded 
on the top of a column containing silica gel. The purification by column chromatography 
(cyclohexane/EtOAc/CH2Cl2, 11:2:1) afforded in the first collected fractions the phosphine 
borane 78 which was contaminated with the phosphine borane 79. After evaporation of the 
solvents, the residue was dissolved in the minimum amount of CH2Cl2 and hexane was 
layered on the top of the saturated solution. The phosphine borane 78 crystallized at –26 °C as 
colourless needles (540 mg, 18%). The major isomer was eluted with CHCl3 to yield the 
phosphine borane 79 which was contaminated with the phosphine borane 78. After 
evaporation of the solvents, the residue was dissolved in the minimum amount of CH2Cl2 and 
hexane was layered on the top of the saturated solution. The phosphine borane 79 crystallized 
in CH2Cl2 at 4 °C as a wool-type solid (1.53 g, 51%). 
 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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79 
 
Phosphine borane 79: 1H NMR (400 MHz, CDCl3): δ = 0.4–1.4 (bs, 3H, BH3), 2.37 (s, 3H, 
H3C-Ph-SO2), 4.14 (ddd, 2JH-H = 14.8 Hz, 3JH-H = 11.4 Hz, 3JP-H = 2.4 Hz, 1H, SCH2), 4.24 
(ddd, 2JH-H = 14.8 Hz, 3JP-H = 8.6 Hz, 3JH-H = 2.3 Hz, 1H, SCH2), 4.45 (ddd, 2JP-H = 16.1 Hz, 
3JH-H = 11.4 Hz, 3JH-H = 2.3 Hz, 1H, SCH2CH), 6.73 (m, 2H), 6.80 (t, J = 7.7 Hz, 2H), 6.93 (m, 
1H), 7.13–7.24 (m, 8H), 7.28–7.44 (m, 4H), 7.64 (m, 5H), 8.01 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 21.5 (CH3, H3C-Ph-SO2), 37.8 (d, 1JP-C = 28.3 Hz, CH, 
SCH2CH), 57.8 (d, 2JP-C = 9.2 Hz, CH2, SCH2), 125.0 (d, 1JP-C = 51.8 Hz, C, i-Ph), 126.2 (d, 
1JP-C = 55.0 Hz, C, i-Ph), 126.3 (CH), 127.54 (CH), 127.57 (CH), 127.59 (CH), 128.1 (d, J = 
10.1 Hz, CH), 128.8 (CH), 128.9 (CH), 129.3 (d, J = 9.8, CH), 129.5 (d, J = 4.2 Hz, CH), 
130.6 (C), 131.2 (d, J = 2.4 Hz, CH), 132.2 (d, J = 2.3 Hz, CH), 132.3 (d, J = 9.0 Hz, CH), 
133.0 (d, J = 8.6 Hz, CH), 133.4 (CH), 136.6 (C), 140.3 (C), 142.5 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 26.27 (bs). 
 
MS (CI, methane): m/z (%) = 597 [M++1] (2), 596 [M+−1] (5), 585 (3), 584 (7), 311 (6), 301 
(5), 300 (7), 299 (30), 295 (8), 291 (3), 280 (3), 219 (5), 215 (6), 212 (6), 203 (4), 200 (5), 
199 (7), 198 (3), 188 (3), 187 (23), 186 (7), 185 (8), 174 (5), 173 (10), 172 (100), 171 (4), 155 
(11), 151 (3), 145 (3), 141 (5), 139 (8), 133 (15), 127 (4), 125 (3), 114 (3), 113 (4), 112 (4), 
111 (48), 110 (5), 109 (25), 106 (8), 105 (97), 104 (7), 103 (4), 101 (5), 99 (3), 92 (3), 91 (12), 
88 (3), 87 (12), 85 (3), 75 (3), 73 (4), 61 (8). 
 
IR (KBr): ν = 3924 (m), 3653 (w), 3463 (m), 3056 (m), 2922 (w), 2410 (m), 1597 (w), 1493 
(w), 1436 (m), 1398 (m), 1316 (s), 1239 (s), 1182 (w), 1154 (s), 1104 (s), 1067 (s), 1018 (w), 
996 (w), 911 (m), 813 (m) cm−1. 
 
 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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Elemental analysis: C33H33BNO3PS2 Calculated Found 
MW = 597.17 g.mol-1 C 66.33 66.34 
H 5.57 5.45 Carried out on a 
mixture of isomers N 2.34 2.23 
 
Melting point: 196 °C. 
 
Optical rotation: [α]D –86.74 (c 0.97, CH2Cl2). 
 
Rf (hexane/EtOAc, 3:1): 0.17. 
 
 
S
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78 
 
Phosphine borane 78: 1H NMR (300 MHz, CDCl3): δ = 0.4–1.4 (bs, 3H, BH3), 2.37 (s, 3H, 
H3C-Ph-SO2), 3.90 (ddd, 2JH-H = 14.7 Hz, 3JP-H = 8.2 Hz, 3JH-H = 2.1 Hz, 1H, SCH2), 4.33 
(ddd, 2JH-H = 14.7 Hz, 3JH-H = 12.2 Hz, 3JP-H = 3.0 Hz, 1H, SCH2), 4.58 (ddd, 2JP-H = 16.1 Hz, 
3JH-H = 12.2 Hz, 3JH-H = 2.1 Hz, 1H, SCH2CH), 6.84 (m, 4H), 6.98 (m, 1H), 7.13–7.27(m, 8H), 
7.30 (m, 1H), 7.44 (m, 1H), 7.47–7.64 (m, 5H), 7.76 (m, 2H), 8.05 (m, 2H). 
 
13C NMR (75 MHz, CDCl3): δ = 25.5 (CH3, H3C-Ph-SO2), 39.1 (d, 1JP-C = 28.0 Hz, CH, 
SCH2CH), 59.1 (d, 2JP-C = 9.8 Hz, CH2, SCH2), 124.8 (d, 1JP-C = 51.7 Hz, C, i-Ph), 126.0 (d, 
1JP-C = 50.5 Hz, C, i-Ph), 126.3 (CH), 127.5 (d, JP-C = 2.6 Hz, CH), 127.6 (d, JP-C = 1.9 Hz, 
CH), 127.8 (CH), 128.1 (d, JP-C = 10.2 Hz, CH), 128.9 (CH), 129.0 (CH), 129.1 (d, JP-C = 9.8 
Hz, CH), 129.8 (d, JP-C = 4.1 Hz, CH), 130.3 (C), 131.2 (d, JP-C = 2.0 Hz, CH), 132.1 (d, JP-C 
= 2.0 Hz, CH), 132.4 (d, JP-C = 8.9 Hz, CH), 133.3 (d, JP-C = 8.7 Hz, CH), 133.6 (CH), 137.2 
(C), 140.5 (C), 142.6 (C).  
 
31P NMR (162 MHz, CDCl3): δ = 26.17 (bs). 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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MS (CI, methane): m/z (%) = 596 [M++1] (2), 584 (5), 317 (5), 311 (5), 307 (4), 305 (8), 301 
(4), 299 (9), 295 (7), 292 (3), 291 (17), 290 (10), 289 (34), 288 (6), 227 (4), 218 (3), 216 (3), 
215 (9), 213 (5), 212 (5), 211 (9), 203 (5), 199 (7), 188 (4), 187 (31), 186 (9), 185 (10), 174 
(3), 173 (7), 172 (61), 170 (4), 155 (7), 145 (6), 141 (5), 139 (6), 133 (15), 127 (4), 124 (3), 
122 (4), 117 (7), 114 (6), 113 (4), 11 (30), 110 (3), 109 (30), 107 (3), 106 (8), 105 (100), 104 
(9), 103 (9), 101 (16), 99 (6), 92 (4), 91 (13), 88 (4), 87 (26), 85 (10), 83 (4), 79 (3), 75 (6), 73 
(5), 71 (5), 61 (21). 
 
IR (KBr): ν = 3676 (w), 3652 (w), 3593 (w), 3447 (m), 3060 (m), 2924 (m), 2392 (s), 1597 
(w), 1493 (m), 1440 (m), 1399 (w), 1315 (s), 1226 (m), 1152 (s), 1091(s), 1063 (s), 1021 (w), 
997 (w), 911 (m), 816 (m) cm−1. 
 
Melting point: 122 °C. 
 
Optical rotation: [α]D +162.35 (c 0.85, CH2Cl2). 
 
Rf (hexane/EtOAc, 3:1): 0.16. 
 
9.4. (+)-Diphenyl((S)-1-phenyl-2-((S)-N-tert-butyl(diphenyl)silyl-S-
phenylsulfonimidoyl)ethyl)phosphine borane (81) and (–)-Diphenyl((R)-1-
phenyl-2-((S)-N-tert-butyl(diphenyl)silyl-S-phenylsulfonimidoyl)ethyl) 
phosphine borane (80) 
 
Following GP-3, the phosphine boranes 80 and 81 were prepared starting from the vinyl 
sulfoximine 61 (2.0 g, 4.16 mmol), diphenylphosphine (851 mg, 4.57 mmol) and t-BuOK 
(46 mg, 410 µmol) in THF (70 mL). After the complete conversion of the sulfoximine 61, 
BH3•THF (9.2 mL, 9.2 mmol) was added and the mixture was worked up after stirring for 1 h. 
The dr of 80:81 was 58:42 (chiralpack−IA column, detector 254 nm, n-
heptane/isopropanol: 95/5, flow: 0.6 mL/min, 31 bar, Rt (80): 12.31 min; Rt (81): 19.53 min). 
Purification by column chromatography (cyclohexane/EtOAc, 93:7) afforded a mixture of 
both diastereoisomers 80 and 81 (2.27 g, 80%) as a sticky oil. The mixture was dissolved in 
hot n-heptane/isopropanol (95:5). After a few days at RT, colourless crystals were formed, 
which were collected and analysed by HPLC. The dr of 80:81 was 98.5:1.5. The crystals were 
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once again dissolved in hot n-heptane/isopropanol (95:5), and after a few days the crystals 
were collected and analysed. The phosphine borane 80 (1.14 g, 40%, de > 99%) was obtained 
as colourless single crystals suitable for X-ray crystal structure analysis. The first mother 
liqueur (enriched in minor isomer 81) was concentrated, and the residue was dissolved in hot 
n-heptane:isopropanol (95:5). After 2 recrystallisations at 4 °C, the minor isomer 81 could be 
isolated (920 mg, 32%, de > 99%) as colourless single crystal suitable for X-ray crystal 
structure analysis. 
 
S
ON P
BH3
Si
 
81 
 
Phosphine borane 81: 1H NMR (400 MHz, CDCl3): δ = 0.4–1.2 (bs, 3H, BH3), 0.99 (s, 9H, 
C(CH3)3), 3.38 (ddd, 2JH-H = 14.6 Hz, 3JP-H = 10.3 Hz, 3JH-H = 1.2 Hz, 1H, SCH2), 4.03 (ddd, 
2JH-H = 14.6 Hz, 3JH-H = 11.8 Hz, 3JP-H = 1.7 Hz, 1H, SCH2), 4.43 (dd, 2JP-H = 16.5 Hz, 3JH-H = 
11.8 Hz, 3JH-H = 1.2 Hz, 1H, SCH2CH), 6.61 (m, 2H), 6.76 (t, J = 7.7 Hz, 2H), 6.90 (m, 1H), 
6.99 (t, J = 7.8 Hz, 2H), 7.11 (m, 4H), 7.17–7.36 (m, 11H), 7.39 (m, 1H), 7.48 (m, 1H), 7.63 
(m, 2H), 7.76 (4H). 
 
13C NMR (100 MHz, CDCl3): δ = 19.4 (C, SiC(CH3)3), 27.1 (CH3, SiC(CH3)3), 39.2 (d, 1JP-C 
= 28.7 Hz, CH, SCH2CH), 59.9 (d, 2JP-C = 6.8 Hz, CH2, SCH2), 125.8 (d, 1JP-C = 51.3 Hz, C, 
i-Ph), 126.98 (d, 1JP-C = 54.6 Hz, C, i-Ph), 127.00 (d, JP-C = 3.0 Hz, CH), 127.1 (CH), 127.26 
(CH), 127.28 (CH), 127.35 (CH), 127.90 (CH), 127.93 (d, JP-C = 9.9 Hz, CH), 128.77 (CH), 
128.82 (CH), 129.0 (d, JP-C = 9.6 Hz, CH), 129.6 (d, JP-C = 4.3 Hz, CH), 130.9 (d, JP-C = 2.4 
Hz, CH), 131.3 (C), 131.50 (CH), 131.55 (d, JP-C = 2.2 Hz, CH), 132.3 (d, JP-C = 8.8 Hz, CH), 
132.8 (d, JP-C = 8.4 Hz, CH), 135.40 (CH), 135.44 (CH), 135.82 (C),135.83 (C),142.7 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 25.42 (bs). 
 
EXPERIMENTAL PART 
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MS (CI, isobutane): m/z (%) = 683 [M++2] (5), 682 [M++1] (15), 681 [M+] (14), 680 [M+−1] 
(23), 679 (6), 420 (6), 381 (5), 380 (18), 301(4), 300 (22), 299 (100), 298 (25), 289 (12), 288 
(4), 286 (8), 199 (7), 187 (9), 126 (6). 
 
IR (KBr): ν = 3058 (m), 2929 (m), 2889 (m), 2853 (m), 2385 (m), 2343 (m), 1585 (w), 1483 
(m), 1435 (m), 1320 (m), 1262 (m), 1149 (m), 1103 (m), 1060 (m), 999 (m), 906 (w), 819 (m) 
cm−1. 
 
Elemental analysis: C42H45BNOPSSi Calculated Found 
MW = 681.75 g.mol-1 C 73.99 74.04 
H 6.65 6.69 Carried out on a 
mixture of isomers N 2.05 2.01 
 
 
Melting point: 135 °C. 
 
Optical rotation: [α]D +115.2 (c 0.50, CHCl3). 
 
Rf (cyclohexane/EtOAc, 15:1): 0.08. 
 
 
S
ON P
BH3
Si
 
80 
 
Phosphine borane 80: 1H NMR (400 MHz, CDCl3): δ = 0.4–1.2 (bs, 3H, BH3), 0.98 (s, 9H, 
C(CH3)3), 3.38 (ddd, 2JH-H = 14.7 Hz, 3JH-H = 10.9 Hz, 3JP-H = 1.3 Hz, 1H, SCH2), 3.92 (ddd, 
2JH-H = 14.7 Hz, 3JP-H = 11.7 Hz, 3JH-H = 1.5 Hz, 1H, SCH2), 4.49 (bdd, 2JP-H = 16.7 Hz, 3JH-H 
= 10.9 Hz, 1H, SCH2CH), 6.72 (m, 2H), 6.84 (t, J = 7.8 Hz, 2H), 6.94 (m, 1H), 7.04 (m, 2H), 
7.09–7.23 (m, 7H), 7.27 (m, 4H), 7.34 (m, 1H), 7.43 (m, 4H), 7.53 (m,3H), 7.62 (m, 2H), 7.89 
(m, 2H). 
 
EXPERIMENTAL PART 
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13C NMR (100.6 MHz, CDCl3): δ = 19.3 (C, SiC(CH3)3), 27.1 (CH3, SiC(CH3)3), 38.1 (d, 1JP-
C = 28.8 Hz, CH, SCH2CH), 60.1 (d, 2JP-C = 6.5 Hz, CH2, SCH2), 126.0 (d, 1JP-C = 51.6 Hz, C, 
i-Ph), 126.99 (CH), 127.01 (CH), 127.15 (CH), 127.18 (CH), 127.21 (d, 1JP-C = 54.4 Hz, C, i-
Ph), 127.3 (d, JP-C = 2.5 Hz, CH), 128.0 (d, JP-C = 10.1 Hz, CH), 128.1 (CH), 128.66 (CH), 
128.74 (CH), 129.0 (d, JP-C = 9.7 Hz, CH), 129.6 (d, JP-C = 4.4 Hz, CH), 130.9 (d, JP-C = 2.4 
Hz, CH), 131.54 (CH), 131.56 (d, JP-C = 4.0 Hz, CH), 131.9 (C), 132.3 (d, JP-C = 8.8 Hz, CH), 
132.9 (d, JP-C = 8.4 Hz, CH), 135.26 (CH), 135.31 (CH), 135.7 (C), 135.8 (C), 143.0 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 26.05 (bs). 
 
MS (CI, isobutane): m/z (%) = 683 [M++2] (5), 682 [M++1] (15), 681 [M+] (14), 680 (23), 
420 (6), 381 (5), 380 (18), 301 (4), 300 (21), 299 (100), 298 (25). 
 
IR (KBr): ν = 3059 (m), 2929 (m), 2889 (m), 2853 (m), 2385 (m), 2343 (m), 1969 (w), 1585 
(w), 1483 (m), 1435 (m), 1320 (m), 1262 (m), 1149 (m), 1103 (m), 1060 (m), 999 (m), 906 
(w), 819 (m), 771 (m), 732 (s), 695 (s), 598 (m), 526 (m), 491 (m) cm-1. 
 
Melting point: 124 °C. 
 
Optical rotation: [α]D –86.6 (c 0.50, CHCl3). 
 
Rf (cyclohexane/EtOAc, 15:1): 0.09. 
 
9.5.  (+)-Diphenyl((1R,2R)-2-((S)-N-methyl-S-phenylsulfonimidoyl)cyclohexyl) 
phosphine borane (120) and (–)-Diphenyl((1S,2S)-2-((S)-N-methyl-S-
phenylsulfonimidoyl)cyclohexyl)phosphine borane (121) 
 
Following GP-3, the phosphine boranes 120 and 121 were prepared starting from the vinyl 
sulfoximine 117 (375 mg, 1.59 mmol), diphenylphosphine (330 mg, 1.77 mmol) and t-BuOK 
(18 mg, 590 µmol) in THF (12 mL). After the complete conversion of the sulfoximine 117, 
BH3•THF (3.45 mL, 3.45 mmol) was added and the mixture was worked up after stirring for 
1 h. The dr of 120:121 was 1:1 (determined by 1H NMR). Purification by column 
chromatography (cyclohexane/EtOAc, 85:15) afforded the phosphine borane 120 (240 mg, 
EXPERIMENTAL PART 
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35%) as a white crystalline solid and the phosphine borane 121 (315 mg, 46%) as a white 
foam. 
 
S
ON PH3C BH3
 
120 
 
Phosphine borane 120: 1H NMR (400 MHz, CDCl3): δ = 0.60–1.40 (bs, 3H, BH3), 1.50 (m, 
2H), 1.63 (m, 1H), 1.77 (bd, J = 15.0 Hz, 1H), 1.90–2.24 (m, 4H), 2.67 (s, 3H, NCH3), 3.17 
(bdd, 3JP-H = 13.8 Hz, 3JH-H = 5.8 Hz, 1H, SCH), 4.57 (bdd, 2JP-H = 19.6 Hz, 3JH-H = 6.2 Hz, 
1H, SCHCHP), 7.49 (m, 11H), 7.86 (m, 2H), 8.14 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 18.5 (CH2), 20.8 (CH2), 21.8 (CH2), 22.0 (d, J = 1.7 Hz, 
CH2), 26.0 (d, 1JP-C = 30.7 Hz, CH, SCHCHP), 29.6 (CH3, NCH3), 58.5 (d, 2JP-C = 7.7 Hz, CH, 
SCH), 128.4 (d, 1JP-C = 56.7 Hz, C, i-Ph), 128.5 (d, JP-C = 9.8 Hz, CH), 128.70 (d, JP-C = 10.0 
Hz, C), 128.72 (d, 1JP-C = 54.0 Hz, C, i-Ph), 129.2 (CH), 129.7 (CH), 131.13 (CH), 131.17 
(CH), 132.5 (CH), 132.6 (d, JP-C = 8.9 Hz, CH), 133.0 (d, JP-C = 8.6 Hz, CH), 136.8 (C, Si-Ph). 
 
31P NMR (162 MHz, CDCl3): δ = 21.98 (bs). 
 
MS (ESI–MS, MeOH): m/z (%) = 458 [M++23] (98), 434 [M+-1] (100). 
 
IR (Capillary, dissolved in CHCl3): ν = 3881 (w), 3836 (w), 3674 (w), 3632 (w), 3450 (w), 
3058 (w), 3012 (w), 2935 (m), 2871 (m), 2804 (w), 2391 (s), 1560 (w), 1441 (m), 1247 (s), 
1137 (s), 1105(s), 1068 (s), 1002 (m), 868 (m), 832 (w) cm−1. 
 
Elemental analysis: C25H31BNOPS Calculated Found 
MW = 435.37 g.mol-1 C 68.97 68.62 
 
H 7.18 6.97 
 
N 3.22 2.94 
 
Melting point: 72 °C. 
EXPERIMENTAL PART 
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Optical rotation: [α]D +70.8 (c 0.12, CHCl3). 
 
Rf (cyclohexane/EtOAc, 4:1): 0.38. 
 
 
S
ON PH3C BH3
 
121 
 
Phosphine borane 121: 1H NMR (400 MHz, CDCl3): δ = 0.60–1.70 (bs, 3H, BH3), 1.58 (m, 
3H), 1.96 (m, 2H), 2.25 (m, 1H), 2.34–2.53 (m, 2H), 2.62 (s, 3H, NCH3), 3.11 (bdd, 3JP-H = 
13.7 Hz, 3JH-H = 5.4 Hz, 1H, SCH), 3.53 (bdd, 2JP-H = 19.1 Hz, 3JH-H = 6.6 Hz, 1H, SCHCHP), 
7.26 (m, 2H), 7.36–7.60 (m, 11H), 7.74 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 20.0 (CH2), 21.2 (CH2), 21.8 (CH2), 22.1 (CH2), 27.7 (d, 
1JP-C = 29.6 Hz, CH, SCHCHP), 29.7 (CH3, NCH3), 58.9 (d, 2JP-C = 7.4 Hz, CH, SCH), 127.8 
(d, 1JP-C = 54.3 Hz, C, i-Ph), 127.9 (d, 1JP-C = 53.0 Hz, C, i-Ph), 128.8 (d, JP-C = 9.6 Hz, CH), 
128.9 (d, JP-C = 9.8 Hz, CH), 129.5 (CH), 129.9 (CH), 131.1 (d, JP-C = 1.8 Hz, CH), 131.5 (d, 
JP-C = 1.8 Hz, CH), 132.5 (d, JP-C = 8.1 Hz, CH), 132.63 (CH), 132.63 (d, JP-C = 7.8 Hz, CH), 
136.8 (C, Si-Ph). 
 
31P NMR (162 MHz, CDCl3): δ = 21.53 (bs). 
 
MS (ESI–MS, MeOH): m/z (%) = 460 (100), 458 [M++23] (90), 434 [M+−1] (80). 
 
IR (Capillary, dissolved in CHCl3): ν = 3940 (w), 3882 (w), 3834 (w), 3783 (w), 3662 (w), 
3534 (w), 3444 (m), 3160 (w), 3058 (w), 2935 (w), 2806 (w), 2393 (s), 2280 (w), 1590 (w), 
1440 (s), 1301 (w), 1234 (s), 1138 (s), 1105 (s), 1070 (s), 862 (m) cm−1. 
 
 
 
EXPERIMENTAL PART 
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Elemental analysis: C25H31BNOPS Calculated Found 
MW = 435.37 g.mol-1 C 68.97 69.12 
 
H 7.18 7.26 
 
N 3.22 3.03 
 
Melting point: 48 °C. 
 
Optical rotation: [α]D –15.9 (c 1.90, CHCl3). 
 
Rf (cyclohexane/EtOAc, 4:1): 0.28. 
 
9.6.  (+)-Diphenyl((1R,2R)-2-((S)-N-benzyl-S-phenylsulfonimidoyl)cyclohexyl) 
phosphine borane (122) and (–)-Diphenyl((1S,2S)-2-((S)-N-benzyl-S-
phenylsulfonimidoyl)cyclohexyl)phosphine borane (123) 
 
Following GP-3, the phosphine boranes 122 and 123 were prepared starting from vinyl 
sulfoximine 118 (1.14 g, 3.66 mmol), diphenylphosphine (718 mg, 3.86 mmol) and t-BuOK 
(40 mg, 356 µmol) in THF (40 mL). After the complete conversion of the sulfoximine 118, 
BH3•THF (8 mL, 8 mmol) was added and the reaction mixture was worked up after stirring 
for 1 h. The dr of 122:123 was 1:1 (determined by 1H NMR). Purification by column 
chromatography (cyclohexane/EtOAc, 9:1) afforded the phosphine borane 122 (768 mg, 41%) 
as a white crystalline solid, and the phosphine borane 123 (730 mg, 39%) as a white foam. 
The isomer 122 could be recrystallised from Et2O at –26 °C, which gave colourless single 
crystals suitable for X-ray crystal structure analysis. 
 
S
ON P BH3
 
122 
C31H35BNOPS 
MW = 511.47 g.mol-1 
 
EXPERIMENTAL PART 
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Phosphine borane 122: 1H NMR (400 MHz, CDCl3): δ = 0.6−1.45 (bs, 3H, BH3) 1.45−1.68 
(m, 3H), 1.74 (m, 1H), 1.92−2.32 (m, 4H), 3.26 (dd, 3JP-H = 13.5 Hz, 3JH-H = 5.5 Hz, 1H, 
SCH), 3.91 (d, 2JH-H = 14.3 Hz, 1H), 4.30 (d, 2JH-H = 14.3 Hz, 1H), 4.70 (dd, 2JP-H = 19.5 Hz, 
3JH-H = 6.3 Hz, 1H, SCHCHP), 7.27 (m, 3H), 7.34−7.50 (m, 10H), 7.55 (m, 3H), 7.83 (m, 2H), 
8.06 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 19.5 (CH2), 20.9 (CH2), 21.9 (CH2), 22.1 (d, 2JP-C = 1.7 Hz, 
CH2, PCHCH2), 26.3 (d, 1JP-C = 30.5 Hz, CH, SCHCHP), 47.1 (CH2, NCH2Ph), 58.7 (d, 2JP-C 
= 7.7 Hz, CH, SCH), 126.3 (CH), 127.4 (CH), 128.0 (CH), 128.3 (d, 1JP-C = 51.9 Hz, C, i-Ph), 
128.5 (d, JP-C = 9.7 Hz, CH), 128.60 (d, 1JP-C = 54.2 Hz, C, i-Ph), 128.66 (d, JP-C = 9.9 Hz, 
CH), 129.1 (CH), 129.5 (CH), 131.0 (d, JP-C = 2.0 Hz, CH), 131.1 (d, JP-C = 2.1 Hz, CH), 
132.46 (d, JP-C = 9.0 Hz, CH), 132.53 (CH), 132.9 (d, JP-C = 8.7 Hz, CH), 137.2 (C, Si-Ph), 
141.7 (C, NCH2i-Ph). 
 
31P NMR (162 MHz, CDCl3): δ = 21.61 (bs). 
 
MS (CI, methane): m/z (%) = 510 [M+−1] (2), 280 (18), 279 (100), 278 (25), 267 (5), 234 (5), 
232 (86), 106 (6). 
 
IR (KBr): ν = 3794 (w), 3685 (w), 3434 (m), 3051 (m), 2931 (m), 2855 (m), 2344 (w), 1611 
(m), 1438 (s), 1258 (s), 1203 (m), 1123 (m), 1061 (m), 1001 (w), 880 (m), 832 (m) cm−1. 
 
Elemental analysis: C31H35BNOPS Calculated Found 
MW = 511.47 g.mol-1 C 72.80 72.60 
 
H 6.90 6.99 
 
N 2.74 2.62 
 
Melting point: 124 °C. 
 
Optical rotation: [α]D +50.4 (c 0.80, CH2Cl2). 
 
Rf (cyclohexane/EtOAc, 92:8): 0.23. 
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‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
 144 
S
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123 
MW = 511.47 g.mol-1 
 
Phosphine borane 123: 1H NMR (400 MHz, CDCl3): δ = 0.6−1.51 (bs, 3H, BH3), 1.51−1.71 
(m, 3H), 1.94 (m, 1H), 2.09 (m, 1H), 2.27 (m, 1H), 2.37−2.58 (m, 2H), 3.15 (dd, 3JP-H = 13.7 
Hz, 3JH-H = 5.2 Hz, 1H, SCH), 3.70 (dd, 2JP-H = 19.0 Hz, 3JH-H = 6.3 Hz, 1H, SCHCHP), 3.96 
(d, 2JH-H = 14.8 Hz, 1H, NCH2), 4.24 (d, 2JH-H = 14.8 Hz, 1H, NCH2), 7.19 (m, 1H), 7.28 (m, 
4H), 7.33−7.50 (m, 8H), 7.53−7.64 (m, 5H), 7.77 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 19.9 (CH2), 21.1 (CH2), 21.9 (d, 2JP-C = 2.3 Hz, CH2, 
PCHCH2), 22.2 (CH2), 27.5 (d, 1JP-C = 29.8 Hz, CH, SCHCHP), 47.0 (CH2), 59.3 (d, 2JP-C = 
7.4 Hz, CH, SCH), 126.1 (CH), 127.0 (CH), 127.65 (d, 1JP-C = 52.6 Hz, C, i-Ph), 127.74 (d, 
1JP-C = 54.6 Hz, C, i-Ph), 127.9 (CH), 128.6 (d, JP-C = 9.9 Hz, CH), 128.7 (d, JP-C = 9.9 Hz, 
CH), 129.2 (CH), 129.5 (CH), 130.9 (d, JP-C = 3.1 Hz, CH), 131.2 (d, JP-C = 2.3 Hz, CH), 
132.41 (d, JP-C = 8.4 Hz, CH), 132.42 (d, JP-C = 8.4 Hz, CH), 132.5 (CH), 137.2 (C, Si-Ph), 
141.4 (C, NCH2i-Ph).  
 
31P NMR (162 MHz, CDCl3): δ = 21.70 (bs). 
 
MS (CI, isobutane): m/z (%) = 511 [M+] (7), 510 [M+−1] (18), 509 (4), 463 (9), 280 (18), 279 
(92), 278 (22), 267 (14), 266 (9), 134 (4), 234 (6), 233 (15), 232 (100), 187 (3), 106 (13). 
 
IR (KBr): ν = 3944 (m), 3930 (m), 3899 (m), 3696 (s), 3677 (s), 3612 (m), 3073 (m), 3052 
(m), 2903 (m), 2871 (m), 2382 (s), 1619 (m), 1491 (w), 1438 (s), 1201 (m), 1126 (s), 1062 (s) 
cm−1. 
 
HRMS (ESI–TOF): C31H36BNOPS Calculated Found 
[M++1] 512.2348 512.2349 CH3CN−H2O + 
0.1%HCO2H 
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Melting point: 59–61 °C. 
 
Optical rotation: [α]D –14.5 (c 1.03, CHCl3). 
 
Rf (cyclohexane/EtOAc, 92:8): 0.15. 
 
10. Synthesis of Phosphino-sulfoximines 
10.1. (–)-Diphenyl((1R)-1-phenyl-2-((S)-N-methyl-S-phenylsulfonimidoyl)ethyl) 
phosphine (68) 
S
ONH3C P
 
68 
C27H26NOPS 
MW = 443.54 g.mol-1 
 
Following GP-4, phosphine 68 was prepared from the phophine borane 62 (100 mg, 218 µmol) 
and DABCO (26 mg, 228 µmol) in toluene (3 mL). Purification by column chromatography 
afforded phosphine 68 (93 mg, 96%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 2.40 (s, 3H, NCH3), 3.52 (ddd, 2JH-H = 14.8 Hz, 3JP-H = 7.5 
Hz, 3JH-H = 1.9 Hz, 1H, SCH2), 3.77 (ddd, 2JH-H = 14.8 Hz, 3JH-H = 11.9 Hz, 3JP-H = 2.0 Hz, 1H, 
SCH2), 4.04 (ddd, 3JH-H = 11.9 Hz, 2JP-H = 3.3 Hz, 3JH-H = 1.9 Hz, 1H, SCH2CH), 6.66 (m, 
2H), 6.76 (m, 3H), 6.91 (m, 2H), 7.00 (m, 2H), 7.08 (m, 3H), 7.22 (m, 1H), 7.35 (m, 5H), 
7.55 (2H). 
 
13C NMR (100 MHz, CDCl3): δ = 28.2 (CH3, NCH3), 38.4 (d, 1JP-C = 17.7 Hz, CH, SCH2CH), 
57.0 (d, 2JP-C = 24.1 Hz, SCH2), 125.1 (d, J = 2.5 Hz, CH), 126.6 (d, J = 1.0 Hz, CH), 126.7 
(d, J = 6.7 Hz, CH), 127.45 (CH), 127.48 (CH), 127.7 (d, J = 5.8 Hz, CH), 127.8 (d, J = 4.9 
Hz, CH), 127.9 (CH), 128.7 (CH), 130.8 (CH), 131.8 (d, 2JP-C = 18.2 Hz, CH, Po-Ph), 132.98 
(d, 2JP-C = 21.0 Hz, CH, Po-Ph), 132.99 (d, 1JP-C = 11.2 Hz, C, i-Ph), 134.0 (d, 1JP-C = 15.6 Hz, 
C, i-Ph), 135.8 (d, 2JP-C = 8.1 Hz, C, PCHi-Ph), 136.1 (C). 
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31P NMR (162 MHz, CDCl3): δ = 1.47 (s). 
 
Melting point: 146 °C. 
 
Optical rotation: [α]D –58.0 (c 0.10, CH2Cl2). 
 
10.2. (+)-Diphenyl((1S)-1-phenyl-2-((S)-N-methyl-S-phenylsulfonimidoyl)ethyl) 
phosphine (69) 
S
ONH3C P
 
69 
C27H26NOPS 
MW = 443.54 g.mol-1 
 
Following GP-4, phosphine 69 was prepared from the phophine borane 63 (100 mg, 218 µmol) 
and DABCO (26 mg, 228 µmol) in toluene (3 mL). Purification by column chromatography 
afforded phosphine 69 (93 mg, 94%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 2.58 (s, 3H, NCH3), 3.48 (ddd, 2JH-H = 14.5 Hz, 3JP-H = 7.6 
Hz, 3JH-H = 1.4 Hz, 1H, SCH2), 3.78 (ddd, 2JH-H = 14.5 Hz, 3JH-H = 12.0 Hz, 3JP-H = 2.3 Hz, 1H, 
SCH2), 3.90 (ddd, 3JH-H = 12.0 Hz, 2JP-H = 2.9 Hz, 3JH-H = 1.4 Hz, 1H, SCH2CH), 6.91 (m, 
4H), 7.05 (m, 5H), 7.15 (m, 1H), 7.29–7.44 (m, 7H), 7.46–7.55 (m, 3H). 
 
13C NMR (100 MHz, CDCl3): δ = 29.4 (CH3, NCH3), 39.9 (d, 1JP-C = 18.6 Hz, CH, SCH2CH), 
58.3 (d, 2JP-C = 23.5 Hz, CH2, SCH2), 126.4 (d, J = 2.5 Hz, CH), 127.7 (d, J = 6.5 Hz, CH), 
127.9 (d, J = 1.2 Hz, CH), 128.4 (CH), 128.6 (d, J = 7.6 Hz, CH), 128.8 (CH), 128.9 (CH), 
129.2 (CH), 129.6 (CH), 132.2 (CH), 132.7 (d, 2J = 17.9 Hz, CH, Po-Ph), 133.94 (d, 1JP-C = 
17.1 Hz, C, i-Ph), 134.03 (d, 2JP-C = 21.1 Hz, CH, Po-Ph), 135.0 (d, 1JP-C = 16.4 Hz, C, i-Ph), 
137.3 (d, 2JP-C = 7.8 Hz, C, PCHi-Ph), 137.8 (C). 
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31P NMR (162 MHz, CDCl3): δ = 2.30 (s). 
 
Melting point: 111−113 °C. 
 
Optical rotation: [α]D +120.71 (c 0.14, CH2Cl2). 
 
10.3. (–)-Diphenyl((1R)-1-phenyl-2-((S)-N-benzyl-S-phenylsulfonimidoyl)ethyl) 
phosphine (84) 
S
ON P
 
84 
C33H30NOPS 
MW = 519.64 g.mol-1 
 
Following GP-4, phosphine 84 was prepared from the phophine borane 76 (178 mg, 333 µmol) 
and DABCO (41 mg, 365 µmol) in toluene (5 mL). Purification by column chromatography 
afforded phosphine 84 (169 mg, 98%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 3.67 (ddd, 2JH-H = 14.7 Hz, 3JP-H = 7.6 Hz, 3JH-H = 1.6 Hz, 
1H, SCH2), 3.87 (d, 2JH-H = 14.7 Hz, 1H, NCH2Ph), 3.90 (ddd, 2JH-H = 14.7 Hz, 3JH-H = 12.0 
Hz, 3JP-H = 2.0 Hz, 1H, SCH2), 4.01 (d, 2JH-H = 14.7 Hz, 1H, NCH2Ph), 3.67 (ddd, 3JH-H = 
12.0 Hz, 2JP-H = 4.6 Hz, 3JH-H = 1.6 Hz, 1H, SCH2CH), 6.76 (m, 2H), 6.87 (m, 3H), 6.96 (m, 
2H), 7.06 (m, 2H), 7.11–7.26 (m, 8H), 7.32 (m, 1H), 7.43 (m, 3H), 7.48 (m, 2H), 7.63 (m, 
2H). 
 
13C NMR (100 MHz, CDCl3): δ = 39.4 (d, 1JP-C = 17.9 Hz, CH, SCH2CH), 46.2 (CH2, 
NCH2Ph), 58.4 (d, 2JP-C = 24.0 Hz, CH2, SCH2), 126.10 (CH), 126.12 (CH), 127.2 (CH), 
127.69 (CH), 127.71 (d, J = 6.9 Hz, CH), 127.9 (CH), 128.4 (CH), 128.5 (CH), 128.7 (d, J = 
7.6 Hz, CH), 128.8 (d, J = 6.6 Hz, CH), 128.9 (CH), 129.7 (CH), 132.0 (CH), 132.8 (d, 2JP-C = 
18.1 Hz, CH, Po-Ph), 133.99 (d, 1JP-C = 17.7 Hz, C, i-Ph), 134.01 (d, 2JP-C = 20.9 Hz, CH, Po-
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Ph), 135.1 (d, 1JP-C = 16.0 Hz, C, i-Ph), 137.0 (d, 2JP-C = 7.9 Hz, C, PCHi-Ph), 137.8 (C), 
141.2 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 1.67 (s). 
 
Melting point: 157–158 °C. 
 
Optical rotation: [α]D –92.25 (c 0.40, CH2Cl2). 
 
10.4. (+)-Diphenyl((1S)-1-phenyl-2-((S)-N-benzyl-S-phenylsulfonimidoyl)ethyl) 
phosphine (85) 
S
ON P
 
85 
C33H30NOPS 
MW = 519.64 g.mol-1 
 
Following GP-4, phosphine 85 was prepared from the phophine borane 77 (100 mg, 188 µmol) 
and DABCO (23 mg, 205 µmol) in toluene (3 mL). Purification by column chromatography 
afforded  phosphine 85 (92 mg, 94%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 3.47 (ddd, 2JH-H = 14.6 Hz, 3JP-H = 7.8 Hz, 3JH-H = 1.4 Hz, 
1H, SCH2), 3.78 (ddd, 2JH-H = 14.6 Hz, 3JH-H = 12.0 Hz, 3JP-H = 1.9 Hz, 1H, SCH2), 3.87 (d, 
2JH-H = 14.8 Hz, 1H, NCH2Ph), 4.01 (bd, 3JH-H = 12.0 Hz, 1H, SCH2CH), 4.07 (d, 2JH-H = 14.8 
Hz, 1H, NCH2Ph), 6.80–6.90 (m, 4H), 6.92–7.02 (m, 5H), 7.05–7.15 (m, 2H), 7.19 (m, 4H), 
7.25 (m, 4H), 7.32 (m, 1H), 7.39 (m, 3H), 7.50 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 38.8 (d, 1JP-C = 18.6 Hz, CH, SCH2CH), 45.5 (CH2, 
NCH2Ph), 57.7 (d, 2JP-C = 23.0 Hz, CH, SCH2), 125.1 (CH), 125.3 (d, J = 2.6 Hz, CH), 126.0 
(CH), 126.7 (d, J = 6.5 Hz, CH), 126.84 (CH), 126.85 (CH), 127.4 (CH), 127.6 (d, J = 7.4 Hz, 
CH), 127.7 (CH), 127.8 (d, J = 6.4 Hz, CH), 128.0 (CH), 128.6 (CH), 131.2 (CH), 131.7 (d, 
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2JP-C = 17.9 Hz, CH, Po-Ph), 132.94 (d, 1JP-C = 17.3 Hz, C, i-Ph), 133.02 (d, 2JP-C = 21.0 Hz, 
CH, Po-Ph), 134.0 (d, 1JC-P = 16.4 Hz, C, i-Ph), 136.3 (d, J = 7.9 Hz, C, PCHi-Ph), 137.6 (C), 
140.3 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 2.42 (s). 
 
Melting point: 129 °C. 
 
Optical rotation: [α]D +117.27 (c 0.11, CH2Cl2). 
 
10.5. (+)-Diphenyl((1R)-1-phenyl-2-((S)-N-tosyl-S-phenylsulfonimidoyl)ethyl) 
phosphine (86) 
S
ON PSOO
 
86 
C33H30NO3PS2 
MW = 583.14 g.mol-1 
 
Following GP-4, phosphine 86 was prepared from the phophine borane 78 (46 mg, 77 µmol) 
and DABCO (11 mg, 98 mmol) in toluene (5 mL). Purification by column chromatography 
afforded phosphine 86 (42 mg, 94%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 2.35 (s, 3H, SO2-pCH3Ph), 3.77 (ddd, 2JH-H = 14.4 Hz, 3JP-H 
= 6.1 Hz, 3JH-H = 2.0 Hz, 1H, SCH2), 4.02 (dt, 3JH-H = 12.3 Hz, 2JP-H = 2.2 Hz, 1H, SCH2CH), 
4.17 (ddd, 2JH-H = 14.4 Hz, 3JH-H = 12.3 Hz, 3JP-H = 2.7 Hz, 1H, SCH2), 6.82 (m, 2H), 6.90 (m, 
2H), 6.97 (m, 3H), 7.06 (m, 2H), 7.17 (m, 3H), 7.31–7.48 (m, 5H), 7.53 (m, 3H), 7.60 (m, 
2H), 7.74 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 21.4 (CH3, SO2-pCH3Ph), 40.0 (d, 1JP-C = 20.2 Hz, CH, 
SCH2CH), 60.7 (d, 2JP-C = 25.9 Hz, CH2, SCH2), 126.4 (CH), 126.7 (d, JP-C = 2.4 Hz, CH), 
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127.8 (d, J = 6.6 Hz, CH), 127.99 (CH), 128.03 (CH), 128.66 (CH), 128.76 (CH), 128.77 
(CH), 128.84 (CH), 128.9 (CH), 130.0 (CH), 132.7 (d, 2JP-C = 18.2 Hz, CH, Po-Ph), 133.1 (d, 
1JP-C = 16.8 Hz, C, i-Ph), 133.6 (CH), 134.20 (d, 2JP-C = 21.7 Hz, CH, Po-Ph), 134.23 (d, 1JP-C 
= 15.7 Hz, C, i-Ph), 135.6 (d, 2JP-C = 7.8 Hz, C, PCHi-Ph), 137.1 (C), 140.6 (C), 142.3 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 3.39 (s). 
 
Melting point: 145 °C. 
 
Optical rotation: [α]D +56 (c 0.1, CH2Cl2). 
 
10.6. (−)-Diphenyl((R)-1-phenyl-2-((S)-N-tert-butyl(diphenyl)silyl-S-
phenylsulfonimidoyl)ethyl)phosphine (87) 
S
ON PSi
 
87 
C42H42NOPSSi 
MW = 667.91 g.mol-1 
 
Following GP-4, phosphine 87 was prepared starting from the phophine borane 80 (80 mg, 
117 µmol) and DABCO (15 mg, 134 µmol) in toluene (2.5 mL). Purification by column 
chromatography afforded phosphine 87 (72 mg, 92%) as a sticky syrup. 
 
1H NMR (400 MHz, CDCl3): δ = 0.99 (s, 9H, C(CH3)3), 3.38 (ddd, 2JH-H = 14.4 Hz, 3JP-H = 
8.4 Hz, 3JH-H = 1.1 Hz, 1H, SCH2), 3.67 (m, 1H, SCH2), 3.17 (m, 1H, SCH2CH), 6.66 (m, 2H), 
6.88 (m, 5H), 7.04 (m, 4H), 7.11–7.29 (m, 7H), 7.30–7.45 (m, 6H), 7.50–7.62 (m, 6H). 
 
13C NMR (100 MHz, CDCl3): δ = 19.3 (C, C(CH3)3), 27.1 (CH3, C(CH3)3), 39.6 (d, 1JP-C = 
18.1 Hz, CH, SCH2CH), 62.3 (d, 2JP-C = 21.1 Hz, CH2, SCH2), 126.0 (d, JP-C = 2.5 Hz, CH), 
126.9 (CH), 127.0 (CH), 127.2 (CH), 127.6 (CH), 127.7 (d, JP-C = 6.6 Hz, CH), 128.0 (CH), 
128.4 (CH), 128.5 (CH), 128.59 (CH), 128.65 (d, JP-C = 2.9 Hz, CH), 129.4 (CH), 131.3 (CH), 
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132.8 (d, 2JP-C = 18.1 Hz, CH, Po-Ph), 133.9 (d, 2JP-C = 20.5 Hz, CH, Po-Ph), 134.1 (d, 1JP-C = 
9.2 Hz, C, i-Ph), 135.2 (d, 1JP-C = 16.0 Hz, C, i-Ph), 135.34 (CH), 135.37 (CH), 135.5 (C), 
136.0 (C), 136.1 (C), 137.2 (d, 2JP-C = 8.1 Hz, C, PCHi-Ph), 143.4 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 2.26 (s). 
 
Optical rotation: [α]D –61.3 (c 0.16, CH2Cl2). 
 
10.7. (+)-Diphenyl((S)-1-phenyl-2-((S)-N-tert-butyl(diphenyl)silyl-S-
phenylsulfonimidoyl)ethyl)phosphine (88) 
S
ON PSi
 
88 
C42H42NOPSSi 
MW = 667.91 g.mol-1 
 
Following GP-4, phosphine 88 was prepared starting from the phophine borane 81 (118 mg, 
173 µmol) and DABCO (21 mg, 187 µmol) in toluene (3 mL). Purification by column 
chromatography afforded phosphine 88 (107 mg, 93%) as a white foam. 
 
1H NMR (400 MHz, CDCl3): δ = 1.04 (s, 9H, C(CH3)3), 3.39 (ddd, 2JH-H = 14.4 Hz, 3JP-H = 
7.6 Hz, 3JH-H = 1.3 Hz, 1H, SCH2), 3.76 (ddd, 2JH-H = 14.4 Hz, 3JH-H = 12.1 Hz, 3JP-H = 2.1 Hz, 
1H, SCH2), 4.09 (m, 1H, SCH2CH), 6.60 (m, 2H), 6.81 (m, 2H), 6.89 (m, 3H), 7.04 (m, 4H), 
7.15 (m, 1H), 7.18–7.46 (m, 14H), 7.64 (m, 2H), 7.74 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 19.4 (C, C(CH3)3), 27.2 (CH3, C(CH3)3), 40.6 (d, 1JP-C = 
18.3 Hz, CH, SCH2CH), 62.0 (d, 2JP-C = 21.5 Hz, CH2, SCH2), 126.0 (d, JP-C = 2.5 Hz, CH), 
127.0 (CH), 127.2 (CH), 127.5 (CH), 127.6 (CH), 127.7 (d, JP-C = 6.7 Hz, CH), 127.8 (CH), 
128.4 (CH), 128.5 (CH), 128.60 (CH), 128.62 (CH), 128.67 (d, JP-C = 2.2 Hz, CH), 129.4 
(CH), 131.3 (CH), 132.9 (d, 2JP-C = 18.3 Hz, CH, Po-Ph), 133.9 (d, 2JP-C = 20.8 Hz, CH, Po-
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Ph), 134.2 (d, 1JP-C = 17.2 Hz, C, i-Ph), 135.2 (d, 1JP-C = 16.1 Hz, C, i-Ph), 135.43 (CH), 
135.46 (CH), 136.0 (C), 136.1 (C), 136.6 (d, 2JP-C = 7.9 Hz, C, PCHi-Ph), 142.9 (C). 
 
31P NMR (162 MHz, CDCl3): δ = 2.43 (s). 
 
Melting point: 76 °C. 
 
Optical rotation: [α]D +109 (c 0.1, CH2Cl2). 
 
10.8. (+)-Diphenyl((1R,2R)-2-((S)-N-methyl-S-phenylsulfonimidoyl)cyclohexyl) 
phosphine (139) 
S
ON PH3C
 
139 
C25H28NOPS 
MW = 421.53 g.mol-1 
 
Following GP-4, phosphine 139 was prepared starting from the phophine borane 120 (112 mg, 
258 µmol) and DABCO (32 mg, 285 µmol) in toluene (3 mL). Purification by column 
chromatography afforded phosphine 139 (105 mg, 97%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 1.37 (bd, J = 14.3 Hz, 1H), 1.56 (bd, J = 10.3 Hz, 2H), 
1.81–2.36 (m, 5H), 2.68 (s, 3H, NCH3), 3.04 (bt, J = 6.5 Hz, 1H, SCH), 3.94 (bs, 1H, 
SCHCHP), 7.31 (m, 6H), 7.49 (m, 5H), 6.65 (m, 4H). 
 
13C NMR (100 MHz, CDCl3): δ = 21.0 (CH2), 21.2 (d, JP-C = 8.2 Hz, CH2), 21.8 (d, JP-C = 5.1 
Hz, CH2), 22.7 (d, JP-C = 11.2 Hz, CH2), 29.7 (CH3, NCH3), 30.4 (d, 1JP-C = 14.0 Hz, CH, 
SCHCHP), 60.4 (d, 2JP-C = 17.6 Hz, CH, SCH), 128.2 (d, JP-C = 7.7 Hz, CH), 128.4 (d, JP-C = 
7.5 Hz, CH), 128.8 (CH), 128.96 (CH), 128.97 (CH), 129.6 (CH), 132.1 (CH), 133.5 (d, JP-C 
= 15.1 Hz, CH), 133.7 (d, JP-C = 15.2 Hz, CH), 136.2 (d, 1JP-C = 44.6 Hz, C, i-Ph), 136.3 (d, 
1JP-C = 46.4 Hz, C, i-Ph), 137.5 (C, Si-Ph). 
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31P NMR (162 MHz, CDCl3): δ = –12.79 (s). 
 
Melting point: 122 °C. 
 
Optical rotation: [α]D +207 (c 0.10, CH2Cl2) 
 
 
10.9.  (−)-Diphenyl((1S,2S)-2-((S)-N-methyl-S-phenylsulfonimidoyl)cyclohexyl) 
phosphine (141) 
S
ON PH3C
 
141 
C25H28NOPS 
MW = 421.53 g.mol-1 
 
Following GP-4, phosphine 141 was prepared starting from the phophine borane 121 (71 mg, 
163 µmol) and DABCO (20 mg, 178 µmol) in toluene (2.5 mL). Purification by column 
chromatography afforded phosphine 141 (63 mg, 91%) as a sticky syrup. 
 
1H NMR (400 MHz, CDCl3): δ = 1.40 (m, 1H), 1.64 (m, 2H), 1.91 (m, 1H), 1.99–2.22 (m, 
2H), 2.55 (m, 1H), 2.60 (s, 3H, NCH3), 2.70 (bd, J = 14.2 Hz, 1H), 2.91 (bt, J = 6.1 Hz, 1H, 
SCH), 2.99 (bs, 1H, SCHCHP), 7.01 (m, 2H), 7.09 (m, 2H), 7.23 (m, 1H), 7.29 (m, 3H), 7.36 
(m, 2H), 7.43 (m, 2H), 7.58 (m, 3H). 
 
13C NMR (100 MHz, CDCl3): δ = 21.3 (d, JP-C = 7.8 Hz, CH2), 21.61 (d, JP-C = 3.4 Hz, CH2), 
21.63 (CH2), 22.2 (d, JP-C = 12.0 Hz, CH2), 29.7 (CH3, NCH3), 31.3 (d, 2JP-C = 15.6 Hz, CH, 
SCHCHP), 60.0 (d, 1JP-C = 16.9 Hz, CH, SCH), 128.3 (d, JP-C = 7.6 Hz, CH), 128.4 (d, JP-C = 
7.9 Hz, CH), 128.9 (CH), 129.0 (CH), 129.1 (CH), 129.8 (CH), 132.1 (CH), 133.2 (d, JP-C = 
17.0 Hz, CH), 133.4 (d, JP-C = 17.6 Hz, CH), 135.4 (d, 1JP-C = 15.1 Hz, C, i-Ph), 135.5 (d,   
1JP-C = 14.8 Hz, C, i-Ph), 136.9 (C, Si-Ph). 
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31P NMR (162 MHz, CDCl3): δ = –13.67 (s). 
 
Optical rotation: [α]D –11.42 (c 0.22, CH2Cl2) 
 
 
10.10. (+)-Diphenyl((1R,2R)-2-((S)-N-benzyl-S-
phenylsulfonimidoyl)cyclohexyl) phosphine (140) 
S
ON P
 
140 
C31H32NOPS 
MW = 497.63 g.mol-1 
 
Following GP-4, phosphine 140 was prepared starting from the phophine borane 122 (200 mg, 
391 µmol) and DABCO (48 mg, 428 µmol) in toluene (6 mL). Purification by column 
chromatography afforded phosphine 140 (63 mg, 97%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 1.38 (m, 1H), 1.58 (m, 2H), 1.80 (bd, J = 14.9 Hz, 1H), 
1.93 (m, 1H), 2.06 (m, 1H), 2.18 (m, 1H), 2.38 (m, 1H), 3.15 (m, 1H, SCH), 3.97 (d, 2JH-H = 
15.0 Hz, 1H, NCH2Ph), 4.14 (bs, 1H, SCHCHP), 4.32 (d, 2JH-H = 15.0 Hz, 1H, NCH2Ph), 
7.23−7.38 (m, 9H), 7.43 (m, 4H), 7.51 (m, 3H), 7.64 (m, 2H), 7.72 (m, 2H). 
 
13C NMR (100 MHz, CDCl3): δ = 19.8 (CH2), 20.1 (d, JP-C = 8.0 Hz, CH2), 20.8 (d, JP-C = 5.0 
Hz, CH2), 21.7 (d, JP-C = 11.0 Hz, CH2), 29.4 (d, 1JP-C = 13.8 Hz, CH, SCHCHP), 46.0 (CH2, 
NCH2Ph), 59.4 (d, 2JP-C = 18.0 Hz, CH, SCH), 125.0 (CH), 126.0 (CH), 126.8 (CH), 127.3 (d, 
JP-C =7.7 Hz, CH), 127.4 (d, JP-C =7.4 Hz, CH), 127.92 (CH), 127.97 (CH), 128.04 (CH), 
128.7 (CH), 131.1 (CH), 132.2 (d, JP-C = 10.6 Hz, CH), 132.4 (d, JP-C = 11.2 Hz, CH), 135.1 
(d, 1JP-C = 30.7 Hz, C, i-Ph), 135.3 (d, 1JP-C = 32.1 Hz, C, i-Ph), 136.6 (C, Si-Ph), 141.0 (C, 
NCH2i-Ph). 
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31P NMR (162 MHz, CDCl3): δ = –13.09 (s). 
 
MS (EI): m/z (%) = 451 (5), 357 (11), 283 (7), 268 (31), 267 (66), 266 (100), 265 (28), 232 
(13), 215 (8), 183 (14), 106 (20), 91 (13). 
 
MS (CI, isobutane): m/z (%) = 498 [M++1] (4), 391 (6), 268 (20), 267 (100), 266 (7). 
 
MS (ESI–MS, dissolved in CH2Cl2 and diluted with MeOH): m/z (%) = 536 [M++39] and/or 
[M(O)++23] (100), 520 [M++23] (72), 375 (12), 297 (13), 283 (10), 185 (6). 
MS (ESI–MS, dissolved in CH2Cl2 and diluted with MeOH, 1 hour later): m/z (%) = 536 
[M++39] and/or [M(O)++23] (100), 520 [M++23] (29), 375 (19), 297 (25), 283 (55), 267 (14), 
185 (3). 
 
 
HRMS (ESI–TOF): C31H33NOPS Calculated Found 
[M++1] 498.2015 498.2009 CH3CN−H2O + 
0.1%HCO2H 
   
 
Melting point: 129 °C. 
 
Optical rotation: [α]D +78.0 (c 0.10, CH2Cl2). 
 
10.11. (–)-Diphenyl((1S,2S)-2-((S)-N-benzyl-S-phenylsulfonimidoyl)cyclohexyl) 
phosphine (142) 
S
ON P
 
142 
C31H32NOPS 
MW = 497.63 g.mol-1 
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Following GP-4, phosphine 142 was prepared starting from the phophine borane 123 (78 mg, 
153 µmol) and DABCO (18 mg, 160 µmol) in toluene (2.5). Purification by column 
chromatography afforded phosphine 142 (71 mg, 93%) as a white solid. 
 
1H NMR (400 MHz, CDCl3): δ = 1.40 (m, 1H), 1.57–1.73 (m, 2H), 1.93 (m, 1H), 2.15 (m, 
2H), 2.58 (m, 1H), 2.76 (m, 1H), 2.98 (m, 1H, SCH), 3.13 (bs, 1H, SCHCHP), 3.91 (d, 2JH-H = 
14.8 Hz, 1H, NCH2Ph), 4.23 (d, 2JH-H = 14.8 Hz, 1H, NCH2Ph), 7.09 (m, 4H), 7.17 (m, 1H), 
7.20−7.49 (m, 12H), 7.56−7.65 (m, 3H). 
 
13C NMR (75 MHz, CDCl3): δ = 20.3 (d, JP-C = 7.6 Hz, CH2), 20.5 (CH2), 20.8 (d, JP-C = 4.8 
Hz, CH2), 21.3 (d, JP-C = 11.8 Hz, CH2), 30.1 (d, 1JP-C = 15.5 Hz, CH, SCHCHP), 46.0 (CH2, 
NCH2Ph), 59.4 (d, 2JP-C = 17.1 Hz, CH, SCH), 125.0 (CH), 126.1 (CH), 126.8 (CH), 127.3 (d, 
JP-C = 7.7 Hz, CH), 127.4 (d, JP-C = 7.8 Hz, CH), 127.45 (d, JP-C = 7.5 Hz, CH), 127.93 (CH), 
127.98 (CH), 128.05 (CH), 128.7 (CH), 131.2 (CH), 132.2 (d, JP-C = 10.6 Hz, CH), 132.4 (d, 
JP-C = 11.5 Hz, CH), 134.4 (d, 1JP-C = 33.1 Hz, C, i-Ph), 134.6 (d, 1JP-C = 33.1 Hz, C, i-Ph), 
136.8 (C, Si-Ph), 140.7 (C, NCH2i-Ph). 
 
31P NMR (162 MHz, CDCl3): δ = −13.48 (s). 
 
Melting point: 89 °C. 
 
Optical rotation: [α]D –34.0 (c 0.10, CH2Cl2). 
 
11. Allylic Substitution 
11.1. (+)-(R)-(E)-Dimethyl 2-(1,3-diphenylallyl)malonate (44) 
 
CO2MeMeO2C
 
44 
MW = 324.37 g.mol-1 
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Following GP-5, the malonate 44 was prepared starting from the racemic acetate 43 (120 mg, 
480 µmol), phophine 140 (7.1 mg, 14 µmol), Pd2DBA3.CHCl3 (7.4 mg, 7 µmol), dimethyl 
malonate (138 µL, 1.19 mmol), N,O-bis(trimethylsilyl)acetamide (320 µL, 1.19 mmol) and 
lithium acetate (1mg) in CH2Cl2 (3 mL). After stirring the mixture for 50 min (complete 
conversion by TLC), it was quenched and worked up as described in GP-5. Purification by 
column chromatography (cyclohexane/ethylacetate, 9:1) gave malonate 44 (151 mg, 98%) 
with 97% ee as colourless viscous oil, which solidified upon standing. The ee value was 
determined by HPLC (chiralcel-OD-H column, detector 254 nm, n-heptane/isopropanol: 95/5, 
flow: 0.75 ml/min, 40 bar, Rt (44): 15.28 min; Rt (ent-44): 19.53 min). 
 
11.2. (+)-(R)-(E)-dimethyl 2-(pent-3-en-2-yl)malonate (145) 
 
Me Me
CO2MeMeO2C
 
145 
MW = 200.23 g.mol-1 
 
Following GP-5, malonate 145 was prepared starting from the racemic acetate 144 (61 mg, 
480 µmol), phophine 140 (7.1 mg, 14 µmol), Pd2DBA3.CHCl3 (7.4 mg, 7 µmol), dimethyl 
malonate (138 µL, 1.19 mmol), N,O-bis(trimethylsilyl)acetamide (320 µL, 1.19 mmol) and 
lithium acetate (1mg) in CH2Cl2 (3 mL). After the mixture for 3.5 h (complete conversion by 
TLC), it was quenched and worked up as described in GP-5. Purification by column 
chromatography (pentane/Et2O, 8:1) gave malonate 145 (90 mg, 95%) with 59% ee as 
colourless viscous oil. The ee value was determined by GC (β-cyclodextrine CP column, 
temperature programme 1, Rt (ent-145): 32.82 min; Rt (145): 32.92 min). 
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11.3. (+)-(R)-Dimethyl 2-(cyclohex-2-enyl)malonate (96) 
 
CO2MeMeO2C
 
96 
MW = 212.23 g.mol-1 
 
Following GP-5, malonate 96 was prepared starting from the racemic acetate 95 (61 mg, 
480 µmol), phophine 140 (7.1 mg, 14 µmol), Pd2DBA3.CHCl3 (7.4 mg, 7 µmol), dimethyl 
malonate (138 µL, 1.19 mmol), N,O-bis(trimethylsilyl)acetamide (320 µL, 1.19 mmol) and 
lithium acetate (1mg) in CH2Cl2 (3 mL). After the mixture for 24 h (complete conversion by 
TLC), it was quenched and worked up as described in GP-5. Purification by column 
chromatography (pentane/Et2O, 10:1) gave malonate 96 (71 mg, 70%) with 36% ee as 
colourless viscous oil. The ee value was determined by GC (β-cyclodextrine CP column, 
temperature programme 2, Rt (ent-96): 25.30 min; Rt(96): 25.48 min).191 
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12.  Isotopic distribution and simulated isotopic patterns  
 
Figure 31: Isotopic distribution (top) and simulated isotopic pattern (bottom) of complex 146. 
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Figure 32: Isotopic distribution (top) and simulated isotopic pattern (bottom) of complex 147.  
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Figure 33: Isotopic distribution (top) and simulated isotopic pattern (bottom) of complex 149. 
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13.  X-ray Crystal Structure Reports 
13.1. X-ray Crystal Structure Report of (+)-Diphenyl((1S)-1-phenyl-2-((R)-N-
methyl-S-phenylsulfonimidoyl)ethyl)phosphine borane (ent-62) 
 
 
 
 
Experimental Details 
Crystal data: 
Chemical formula : (C27H29BNOPS)2 (two symm. indep. molecules in the asymm. 
unit) 
formula weight  : 914.77 
Crystal system  : monochlinic 
Space group (No.)  : P21 (4) 
Z    : 4 
a (Å)    : 12.1863(3) 
b (Å)    : 16.9072(4) 
c (Å)    : 12.3813(6) 
α  (°)    : 90.0 
β  (°)    : 100.811(1) 
γ (°)    : 90.0 
cell volume   : 2505.7(1)Å3 
Density calc.   : 1.212g/cm3 
Radiation   : CuKα (1.54179Å) 
Range for lattice parameters : <Θ < 
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Absorption coefficient : 1.886mm-1 
Temperature   : 100K 
Crystal source   : recrystallized from CH2Cl2/hexane  
Crystal colour   : colourless 
Crystal shape   : irregular 
Crystal size   : ca. 0.6 x 0.6 x 0.6mm 
 
Data Collection 
Diffractometer type  : Bruker Proteum X8 mit FR591 Drehanode, Pt135  
  CCD-Detektor 
 
collection method  :  
Absorption correction : SADABS 
No. of reflections measured : 73137 
No. of independent reflections: 8935 
No. of observed reflections : 7841 
 Θ max  (Ε)   : 68.04 
hmin 6 hmax   :   - 14    6   14 
kmin 6 kmax   :   - 20    6   20 
lmin 6  lmax   :   - 14    6   14 
 
Criterion for observed : I > 2σ (I ) 
Rint    : 0.02(2) 
Standard reflections  :   
Variation   :  
Refinement:  
On    : F 
Treatment of hydrogens : Calculated in idealized positions. Us fixed at 1.5×U of the  
corresponding heavy atom prior to final refinement. No 
refinement of hydrogen parameters.    
R    : 0.042 
Rw    : 0.050 
Weighting scheme  : w=1/σ2(F) 
No. of parameters refined : 577 
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No. of reflections in refmnt. : 7841 
Residual electron density : -1.06/0.34e/Å3  
r*[1]    : not refined 
XABS[2]   : 0.016(18)  
Goodness of fit  : 3.291 
Solution   : XTAL3.7[3] 
Remarks   : 192 
 
Definitions: 
Ueq = 1/3ΣiΣjUijai*aj*ai aj 
The anisotropic displacement factor in the structure factor expression is: 
t = exp[-2π2(ΣiΣjUijhihjai*aj* )] 
 
 
13.2. X-ray Crystal Structure Report of (–)-Diphenyl((R)-1-phenyl-2-((S)-N-
tert-butyl(diphenyl)silyl-S-phenylsulfonimidoyl)ethyl) phosphine borane 
(80) 
 
 
 
 
 
EXPERIMENTAL PART 
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Experimental Details 
Crystal data: 
Chemical formula  : (C42H45BNOPSSi)2 
formula weight  : 1363.53 
Crystal system  : triclinic 
Space group (No.)  : P1 (1) 
Z    : 1 
a (Å)    : 9.8937(8) 
b (Å)    : 10.0435(8) 
c (Å)    : 19.1219(15) 
α  (°)    : 86.839(1) 
β  (°)    : 83.024(1) 
γ (°)    : 84.547(1) 
cell volume   : 1875.7(3)Å3 
Density calc.   : 1.207g/cm3 
Radiation   : MoKα (0.71073Å) 
Range for lattice parameters : Ε<Θ <Ε 
Absorption coefficient : 0.194mm-1 
Temperature   : 298K 
Crystal source   : recrystallized from   
Crystal colour   : colourless 
Crystal shape   : irregular 
Crystal size   : ca. 0.2x0.2.x0.2mm 
 
Data Collection 
Diffractometer type  : Bruker SMART APEX 
collection method  : ϕ and ω scans 
Absorption correction : SADABS (1.0 : 0.9184) 
No. of reflections measured : 79548 
No. of independent reflections: 15492 
No. of observed reflections : 15170 
 Θ max  (Ε)   : 26.47 
hmin 6 hmax   :   -  12    6  12 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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kmin 6 kmax   :   - 12    6  12 
lmin 6  lmax   :   - 23    6  23 
 
Criterion for observed : I > 2σ (I ) 
Rint    : 0.022(30) 
Standard reflections  : 
Variation   : 
Refinement:  
On    : F 
Treatment of hydrogens : Calculated and not refined. Us fixed at 1.5 times U of the 
relevant heavy atom before final refinement. 
R    : 0.036 
Rw    : 0.038 
Weighting scheme  : w=1/σ2(F) 
No. of parameters refined : 865 
No. of reflections in refmnt. : 15170 
Residual electron density : -0.31/0.42e/Å3  
r*[1]    : not refined 
XABS[2]a)   : -0.012(53)a)  
Goodness of fit  : 1.867 
Solution   : XTAL3.7[3] 
Remarks   : a)From separate calculation 
 
Definitions: 
Ueq = 1/3ΣiΣjUijai*aj*ai aj 
The anisotropic displacement factor in the structure factor expression is: 
t = exp[-2π2(ΣiΣjUijhihjai*aj* )] 
 
 
 
 
 
EXPERIMENTAL PART 
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13.3. X-ray Crystal Structure Report of (+)-Diphenyl((1R,2R)-2-((S)-N-benzyl-
S-phenylsulfonimidoyl)cyclohexyl)phosphine borane (122) 
 
 
 
Experimental Details 
Crystal data: 
Chemical formula  : (C31H35BNOPS)2 two symmetrically independent molecules in  
    the asymmetric unit 
formula weight  : 2×511.48 
Crystal system  : monoclinic 
Space group (No.)  :  P21 (4) 
Z    : 2 
a (Å)    : 11.516(4) 
b (Å)    : 13.952(1) 
c (Å)    : 18.732(4) 
α  (°)    : 90.0 
β  (°)    : 107.01(1) 
γ (°)    : 90.0 
cell volume   : 2878.0(12)Å3 
Density calc.   : 1.180g/cm3 
Radiation   : CuKα (1.54179Å) 
Range for lattice parameters : 14.23Ε< Θ <36.24Ε 
Absorption coefficient : 1.693 mm-1 
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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Temperature   : 298K 
Crystal source   : recrystallized from Et2O 
Crystal colour   : colourless 
Crystal shape   : irregular 
Crystal size   : ca. 0.3x0.3.x0.3mm 
 
Data Collection 
Diffractometer type  : Enraf-Nonius CAD4 
collection method  : ω/2ϑ scans 
Absorption correction : none 
No. of reflections measured : 11201 
No. of independent reflections: 10387 
No. of observed reflections : 9709 
 Θ max  (Ε)   : 67.76 
hmin 6 hmax   :   - 13    6   13 
kmin 6 kmax   :   - 16    6   16 
lmin 6  lmax   :   - 22    6   22 
Criterion for observed : I > 2σ (I ) 
Rint    : 0.023(36) 
Standard reflections  : 2    3   -6, -2   -3    6, 2    2    -5 
Variation   : 6071(159) 6180(171) 14031(387) 
 
Refinement:  
On    : F 
Treatment of hydrogens : Calculated in idealized positions. Us fixed at 1.5×U of the 
corresponding heavy atom. No refinement of hydrogen 
parameters 
 
R    : 0.060 
Rw    : 0.077 
Weighting scheme  : w=1/σ2(F) 
No. of parameters refined : 648 
No. of reflections in refmnt. : 9702 
Residual electron density : -0.53/0.34e/Å3  
EXPERIMENTAL PART 
‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾‾ 
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r*[1]    : not refined 
XABS[2]   : 0.0190(245)  
Goodness of fit  : 2.818 
Solution   : XTAL3.7[3] 
Remarks   : 192 
 
Definitions: 
Ueq = 1/3ΣiΣjUijai*aj*ai aj 
The anisotropic displacement factor in the structure factor expression is: 
t = exp[-2π2(ΣiΣjUijhihjai*aj* )] 
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